National Library of Energy BETA

Sample records for anch pet ersburg

  1. Positron Emission Tomography (PET)

    DOE R&D Accomplishments [OSTI]

    Welch, M. J.

    1990-01-01

    Positron emission tomography (PET) assesses biochemical processes in the living subject, producing images of function rather than form. Using PET, physicians are able to obtain not the anatomical information provided by other medical imaging techniques, but pictures of physiological activity. In metaphoric terms, traditional imaging methods supply a map of the body's roadways, its, anatomy; PET shows the traffic along those paths, its biochemistry. This document discusses the principles of PET, the radiopharmaceuticals in PET, PET research, clinical applications of PET, the cost of PET, training of individuals for PET, the role of the United States Department of Energy in PET, and the futures of PET.

  2. Laboratory and cyclotron requirements for PET research

    SciTech Connect (OSTI)

    Schlyer, D.J.

    1993-06-01

    This report describes four types of PET facilities: Clinical PET with no radionuclide production; clinical PET with a small accelerator; clinical PET with research support; and research PET facilities. General facility considerations are also discussed.

  3. Progress reported in PET recycling

    SciTech Connect (OSTI)

    Not Available

    1989-06-01

    The Goodyear Polyester Division has demonstrated its ability to break down polyethylene terephthalate (PET) from recycled plastic soft drink bottles and remanufacture the material into PET suitable for containers. Most people are familiar with PET in the form of lightweight, shatter resistant beverage bottles. About 20 percent of these beverage containers currently are being recycled. The recycled PET is currently used in many applications such as carpeting, pillow stuffing, sleeping bag filling, insulation for water heaters and non-food containers. This is the first step of Goodyear's increased efforts to recycle PET from containers into a material suitable for food packing. The project is extremely complex, involving sophisticated understanding of the chemical reactions involved, PET production and the technology testing protocols necessary to design a process that addresses all the technical, safety, and regulatory concerns. The research conducted so far indicated that additional processing beyond simply cleaning the shredded material, called flake, will be required to assure a quality polymer.

  4. SynchroPET LLC | Department of Energy

    Energy Savers [EERE]

    SynchroPET LLC America's Next Top Energy Innovator Challenge 665 likes SynchroPET LLC Brookhaven National Laboratory Two of our devices have pre-clinical applications that can be very useful for drug development and research The RatCAP is a miniature PET scanner allows whole brain imaging in fully conscious rats for the first time. By far the world's smallest and lightest PET scanner, it is the only PET system able to be mounted on the head of a lab rat, allowing for the first-time functional

  5. Development of PET/MRI with insertable PET for simultaneous PET and MR imaging of human brain

    SciTech Connect (OSTI)

    Jung, Jin Ho; Choi, Yong Jung, Jiwoong; Kim, Sangsu; Lim, Hyun Keong; Im, Ki Chun; Oh, Chang Hyun; Park, Hyun-wook; Kim, Kyung Min; Kim, Jong Guk

    2015-05-15

    Purpose: The purpose of this study was to develop a dual-modality positron emission tomography (PET)/magnetic resonance imaging (MRI) with insertable PET for simultaneous PET and MR imaging of the human brain. Methods: The PET detector block was composed of a 4 × 4 matrix of detector modules, each consisting of a 4 × 4 array LYSO coupled to a 4 × 4 Geiger-mode avalanche photodiode (GAPD) array. The PET insert consisted of 18 detector blocks, circularly mounted on a custom-made plastic base to form a ring with an inner diameter of 390 mm and axial length of 60 mm. The PET gantry was shielded with gold-plated conductive fabric tapes with a thickness of 0.1 mm. The charge signals of PET detector transferred via 4 m long flat cables were fed into the position decoder circuit. The flat cables were shielded with a mesh-type aluminum sheet with a thickness of 0.24 mm. The position decoder circuit and field programmable gate array-embedded DAQ modules were enclosed in an aluminum box with a thickness of 10 mm and located at the rear of the MR bore inside the MRI room. A 3-T human MRI system with a Larmor frequency of 123.7 MHz and inner bore diameter of 60 cm was used as the PET/MRI hybrid system. A custom-made radio frequency (RF) coil with an inner diameter of 25 cm was fabricated. The PET was positioned between gradient and the RF coils. PET performance was measured outside and inside the MRI scanner using echo planar imaging, spin echo, turbo spin echo, and gradient echo sequences. MRI performance was also evaluated with and without the PET insert. The stability of the newly developed PET insert was evaluated and simultaneous PET and MR images of a brain phantom were acquired. Results: No significant degradation of the PET performance caused by MR was observed when the PET was operated using various MR imaging sequences. The signal-to-noise ratio of MR images was slightly degraded due to the PET insert installed inside the MR bore while the homogeneity was maintained. The change of gain of the 256 GAPD/scintillator elements of a detector block was <3% for 60 min, and simultaneous PET and MR images of a brain phantom were successfully acquired. Conclusions: Experimental results indicate that a compact and lightweight PET insert for hybrid PET/MRI can be developed using GAPD arrays and charge signal transmission method proposed in this study without significant interference.

  6. SynchroPET LLC | Department of Energy

    Broader source: Energy.gov (indexed) [DOE]

    65 likes SynchroPET LLC Brookhaven National Laboratory Two of our devices have pre-clinical applications that can be very useful for drug development and research The RatCAP is a miniature PET scanner allows whole brain imaging in fully conscious rats for the first time. By far the world's smallest and lightest PET scanner, it is the only PET system able to be mounted on the head of a lab rat, allowing for the first-time functional images of the whole brain during the rat's typical behavior.

  7. The Heritage of Radiotracers for PET

    DOE R&D Accomplishments [OSTI]

    Fowler, J. S.; Wolf, A. P.

    1988-05-01

    The history of PET research clearly demonstrates that it is advances in chemistry coupled with a detailed examination of the biochemistry of new radiotracers which has allowed the PET method to be applied to new areas of biology and medicine. Radiotracers whose regional distribution reflects glucose metabolism, neutrotransmitter activity and enzyme activity have all required the development of rapid synthetic methods for the radiotracers themselves and the characterization of their biochemical behavior. This article traces some of the advances in the production of labeled precursors and in radiotracer synthesis and evaluation which have shaped the rapidly expanding application of PET to problems in the neurosciences, in cardiology and in oncology.

  8. PET

    ScienceCinema (OSTI)

    None

    2011-04-25

    le DG fait l'introduction et laisse la parole à plusieurs intervenants au sujet de la physique des particules

  9. Combined PET/MRI scanner

    DOE Patents [OSTI]

    Schlyer, David (Bellport, NY); Woody, Craig L. (Setauket, NY); Rooney, William (Miller Place, NY); Vaska, Paul (Sound Beach, NY); Stoll, Sean (Wading River, NY); Pratte, Jean-Francois (Stony Brook, NY); O'Connor, Paul (Bellport, NY)

    2007-10-23

    A combined PET/MRI scanner generally includes a magnet for producing a magnetic field suitable for magnetic resonance imaging, a radiofrequency (RF) coil disposed within the magnetic field produced by the magnet and a ring tomograph disposed within the magnetic field produced by the magnet. The ring tomograph includes a scintillator layer for outputting at least one photon in response to an annihilation event, a detection array coupled to the scintillator layer for detecting the at least one photon outputted by the scintillator layer and for outputting a detection signal in response to the detected photon and a front-end electronic array coupled to the detection array for receiving the detection signal, wherein the front-end array has a preamplifier and a shaper network for conditioning the detection signal.

  10. Positron Emission Tomography (PET) and Positron Scanning

    Office of Scientific and Technical Information (OSTI)

    Positron Emission Tomography (PET) and Positron Scanning Resources with Additional Information Positron Emission Tomography (PET) Scanner Courtesy Lawrence Berkeley National Laboratory 'Positron Emission Tomography ... [is a medical imaging technique that] can track chemical reactions in living tissues and merges chemistry with biological imaging. Its strength has been in studies of the brain where there has been significant progress in investigations of drug addiction, aging, mental illness,

  11. PRODUCTION CONSIDERATIONS FOR THE CLASSICAL PET NUCLIDES.

    SciTech Connect (OSTI)

    FINN,R.; SCHLYER,D.

    2001-06-25

    Nuclear Medicine is the specialty of medical imaging, which utilizes a variety of radionuclides incorporated into specific compounds for diagnostic imaging and therapeutic applications. During recent years, research efforts associated with this discipline have concentrated on the decay characteristics of particular radionuclides and the design of unique radiolabeled tracers necessary to achieve time-dependent molecular images. The specialty is expanding with specific Positron emission tomography (PET) and SPECT radiopharmaceuticals allowing for an extension from functional process imaging in tissue to pathologic processes and nuclide directed treatments. PET is an example of a technique that has been shown to yield the physiologic information necessary for clinical oncology diagnoses based upon altered tissue metabolism. Most PET drugs are currently produced using a cyclotron at locations that are in close proximity to the hospital or academic center at which the radiopharmaceutical will be administered. In November 1997, a law was enacted called the Food and Drug Administration Modernization Act of 1997 which directed the Food and Drug Administration (FDA) to establish appropriate procedures for the approval of PET drugs in accordance with section 505 of the Federal Food, Drug, and Cosmetic Act and to establish current good manufacturing practice requirements for such drugs. At this time the FDA is considering adopting special approval procedures and cGMP requirements for PET drugs. The evolution of PET radiopharmaceuticals has introduced a new class of ''drugs'' requiring production facilities and product formulations that must be closely aligned with the scheduled clinical utilization. The production of the radionuclide in the appropriate synthetic form is but one critical component in the manufacture of the finished radiopharmaceutical.

  12. Modular strategies for PET imaging agents

    SciTech Connect (OSTI)

    Hooker, , J.M.

    2010-03-01

    In recent years, modular and simplified chemical and biological strategies have been developed for the synthesis and implementation of positron emission tomography (PET) radiotracers. New developments in bioconjugation and synthetic methodologies, in combination with advances in macromolecular delivery systems and gene-expression imaging, reflect a need to reduce radiosynthesis burden in order to accelerate imaging agent development. These new approaches, which are often mindful of existing infrastructure and available resources, are anticipated to provide a more approachable entry point for researchers interested in using PET to translate in vitro research to in vivo imaging.

  13. Miniature 'Wearable' PET Scanner Ready for Use

    ScienceCinema (OSTI)

    Paul Vaska

    2013-07-22

    Scientists from BNL, Stony Brook University, and collaborators have demonstrated the efficacy of a "wearable," portable PET scanner they've developed for rats. The device will give neuroscientists a new tool for simultaneously studying brain function and behavior in fully awake, moving animals.

  14. Integrated X-Ray Reflectivity Measurements for Elliptically Curved PET

    Office of Scientific and Technical Information (OSTI)

    Crystals (Conference) | SciTech Connect Integrated X-Ray Reflectivity Measurements for Elliptically Curved PET Crystals Citation Details In-Document Search Title: Integrated X-Ray Reflectivity Measurements for Elliptically Curved PET Crystals Spectroscopy provides valuable information about the temperature and density of a compressed pellet in a plasma. Elliptically curved pentaerythritol (PET) crystals are used as components for spectrometers. Their elliptical geometry gives several

  15. Integrated X-ray Reflectivity Measurements for Elliptically Curved PET

    Office of Scientific and Technical Information (OSTI)

    Crystals (Conference) | SciTech Connect ray Reflectivity Measurements for Elliptically Curved PET Crystals Citation Details In-Document Search Title: Integrated X-ray Reflectivity Measurements for Elliptically Curved PET Crystals The elliptically curved pentaerythritol (PET) crystals used in the Supersnout 2 X-ray spectrometer on the National Ignition Facility (NIF) at Lawrence Livermore National Laboratory (LLNL) have been calibrated photometrically in the range of 5.5 to 16 keV. The

  16. The Dog Days of Summer - Capitalizing on the Pet Market

    Office of Energy Efficiency and Renewable Energy (EERE) Indexed Site

    Dog Days of Summer - Capitalizing on the Pet Market July 9, 2015 Call Slides and Discussion Summary Agenda  Call Logistics and Opening Poll #1  Introductions  Residential Network and Peer Exchange Call Overview  Opening Poll #2 and #3  Setting the Stage: Pet Market Statistics  Featured Speaker  Julie Saporito, Program Administrator, City and County of Denver (Network Member)  Discussion  What opportunities exist for leveraging the pet market to promote residential

  17. High-Resolution PET Detector. Final report

    SciTech Connect (OSTI)

    Karp, Joel

    2014-03-26

    The objective of this project was to develop an understanding of the limits of performance for a high resolution PET detector using an approach based on continuous scintillation crystals rather than pixelated crystals. The overall goal was to design a high-resolution detector, which requires both high spatial resolution and high sensitivity for 511 keV gammas. Continuous scintillation detectors (Anger cameras) have been used extensively for both single-photon and PET scanners, however, these instruments were based on NaI(Tl) scintillators using relatively large, individual photo-multipliers. In this project we investigated the potential of this type of detector technology to achieve higher spatial resolution through the use of improved scintillator materials and photo-sensors, and modification of the detector surface to optimize the light response function.We achieved an average spatial resolution of 3-mm for a 25-mm thick, LYSO continuous detector using a maximum likelihood position algorithm and shallow slots cut into the entrance surface.

  18. Sinking a Pet's Teeth into Energy Saving | Department of Energy

    Energy Savers [EERE]

    Sinking a Pet's Teeth into Energy Saving Sinking a Pet's Teeth into Energy Saving August 28, 2012 - 11:23am Addthis Ernie Tucker Editor, National Renewable Energy Laboratory The Humane Society of the United States cites a recent national survey reporting that Americans own approximately 78 million dogs and 86 million cats. And while feline-lovers might see this as a reason to break out the tuna since they are, well, top cat, there's a more sobering statistic: more than half of our pets are

  19. I 'RADIOPHARNACEUTICALS IN PET, PROGRESS AND PROMISE F

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    4198 1 I 'RADIOPHARNACEUTICALS IN PET, PROGRESS AND PROMISE : F j - c ? R7 ~ . m f* -,.. Alfred P. Wolf and Joanna S. Fowler The PET method is designed to probe human biochemistry and physiology in both normal and pathological states. allow the determination or delineation of these biochemical or physiological parameters in a quantitative manner. The technology is driven by the short half-life of the major positron emitters, carbon-11, nitrogen-13 and fluorine- 18 and oxygen-15 and their

  20. MR-based motion correction for PET imaging using wired active MR microcoils in simultaneous PET-MR: Phantom study

    SciTech Connect (OSTI)

    Huang, Chuan; Brady, Thomas J.; El Fakhri, Georges; Ouyang, Jinsong; Ackerman, Jerome L.; Petibon, Yoann

    2014-04-15

    Purpose: Artifacts caused by head motion present a major challenge in brain positron emission tomography (PET) imaging. The authors investigated the feasibility of using wired active MR microcoils to track head motion and incorporate the measured rigid motion fields into iterative PET reconstruction. Methods: Several wired active MR microcoils and a dedicated MR coil-tracking sequence were developed. The microcoils were attached to the outer surface of an anthropomorphic{sup 18}F-filled Hoffman phantom to mimic a brain PET scan. Complex rotation/translation motion of the phantom was induced by a balloon, which was connected to a ventilator. PET list-mode and MR tracking data were acquired simultaneously on a PET-MR scanner. The acquired dynamic PET data were reconstructed iteratively with and without motion correction. Additionally, static phantom data were acquired and used as the gold standard. Results: Motion artifacts in PET images were effectively removed by wired active MR microcoil based motion correction. Motion correction yielded an activity concentration bias ranging from ?0.6% to 3.4% as compared to a bias ranging from ?25.0% to 16.6% if no motion correction was applied. The contrast recovery values were improved by 37%156% with motion correction as compared to no motion correction. The image correlation (mean standard deviation) between the motion corrected (uncorrected) images of 20 independent noise realizations and static reference was R{sup 2} = 0.978 0.007 (0.588 0.010, respectively). Conclusions: Wired active MR microcoil based motion correction significantly improves brain PET quantitative accuracy and image contrast.

  1. Positron Emission Tomography (PET) for Imaging Body Chemistry

    SciTech Connect (OSTI)

    Krohn, Ken

    2001-04-25

    PET is a nuclear medicine technology for imaging chemical processes as they are occurring in the human body. This distinguishes it from conventional radiographic and NMR imaging, which depict anatomic changes that generally occur secondary to chemical changes. As our knowledge about human genomics and molecular biology increases and as we develop new approaches to therapy based on this biochemical information, it becomes increasingly important to be able to image important chemical processes occurring in vivo. Methods exist for imaging metabolic rates for energy utilization, cellular proliferation, and protein synthesis. The sending and receiving function of neurotransmitters can be imaged to test for mismatch in their communication function. Gene transfection can be imaged with PET reporters. All of these approaches allow the physician to better select the appropriate treatment for an individual patient, rather than basing treatment on historical experience for a population of similar patients. The technology for PET requires synthesis of positron emitting radioactive molecules, most commonly labeled with C-11 (20.4m) and F-18 (109.8 m) which are made on site with an accelerator. FNAL was involved in developing new RFQ technology for making PET isotopes. The technology also requires better imaging technology, including scintillators, and more robust algorithms for image reconstruction and data analysis.

  2. Compact and mobile high resolution PET brain imager

    DOE Patents [OSTI]

    Majewski, Stanislaw; Proffitt, James

    2011-02-08

    A brain imager includes a compact ring-like static PET imager mounted in a helmet-like structure. When attached to a patient's head, the helmet-like brain imager maintains the relative head-to-imager geometry fixed through the whole imaging procedure. The brain imaging helmet contains radiation sensors and minimal front-end electronics. A flexible mechanical suspension/harness system supports the weight of the helmet thereby allowing for patient to have limited movements of the head during imaging scans. The compact ring-like PET imager enables very high resolution imaging of neurological brain functions, cancer, and effects of trauma using a rather simple mobile scanner with limited space needs for use and storage.

  3. The Dog Days of Summer - Capitalizing on the Pet Market | Department of

    Energy Savers [EERE]

    Energy Dog Days of Summer - Capitalizing on the Pet Market The Dog Days of Summer - Capitalizing on the Pet Market Better Buildings Residential Network Peer Exchange Call Series: The Dog Days of Summer - Capitalizing on the Pet Market, call slides and discussion summary. PDF icon Call Slides and Discussion Summary More Documents & Publications Leveraging Seasonal Opportunities for Marketing Energy Efficiency Hit the Road: Applying Lessons from National Campaigns to a Local Context (201)

  4. PET computer programs for use with the 88-inch cyclotron

    SciTech Connect (OSTI)

    Gough, R.A.; Chlosta, L.

    1981-06-01

    This report describes in detail several offline programs written for the PET computer which provide an efficient data management system to assist with the operation of the 88-Inch Cyclotron. This function includes the capability to predict settings for all cyclotron and beam line parameters for all beams within the present operating domain of the facility. The establishment of a data base for operational records is also described from which various aspects of the operating history can be projected.

  5. Gamma-ray tracking method for pet systems

    DOE Patents [OSTI]

    Mihailescu, Lucian; Vetter, Kai M.

    2010-06-08

    Gamma-ray tracking methods for use with granular, position sensitive detectors identify the sequence of the interactions taking place in the detector and, hence, the position of the first interaction. The improved position resolution in finding the first interaction in the detection system determines a better definition of the direction of the gamma-ray photon, and hence, a superior source image resolution. A PET system using such a method will have increased efficiency and position resolution.

  6. Validation of a 4D-PET Maximum Intensity Projection for Delineation of an Internal Target Volume

    SciTech Connect (OSTI)

    Callahan, Jason; Kron, Tomas; Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne ; Schneider-Kolsky, Michal; Dunn, Leon; Thompson, Mick; Siva, Shankar; Aarons, Yolanda; Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne ; Binns, David; Hicks, Rodney J.; Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne

    2013-07-15

    Purpose: The delineation of internal target volumes (ITVs) in radiation therapy of lung tumors is currently performed by use of either free-breathing (FB) {sup 18}F-fluorodeoxyglucose-positron emission tomography-computed tomography (FDG-PET/CT) or 4-dimensional (4D)-CT maximum intensity projection (MIP). In this report we validate the use of 4D-PET-MIP for the delineation of target volumes in both a phantom and in patients. Methods and Materials: A phantom with 3 hollow spheres was prepared surrounded by air then water. The spheres and water background were filled with a mixture of {sup 18}F and radiographic contrast medium. A 4D-PET/CT scan was performed of the phantom while moving in 4 different breathing patterns using a programmable motion device. Nine patients with an FDG-avid lung tumor who underwent FB and 4D-PET/CT and >5 mm of tumor motion were included for analysis. The 3 spheres and patient lesions were contoured by 2 contouring methods (40% of maximum and PET edge) on the FB-PET, FB-CT, 4D-PET, 4D-PET-MIP, and 4D-CT-MIP. The concordance between the different contoured volumes was calculated using a Dice coefficient (DC). The difference in lung tumor volumes between FB-PET and 4D-PET volumes was also measured. Results: The average DC in the phantom using 40% and PET edge, respectively, was lowest for FB-PET/CT (DCAir = 0.72/0.67, DCBackground 0.63/0.62) and highest for 4D-PET/CT-MIP (DCAir = 0.84/0.83, DCBackground = 0.78/0.73). The average DC in the 9 patients using 40% and PET edge, respectively, was also lowest for FB-PET/CT (DC = 0.45/0.44) and highest for 4D-PET/CT-MIP (DC = 0.72/0.73). In the 9 lesions, the target volumes of the FB-PET using 40% and PET edge, respectively, were on average 40% and 45% smaller than the 4D-PET-MIP. Conclusion: A 4D-PET-MIP produces volumes with the highest concordance with 4D-CT-MIP across multiple breathing patterns and lesion sizes in both a phantom and among patients. Freebreathing PET/CT consistently underestimates ITV when compared with 4D PET/CT for a lesion affected by respiration.

  7. PET Scans Reveal Key Details of Alzheimer's Protein Growth in Aging

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Brains PET Scans Reveal Key Details of Alzheimer's Protein Growth in Aging Brains The research shows for the first time that PET scans can track the progressive stages of Alzheimer's disease in cognitively normal adults, a key advance in the early diagnosis and staging of the neurodegenerative disorder. Berkeley Lab's William Jagust is the study's principal investigator

  8. Dual energy CT for attenuation correction with PET/CT

    SciTech Connect (OSTI)

    Xia, Ting; Alessio, Adam M.; Kinahan, Paul E.

    2014-01-15

    Purpose: The authors evaluate the energy dependent noise and bias properties of monoenergetic images synthesized from dual-energy CT (DECT) acquisitions. These monoenergetic images can be used to estimate attenuation coefficients at energies suitable for positron emission tomography (PET) and single-photon emission computed tomography (SPECT) imaging. This is becoming more relevant with the increased use of quantitative imaging by PET/CT and SPECT/CT scanners. There are, however, potential variations in the noise and bias of synthesized monoenergetic images as a function of energy. Methods: The authors used analytic approximations and simulations to estimate the noise and bias of synthesized monoenergetic images of water-filled cylinders with different shapes and the NURBS-based cardiac-torso (NCAT) phantom from 40 to 520 keV, the range of SPECT and PET energies. The dual-kVp spectra were based on the GE Lightspeed VCT scanner at 80 and 140 kVp with added filtration of 0.5 mm Cu. The authors evaluated strategies of noise suppression with sinogram smoothing and dose minimization with reduction of tube currents at the two kVp settings. The authors compared the impact of DECT-based attenuation correction with single-kVp CT-based attenuation correction on PET quantitation for the NCAT phantom for soft tissue and high-Z materials of bone and iodine contrast enhancement. Results: Both analytic calculations and simulations displayed the expected minimum noise value for a synthesized monoenergetic image at an energy between the mean energies of the two spectra. In addition the authors found that the normalized coefficient of variation in the synthesized attenuation map increased with energy but reached a plateau near 160 keV, and then remained constant with increasing energy up to 511 keV and beyond. The bias was minimal, as the linear attenuation coefficients of the synthesized monoenergetic images were within 2.4% of the known true values across the entire energy range. Compared with no sinogram smoothing, sinogram smoothing can dramatically reduce noise in the DECT-derived attenuation map. Through appropriate selection of tube currents for high and low kVp scans, DECT can deliver roughly the same amount of radiation dose as that of a single kVp CT scan, but could be used for PET attenuation correction with reduced bias in contrast agent regions by a factor of ?2.6 and slightly reduced RMSE for the total image. Conclusions: When DECT is used for attenuation correction at higher energies, there is a noise amplification that is dependent on the energy of the synthesized monoenergetic image of linear attenuation coefficients. Sinogram smoothing reduces the noise amplification in DECT-derived attenuation maps without increasing bias. With an appropriate selection of CT techniques, a DECT scan with the same radiation dose as a single CT scan can result in a PET image with improved quantitative accuracy.

  9. Evaluation of the spline reconstruction technique for PET

    SciTech Connect (OSTI)

    Kastis, George A. Kyriakopoulou, Dimitra; Gaitanis, Anastasios; Fernndez, Yolanda; Hutton, Brian F.; Fokas, Athanasios S.

    2014-04-15

    Purpose: The spline reconstruction technique (SRT), based on the analytic formula for the inverse Radon transform, has been presented earlier in the literature. In this study, the authors present an improved formulation and numerical implementation of this algorithm and evaluate it in comparison to filtered backprojection (FBP). Methods: The SRT is based on the numerical evaluation of the Hilbert transform of the sinogram via an approximation in terms of custom made cubic splines. By restricting reconstruction only within object pixels and by utilizing certain mathematical symmetries, the authors achieve a reconstruction time comparable to that of FBP. The authors have implemented SRT in STIR and have evaluated this technique using simulated data from a clinical positron emission tomography (PET) system, as well as real data obtained from clinical and preclinical PET scanners. For the simulation studies, the authors have simulated sinograms of a point-source and three digital phantoms. Using these sinograms, the authors have created realizations of Poisson noise at five noise levels. In addition to visual comparisons of the reconstructed images, the authors have determined contrast and bias for different regions of the phantoms as a function of noise level. For the real-data studies, sinograms of an{sup 18}F-FDG injected mouse, a NEMA NU 4-2008 image quality phantom, and a Derenzo phantom have been acquired from a commercial PET system. The authors have determined: (a) coefficient of variations (COV) and contrast from the NEMA phantom, (b) contrast for the various sections of the Derenzo phantom, and (c) line profiles for the Derenzo phantom. Furthermore, the authors have acquired sinograms from a whole-body PET scan of an {sup 18}F-FDG injected cancer patient, using the GE Discovery ST PET/CT system. SRT and FBP reconstructions of the thorax have been visually evaluated. Results: The results indicate an improvement in FWHM and FWTM in both simulated and real point-source studies. In all simulated phantoms, the SRT exhibits higher contrast and lower bias than FBP at all noise levels, by increasing the COV in the reconstructed images. Finally, in real studies, whereas the contrast of the cold chambers are similar for both algorithms, the SRT reconstructed images of the NEMA phantom exhibit slightly higher COV values than those of FBP. In the Derenzo phantom, SRT resolves the 2-mm separated holes slightly better than FBP. The small-animal and human reconstructions via SRT exhibit slightly higher resolution and contrast than the FBP reconstructions. Conclusions: The SRT provides images of higher resolution, higher contrast, and lower bias than FBP, by increasing slightly the noise in the reconstructed images. Furthermore, it eliminates streak artifacts outside the object boundary. Unlike other analytic algorithms, the reconstruction time of SRT is comparable with that of FBP. The source code for SRT will become available in a future release of STIR.

  10. Lanthanum halide scintillators for time-of-flight 3-D pet

    DOE Patents [OSTI]

    Karp, Joel S. (Glenside, PA); Surti, Suleman (Philadelphia, PA)

    2008-06-03

    A Lanthanum Halide scintillator (for example LaCl.sub.3 and LaBr.sub.3) with fast decay time and good timing resolution, as well as high light output and good energy resolution, is used in the design of a PET scanner. The PET scanner includes a cavity for accepting a patient and a plurality of PET detector modules arranged in an approximately cylindrical configuration about the cavity. Each PET detector includes a Lanthanum Halide scintillator having a plurality of Lanthanum Halide crystals, a light guide, and a plurality of photomultiplier tubes arranged respectively peripherally around the cavity. The good timing resolution enables a time-of-flight (TOF) PET scanner to be developed that exhibits a reduction in noise propagation during image reconstruction and a gain in the signal-to-noise ratio. Such a PET scanner includes a time stamp circuit that records the time of receipt of gamma rays by respective PET detectors and provides timing data outputs that are provided to a processor that, in turn, calculates time-of-flight (TOF) of gamma rays through a patient in the cavity and uses the TOF of gamma rays in the reconstruction of images of the patient.

  11. High resolution PET breast imager with improved detection efficiency

    DOE Patents [OSTI]

    Majewski, Stanislaw

    2010-06-08

    A highly efficient PET breast imager for detecting lesions in the entire breast including those located close to the patient's chest wall. The breast imager includes a ring of imaging modules surrounding the imaged breast. Each imaging module includes a slant imaging light guide inserted between a gamma radiation sensor and a photodetector. The slant light guide permits the gamma radiation sensors to be placed in close proximity to the skin of the chest wall thereby extending the sensitive region of the imager to the base of the breast. Several types of photodetectors are proposed for use in the detector modules, with compact silicon photomultipliers as the preferred choice, due to its high compactness. The geometry of the detector heads and the arrangement of the detector ring significantly reduce dead regions thereby improving detection efficiency for lesions located close to the chest wall.

  12. Post-injection transmission attenuation measurements for PET

    SciTech Connect (OSTI)

    Daube-Witherspoon, M.E.; Carson, R.E.; Green, M.V.

    1988-02-01

    The feasibility of acquiring PET transmission information after tracer injection was studied using ring and rotating pin transmission sources. A combined transmission/emission scan was acquired, followed by an emission scan, used to subtract the emission counts from the transmission/emission data. The ratio of emission count rate for FDG brain scans to transmission count rate is 50-100% for a 5-mCi ring source and less than 5% for a 5-mCi pin source. Windowing of the sinogram, which rejects most random and scattered coincidences, also eliminates most emission counts. The magnitude and effects of residual random and scattered coincidences as well as increases in variability from tranmission/emission scans were studied. In addition, the results of combined transmission/emission scans for a high-contrast emission source distribution using ring and pin sources are described.

  13. 6.19 MicroPET Enhances Studies of Small Animals

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    is now a standard method for studying the metabolism of the brain, the heart, and cancer. ... R.W., Meadors, K., Phelps, M.E., "Brain imaging in small animals with MircoPET," ...

  14. Monte Carlo simulation of PET and SPECT imaging of {sup 90}Y (Journal

    Office of Scientific and Technical Information (OSTI)

    Article) | SciTech Connect Monte Carlo simulation of PET and SPECT imaging of {sup 90}Y Citation Details In-Document Search Title: Monte Carlo simulation of PET and SPECT imaging of {sup 90}Y Purpose: Yittrium-90 ({sup 90}Y) is traditionally thought of as a pure beta emitter, and is used in targeted radionuclide therapy, with imaging performed using bremsstrahlung single-photon emission computed tomography (SPECT). However, because {sup 90}Y also emits positrons through internal pair

  15. F-18 Labeled Diabody-Luciferase Fusion Proteins for Optical-ImmunoPET

    SciTech Connect (OSTI)

    Wu, Anna M

    2013-01-18

    The goal of the proposed work is to develop novel dual-labeled molecular imaging probes for multimodality imaging. Based on small, engineered antibodies called â??diabodiesâ?, these probes will be radioactively tagged with Fluorine-18 for PET imaging, and fused to luciferases for optical (bioluminescence) detection. Performance will be evaluated and validated using a prototype integrated optical-PET imaging system, OPET. Multimodality probes for optical-PET imaging will be based on diabodies that are dually labeled with 18F for PET detection and fused to luciferases for optical imaging. 1) Two sets of fusion proteins will be built, targeting the cell surface markers CEA or HER2. Coelenterazine-based luciferases and variant forms will be evaluated in combination with native substrate and analogs, in order to obtain two distinct probes recognizing different targets with different spectral signatures. 2) Diabody-luciferase fusion proteins will be labeled with 18F using amine reactive [18F]-SFB produced using a novel microwave-assisted, one-pot method. 3) Sitespecific, chemoselective radiolabeling methods will be devised, to reduce the chance that radiolabeling will inactivate either the target-binding properties or the bioluminescence properties of the diabody-luciferase fusion proteins. 4) Combined optical and PET imaging of these dual modality probes will be evaluated and validated in vitro and in vivo using a prototype integrated optical-PET imaging system, OPET. Each imaging modality has its strengths and weaknesses. Development and use of dual modality probes allows optical imaging to benefit from the localization and quantitation offered by the PET mode, and enhances the PET imaging by enabling simultaneous detection of more than one probe.

  16. Ultralow dose computed tomography attenuation correction for pediatric PET CT using adaptive statistical iterative reconstruction

    SciTech Connect (OSTI)

    Brady, Samuel L.; Shulkin, Barry L.

    2015-02-15

    Purpose: To develop ultralow dose computed tomography (CT) attenuation correction (CTAC) acquisition protocols for pediatric positron emission tomography CT (PET CT). Methods: A GE Discovery 690 PET CT hybrid scanner was used to investigate the change to quantitative PET and CT measurements when operated at ultralow doses (1035 mA s). CT quantitation: noise, low-contrast resolution, and CT numbers for 11 tissue substitutes were analyzed in-phantom. CT quantitation was analyzed to a reduction of 90% volume computed tomography dose index (0.39/3.64; mGy) from baseline. To minimize noise infiltration, 100% adaptive statistical iterative reconstruction (ASiR) was used for CT reconstruction. PET images were reconstructed with the lower-dose CTAC iterations and analyzed for: maximum body weight standardized uptake value (SUV{sub bw}) of various diameter targets (range 837 mm), background uniformity, and spatial resolution. Radiation dose and CTAC noise magnitude were compared for 140 patient examinations (76 post-ASiR implementation) to determine relative dose reduction and noise control. Results: CT numbers were constant to within 10% from the nondose reduced CTAC image for 90% dose reduction. No change in SUV{sub bw}, background percent uniformity, or spatial resolution for PET images reconstructed with CTAC protocols was found down to 90% dose reduction. Patient population effective dose analysis demonstrated relative CTAC dose reductions between 62% and 86% (3.2/8.30.9/6.2). Noise magnitude in dose-reduced patient images increased but was not statistically different from predose-reduced patient images. Conclusions: Using ASiR allowed for aggressive reduction in CT dose with no change in PET reconstructed images while maintaining sufficient image quality for colocalization of hybrid CT anatomy and PET radioisotope uptake.

  17. Preventive maintenance system for the photomultiplier detector blocks of PET scanners

    DOE Patents [OSTI]

    Levy, A.V.; Warner, D.

    1995-01-24

    A system including a method and apparatus for preventive maintenance of PET scanner photomultiplier detector blocks is disclosed. The qualitative comparisons used in the method of the present invention to provide an indication in the form of a display or printout advising the user that the photomultiplier block is stable, intermittently unstable, or drifting unstable, and also advising of the expected date of failure of a photomultiplier block in the PET scanner. The system alerts the user to replace the defective photomultiplier block prior to catastrophic failure in a scheduled preventative maintenance program, thus eliminating expensive and unscheduled downtime of the PET scanner due to photomultiplier failure. The apparatus for carrying out the method of the present invention preferably resides in the host computer controlling a PET scanner. It includes a memory adapted for storing a record of a number of iterative adjustments that are necessary to calibrate the gain of a photomultiplier detector block i at a time t[sub 0], a time t[sub 1] and a time T, where T>t[sub 1]>t[sub 0], which is designated as Histo(i,j(t)). The apparatus also includes a processor configured by a software program or a combination of programmed RAM and ROM devices to perform a number of calculations and operations on these values, and also includes a counter for analyzing each photomultiplier detector block i=1 through I of a PET scanner. 40 figures.

  18. Preventive maintenance system for the photomultiplier detector blocks of pet scanners

    DOE Patents [OSTI]

    Levy, Alejandro V. (Center Moriches, NY); Warner, Donald (Shirley, NY)

    1995-01-24

    A system including a method and apparatus for preventive maintenance of PET scanner photomultiplier detector blocks is disclosed. The quantitive comparisons used in the method of the present invention to provide an indication in the form of a display or printout advising the user that the photomultiplier block is stable, intermittently unstable, or drifting unstable, and also advising of the expected date of failure of a photomultiplier block in the PET scanner. The system alerts the user to replace the defective photomultiplier block prior to catastrophic failure in a scheduled preventative maintenance program, thus eliminating expensive and unscheduled downtime of the PET scanner due to photomultiplier failure. The apparatus for carrying out the method of the present invention preferably resides in the host computer controlling a PET scanner. It includes a memory adapted for storing a record of a number of iterative adjustments that are necessary to calibrate the gain of a photomultiplier detector block i at a time t.sub.0, a time t.sub.1 and a time T, where T>t.sub.1 >t.sub.0, which is designated as Histo(i,j(t)). The apparatus also includes a processor configured by a software program or a combination of programmed RAM and ROM devices to perform a number of calculations and operations on these values, and also includes a counter for analyzing each photomultiplier detector block i=1 through I of a PET scanner.

  19. A comprehensive plant-wide assessment of Amcor PET Packaging at Fairfield, California

    SciTech Connect (OSTI)

    Kevin Losh; Hui Choi; Yin Yin Wu; Bryan W. Hackett; Ahmad R. Ganji

    2008-02-29

    This report includes the results of the plant-wide assessment of AMCOR PET plants in Fairfield, City of Commerce, and Lathrop California. The project (except the assessment of Lathrop plant) was a cost shared effort between US Department of Energy through Golden Field Office, Golden CO and AMCOR PET Packaging Co. The DOE share of the plant-wide assessment cost was awarded to AMCOR PET in response to the RFP DE-PS36-05GO95009, the 2005 round of funding for Plant-Wide Energy Efficiency Opportunity Assessments. The plant-wide assessment included the processes, electrical and gas equipment. Current production practices have been evaluated against best practice standards, as well as utilization of modern technology to improve energy efficiency, reduce the wastes, and improve productivity.

  20. High-resolution PET [Positron Emission Tomography] for Medical Science Studies

    DOE R&D Accomplishments [OSTI]

    Budinger, T. F.; Derenzo, S. E.; Huesman, R. H.; Jagust, W. J.; Valk, P. E.

    1989-09-01

    One of the unexpected fruits of basic physics research and the computer revolution is the noninvasive imaging power available to today's physician. Technologies that were strictly the province of research scientists only a decade or two ago now serve as the foundations for such standard diagnostic tools as x-ray computer tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), ultrasound, single photon emission computed tomography (SPECT), and positron emission tomography (PET). Furthermore, prompted by the needs of both the practicing physician and the clinical researcher, efforts to improve these technologies continue. This booklet endeavors to describe the advantages of achieving high resolution in PET imaging.

  1. Photo of the Week: Pre-PET Headgear | Department of Energy

    Office of Energy Efficiency and Renewable Energy (EERE) Indexed Site

    Pre-PET Headgear Photo of the Week: Pre-PET Headgear March 26, 2014 - 3:49pm Addthis In 1961, chemists at Brookhaven National Laboratory studied how to detect small brain tumors by analyzing the decay of radioactive material injected into the patient's bloodstream and absorbed by the tumor. To help them, BNL's Instrumentation Division built different arrays of detectors, and this circular type proved best. In the 1970s, BNL helped reconstruct the raw data received by the detectors into an image

  2. Distributed Microprocessor Automation Network for Synthesizing Radiotracers Used in Positron Emission Tomography [PET

    DOE R&D Accomplishments [OSTI]

    Russell, J. A. G.; Alexoff, D. L.; Wolf, A. P.

    1984-09-01

    This presentation describes an evolving distributed microprocessor network for automating the routine production synthesis of radiotracers used in Positron Emission Tomography. We first present a brief overview of the PET method for measuring biological function, and then outline the general procedure for producing a radiotracer. The paper identifies several reasons for our automating the syntheses of these compounds. There is a description of the distributed microprocessor network architecture chosen and the rationale for that choice. Finally, we speculate about how this network may be exploited to extend the power of the PET method from the large university or National Laboratory to the biomedical research and clinical community at large. (DT)

  3. Factors affecting degradation of polyethylene terephthalate (PET) during pre-flotation conditioning

    SciTech Connect (OSTI)

    Caparanga, Alvin R. Basilia, Blessie A.; Dagbay, Kevin B.; Salvacion, Jonathan W.L.

    2009-09-15

    In general, plastics are exposed to different degrading agents in every procedure involved in their recovery from waste mixture and from subsequent recycling. In this study, two methods of pre-flotation conditioning were used to determine how these methods affect the general properties of the pre-conditioned PET particles to be recovered from the PET-PVC mixture. The first method comprised the conditioning of PET samples using an alkaline solution of nonionic surfactant (Triton X-100) based on the patent by the Goodyear Tire and Rubber Company. The second method, developed in this study, was a conditioning process which used an alkali-less solution of the same nonionic surfactant (Triton X-100) used in the first method. The following analytical methods were used to characterize properties of the pre-conditioned PET samples that were correlated to relative degradation of the samples: differential scanning calorimetry (DSC), for thermal behavior of the samples; FT-IR spectroscopy, for functional groups present in the samples; and, Pohl's method, for carboxyl end-group concentration count. Results show that in addition to water the presence of NaOH in the conditioning solution contributes to the further degradation of the polymer.

  4. Tumor Response and Survival Predicted by Post-Therapy FDG-PET/CT in Anal Cancer

    SciTech Connect (OSTI)

    Schwarz, Julie K.; Siegel, Barry A.; Dehdashti, Farrokh; Myerson, Robert J.; Fleshman, James W.; Grigsby, Perry W.

    2008-05-01

    Purpose: To evaluate the response to therapy for anal carcinoma using post-therapy imaging with positron emission tomography (PET)/computed tomography and F-18 fluorodeoxyglucose (FDG) and to compare the metabolic response with patient outcome. Patients and Methods: This was a prospective cohort study of 53 consecutive patients with anal cancer. All patients underwent pre- and post-treatment whole-body FDG-PET/computed tomography. Patients had been treated with external beam radiotherapy and concurrent chemotherapy. Whole-body FDG-PET was performed 0.9-5.4 months (mean, 2.1) after therapy completion. Results: The post-therapy PET scan did not show any abnormal FDG uptake (complete metabolic response) in 44 patients. Persistent abnormal FDG uptake (partial metabolic response) was found in the anal tumor in 9 patients. The 2-year cause-specific survival rate was 94% for patients with a complete vs. 39% for patients with a partial metabolic response in the anal tumor (p = 0.0008). The 2-year progression-free survival rate was 95% for patients with a complete vs. 22% for patients with a partial metabolic response in the anal tumor (p < 0.0001). A Cox proportional hazards model of survival outcome indicated that a complete metabolic response was the most significant predictor of progression-free survival in our patient population (p = 0.0003). Conclusions: A partial metabolic response in the anal tumor as determined by post-therapy FDG-PET is predictive of significantly decreased progression-free and cause-specific survival after chemoradiotherapy for anal cancer.

  5. A systematic investigation of PET Radionuclide Specific Activity on Miniaturization of Radiochemistry

    SciTech Connect (OSTI)

    Jeanne M Link, PhD

    2012-03-08

    The PET radionuclides, 18F and 11C consist of very high radiation to mass amounts and should be easily adapted to new technologies such as â??chip chemistryâ? with nanofluidics. However, environmental contamination with nonradioactive fluorine, carbon and other trace contaminants add sufficient mass, micrograms to milligrams, to prevent adapting PET radiochemistry to the nanochip technologies. In addition, the large volumes of material required for beam irradiation make it necessary to also remove the 18F and 11C from their chemical matrices. These steps add contaminants. The work described in this report was a systematic investigation of sources of these contaminants and methods to reduce these contaminants and the reaction volumes for radiochemical synthesis. Several methods were found to lower the contaminants and matrices to within a factor of 2 to 100 of those needed to fully implement chip technology but further improvements are needed.

  6. Dedicated mobile high resolution prostate PET imager with an insertable transrectal probe

    DOE Patents [OSTI]

    Majewski, Stanislaw (Yorktown, VA); Proffitt, James (Newport News, VA)

    2010-12-28

    A dedicated mobile PET imaging system to image the prostate and surrounding organs. The imaging system includes an outside high resolution PET imager placed close to the patient's torso and an insertable and compact transrectal probe that is placed in close proximity to the prostate and operates in conjunction with the outside imager. The two detector systems are spatially co-registered to each other. The outside imager is mounted on an open rotating gantry to provide torso-wide 3D images of the prostate and surrounding tissue and organs. The insertable probe provides closer imaging, high sensitivity, and very high resolution predominately 2D view of the prostate and immediate surroundings. The probe is operated in conjunction with the outside imager and a fast data acquisition system to provide very high resolution reconstruction of the prostate and surrounding tissue and organs.

  7. Precise Measurement of Strontium-82 Radioactivity in the Sr-Rb PET

    Office of Science (SC) Website

    Generator | U.S. DOE Office of Science (SC) Precise Measurement of Strontium-82 Radioactivity in the Sr-Rb PET Generator Nuclear Physics (NP) NP Home About Research Facilities Science Highlights Benefits of NP Applications of Nuclear Science Applications of Nuclear Science Archives Small Business Innovation / Technology Transfer Funding Opportunities Nuclear Science Advisory Committee (NSAC) Community Resources Contact Information Nuclear Physics U.S. Department of Energy SC-26/Germantown

  8. Microfluidics without channels: highly-flexible synthesis on a digital-microfluidic chip for production of diverse PET tracers

    SciTech Connect (OSTI)

    Van Dam, Robert Michael [Univ. of California, Los Angeles, CA (United States)

    2010-09-01

    Positron emission tomography (PET) imaging is used for fundamental studies of living biological organisms and microbial ecosystems in applications ranging from biofuel production to environmental remediation to the study, diagnosis, and treatment monitoring of human disease. Routine access to PET imaging, to monitor biochemical reactions in living organisms in real time, could accelerate a broad range of research programs of interest to DOE. Using PET requires access to short-lived radioactive-labeled compounds that specifically probe the desired living processes. The overall aims of this project were to develop a miniature liquid-handling technology platform (called microfluidics) that increases the availability of diverse PET probes by reducing the cost and complexity of their production. Based on preliminary experiments showing that microfluidic chips can synthesis such compounds, we aimed to advance this technology to improve its robustness, increase its flexibility for a broad range of probes, and increase its user-friendliness. Through the research activities of this project, numerous advances were made; Tools were developed to enable the visualization of radioactive materials within microfluidic chips; Fundamental advances were made in the microfluidic chip architecture and fabrication process to increase its robustness and reliability; The microfluidic chip technology was shown to produce useful quantities of an example PET probes, and methods to further increase the output were successfully pursued; A universal chip was developed that could produce multiple types of PET probes, enabling the possibility of on demand synthesis of different probes; and Operation of the chip was automated to ensure minimal radiation exposure to the operator Based on the demonstrations of promising technical feasibility and performance, the microfluidic chip technology is currently being commercialized. It is anticipated that costs of microfluidic chips can be dramatically reduced in the future by leveraging economies of scale in the microelectronics industry, leading to low cost production of PET probes.

  9. Longitudinal, intermodality registration of quantitative breast PET and MRI data acquired before and during neoadjuvant chemotherapy: Preliminary results

    SciTech Connect (OSTI)

    Atuegwu, Nkiruka C.; Williams, Jason M.; Li, Xia; Arlinghaus, Lori R.; Abramson, Richard G.; Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2675; Vanderbilt Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6838 ; Chakravarthy, A. Bapsi; Abramson, Vandana G.; Yankeelov, Thomas E.

    2014-05-15

    Purpose: The authors propose a method whereby serially acquired DCE-MRI, DW-MRI, and FDG-PET breast data sets can be spatially and temporally coregistered to enable the comparison of changes in parameter maps at the voxel level. Methods: First, the authors aligned the PET and MR images at each time point rigidly and nonrigidly. To register the MR images longitudinally, the authors extended a nonrigid registration algorithm by including a tumor volume-preserving constraint in the cost function. After the PET images were aligned to the MR images at each time point, the authors then used the transformation obtained from the longitudinal registration of the MRI volumes to register the PET images longitudinally. The authors tested this approach on ten breast cancer patients by calculating a modified Dice similarity of tumor size between the PET and MR images as well as the bending energy and changes in the tumor volume after the application of the registration algorithm. Results: The median of the modified Dice in the registered PET and DCE-MRI data was 0.92. For the longitudinal registration, the median tumor volume change was ?0.03% for the constrained algorithm, compared to ?32.16% for the unconstrained registration algorithms (p = 8 10{sup ?6}). The medians of the bending energy were 0.0092 and 0.0001 for the unconstrained and constrained algorithms, respectively (p = 2.84 10{sup ?7}). Conclusions: The results indicate that the proposed method can accurately spatially align DCE-MRI, DW-MRI, and FDG-PET breast images acquired at different time points during therapy while preventing the tumor from being substantially distorted or compressed.

  10. Improved UTE-based attenuation correction for cranial PET-MR using dynamic magnetic field monitoring

    SciTech Connect (OSTI)

    Aitken, A. P.; Giese, D.; Tsoumpas, C.; Schleyer, P.; Kozerke, S.; Prieto, C.; Schaeffter, T.

    2014-01-15

    Purpose: Ultrashort echo time (UTE) MRI has been proposed as a way to produce segmented attenuation maps for PET, as it provides contrast between bone, air, and soft tissue. However, UTE sequences require samples to be acquired during rapidly changing gradient fields, which makes the resulting images prone to eddy current artifacts. In this work it is demonstrated that this can lead to misclassification of tissues in segmented attenuation maps (AC maps) and that these effects can be corrected for by measuring the true k-space trajectories using a magnetic field camera. Methods: The k-space trajectories during a dual echo UTE sequence were measured using a dynamic magnetic field camera. UTE images were reconstructed using nominal trajectories and again using the measured trajectories. A numerical phantom was used to demonstrate the effect of reconstructing with incorrect trajectories. Images of an ovine leg phantom were reconstructed and segmented and the resulting attenuation maps were compared to a segmented map derived from a CT scan of the same phantom, using the Dice similarity measure. The feasibility of the proposed method was demonstrated inin vivo cranial imaging in five healthy volunteers. Simulated PET data were generated for one volunteer to show the impact of misclassifications on the PET reconstruction. Results: Images of the numerical phantom exhibited blurring and edge artifacts on the bone–tissue and air–tissue interfaces when nominal k-space trajectories were used, leading to misclassification of soft tissue as bone and misclassification of bone as air. Images of the tissue phantom and thein vivo cranial images exhibited the same artifacts. The artifacts were greatly reduced when the measured trajectories were used. For the tissue phantom, the Dice coefficient for bone in MR relative to CT was 0.616 using the nominal trajectories and 0.814 using the measured trajectories. The Dice coefficients for soft tissue were 0.933 and 0.934 for the nominal and measured cases, respectively. For air the corresponding figures were 0.991 and 0.993. Compared to an unattenuated reference image, the mean error in simulated PET uptake in the brain was 9.16% when AC maps derived from nominal trajectories was used, with errors in the SUV{sub max} for simulated lesions in the range of 7.17%–12.19%. Corresponding figures when AC maps derived from measured trajectories were used were 0.34% (mean error) and −0.21% to +1.81% (lesions). Conclusions: Eddy current artifacts in UTE imaging can be corrected for by measuring the true k-space trajectories during a calibration scan and using them in subsequent image reconstructions. This improves the accuracy of segmented PET attenuation maps derived from UTE sequences and subsequent PET reconstruction.

  11. Compartment modeling of dynamic brain PETThe impact of scatter corrections on parameter errors

    SciTech Connect (OSTI)

    Hggstrm, Ida Karlsson, Mikael; Larsson, Anne; Schmidtlein, C. Ross

    2014-11-01

    Purpose: The aim of this study was to investigate the effect of scatter and its correction on kinetic parameters in dynamic brain positron emission tomography (PET) tumor imaging. The 2-tissue compartment model was used, and two different reconstruction methods and two scatter correction (SC) schemes were investigated. Methods: The GATE Monte Carlo (MC) software was used to perform 2 15 full PET scan simulations of a voxelized head phantom with inserted tumor regions. The two sets of kinetic parameters of all tissues were chosen to represent the 2-tissue compartment model for the tracer 3?-deoxy-3?-({sup 18}F)fluorothymidine (FLT), and were denoted FLT{sub 1} and FLT{sub 2}. PET data were reconstructed with both 3D filtered back-projection with reprojection (3DRP) and 3D ordered-subset expectation maximization (OSEM). Images including true coincidences with attenuation correction (AC) and true+scattered coincidences with AC and with and without one of two applied SC schemes were reconstructed. Kinetic parameters were estimated by weighted nonlinear least squares fitting of image derived timeactivity curves. Calculated parameters were compared to the true input to the MC simulations. Results: The relative parameter biases for scatter-eliminated data were 15%, 16%, 4%, 30%, 9%, and 7% (FLT{sub 1}) and 13%, 6%, 1%, 46%, 12%, and 8% (FLT{sub 2}) for K{sub 1}, k{sub 2}, k{sub 3}, k{sub 4}, V{sub a}, and K{sub i}, respectively. As expected, SC was essential for most parameters since omitting it increased biases by 10 percentage points on average. SC was not found necessary for the estimation of K{sub i} and k{sub 3}, however. There was no significant difference in parameter biases between the two investigated SC schemes or from parameter biases from scatter-eliminated PET data. Furthermore, neither 3DRP nor OSEM yielded the smallest parameter biases consistently although there was a slight favor for 3DRP which produced less biased k{sub 3} and K{sub i} estimates while OSEM resulted in a less biased V{sub a}. The uncertainty in OSEM parameters was about 26% (FLT{sub 1}) and 12% (FLT{sub 2}) larger than for 3DRP although identical postfilters were applied. Conclusions: SC was important for good parameter estimations. Both investigated SC schemes performed equally well on average and properly corrected for the scattered radiation, without introducing further bias. Furthermore, 3DRP was slightly favorable over OSEM in terms of kinetic parameter biases and SDs.

  12. Macrocyclic polyaminocarboxylates for stable radiometal antibody conjugates for therapy, spect and pet imaging

    DOE Patents [OSTI]

    Mease, Ronnie C. (Fairfax, VA); Mausner, Leonard F. (Stony Brook, NY); Srivastava, Suresh C. (Setauket, NY)

    1997-06-17

    A simple method for the synthesis of 1,4,7, 10-tetraazacyclododecane N,N'N",N'"-tetraacetic acid and 1,4,8,11-tetraazacyclotetradecane N,N',N",N'"-tetraacetic acid involves cyanomethylating 1,4,7, 10-tetraazacyclododecane or 1,4,8,11-tetraazacyclotetradecane to form a tetranitrile and hydrolyzing the tetranitrile. These macrocyclic compounds are functionalized through one of the carboxylates and then conjugated to various biological molecules including monoclonal antibodies. The resulting conjugated molecules are labeled with radiometals for SPECT and PET imaging and for radiotherapy.

  13. Macrocyclic polyaminocarboxylates for stable radiometal antibody conjugates for therapy, SPECT and PET imaging

    DOE Patents [OSTI]

    Mease, R.C.; Mausner, L.F.; Srivastava, S.C.

    1997-06-17

    A simple method for the synthesis of 1,4,7, 10-tetraazacyclododecane N,N{prime}N{double_prime},N{prime}{double_prime}-tetraacetic acid and 1,4,8,11-tetraazacyclotetradecane N,N{prime},N{double_prime},N{prime}{double_prime}-tetraacetic acid involves cyanomethylating 1,4,7,10-tetraazacyclododecane or 1,4,8,11-tetraazacyclotetradecane to form a tetranitrile and hydrolyzing the tetranitrile. These macrocyclic compounds are functionalized through one of the carboxylates and then conjugated to various biological molecules including monoclonal antibodies. The resulting conjugated molecules are labeled with radiometals for SPECT and PET imaging and for radiotherapy. 4 figs.

  14. Characterization of silicon photomultipliers at National Nano-Fab Center for PET-MR

    SciTech Connect (OSTI)

    Kim, Hyoungtaek; Cho, Gyuseong; Sul, Woo Suk

    2014-10-15

    The silicon photomultipliers (SiPMs) were fabricated for magnetic resonance compatible positron emission tomography (PET) applications using customized CMOS processes at National NanoFab Center. Each micro-cell consists of a shallow n+/p well junction on a p-type epitaxial wafer and passive quenching circuit was applied. The size of the SiPM is 3 3 mm{sup 2} and the pitch of each micro-cell is 65 ?m. In this work, several thousands of SiPMs were packaged and tested to build a PET ring detector which has a 60 mm axial and 390 mm radial field of view. I-V characteristics of the SiPMs are shown good uniformity and breakdown voltage is around 20 V. The photon detection efficiency was measured via photon counting method and the maximum value was recorded as 16% at 470 nm. The gamma ray spectrum of a Ge-68 isotope showed nearly 10% energy resolution at 511 keV with a 3 3 20 mm{sup 3} LYSO crystal.

  15. Effect of 200 keV Ar{sup +} implantation on optical and electrical properties of polyethyleneterepthalate (PET)

    SciTech Connect (OSTI)

    Kumar, Rajiv Goyal, Meetika Sharma, Ambika; Aggarwal, Sanjeev; Sharma, Annu; Kanjilal, D.

    2015-05-15

    In the present paper we have discussed the effect of 200 keV Ar{sup +} ions on the electrical and optical properties of PET samples. PET samples were implanted with 200 keV Ar{sup +} ions to various doses ranging from 110{sup 15} to 110{sup 17} Ar{sup +} cm{sup 2}. The changes in the electrical and optical properties of pristine and implanted PET specimens have been studied by using Keithley electrometer and UV-Visible absorption spectroscopy. The electrical conductivity has found to be increased with increasing ion dose. The optical studies have revealed the drastic alterations in optical band gap from 3.63 eV to 1.48 eV and also increase in number of carbon atoms per cluster from 215 to 537. Further, the change in the electrical conductivity and optical band gap has also been correlated with the formation of conductive islands in the implanted layers of PET.

  16. Cholecystokinin-Assisted Hydrodissection of the Gallbladder Fossa during FDG PET/CT-guided Liver Ablation

    SciTech Connect (OSTI)

    Tewari, Sanjit O.; Petre, Elena N.; Osborne, Joseph; Sofocleous, Constantinos T.

    2013-12-15

    A 68-year-old female with colorectal cancer developed a metachronous isolated fluorodeoxyglucose-avid (FDG-avid) segment 5/6 gallbladder fossa hepatic lesion and was referred for percutaneous ablation. Pre-procedure computed tomography (CT) images demonstrated a distended gallbladder abutting the segment 5/6 hepatic metastasis. In order to perform ablation with clear margins and avoid direct puncture and aspiration of the gallbladder, cholecystokinin was administered intravenously to stimulate gallbladder contraction before hydrodissection. Subsequently, the lesion was ablated successfully with sufficient margins, of greater than 1.0 cm, using microwave with ultrasound and FDG PET/CT guidance. The patient tolerated the procedure very well and was discharged home the next day.

  17. Correction for FDG PET dose extravasations: Monte Carlo validation and quantitative evaluation of patient studies

    SciTech Connect (OSTI)

    Silva-Rodrguez, Jess Aguiar, Pablo; Servicio de Medicina Nuclear, Complexo Hospitalario Universidade de Santiago de Compostela , 15782, Galicia; Grupo de Imaxe Molecular, Instituto de Investigacin Sanitarias , Santiago de Compostela, 15706, Galicia ; Snchez, Manuel; Mosquera, Javier; Luna-Vega, Vctor; Corts, Julia; Garrido, Miguel; Pombar, Miguel; Ruibal, lvaro; Grupo de Imaxe Molecular, Instituto de Investigacin Sanitarias , Santiago de Compostela, 15706, Galicia; Fundacin Tejerina, 28003, Madrid

    2014-05-15

    Purpose: Current procedure guidelines for whole body [18F]fluoro-2-deoxy-D-glucose (FDG)-positron emission tomography (PET) state that studies with visible dose extravasations should be rejected for quantification protocols. Our work is focused on the development and validation of methods for estimating extravasated doses in order to correct standard uptake value (SUV) values for this effect in clinical routine. Methods: One thousand three hundred sixty-seven consecutive whole body FDG-PET studies were visually inspected looking for extravasation cases. Two methods for estimating the extravasated dose were proposed and validated in different scenarios using Monte Carlo simulations. All visible extravasations were retrospectively evaluated using a manual ROI based method. In addition, the 50 patients with higher extravasated doses were also evaluated using a threshold-based method. Results: Simulation studies showed that the proposed methods for estimating extravasated doses allow us to compensate the impact of extravasations on SUV values with an error below 5%. The quantitative evaluation of patient studies revealed that paravenous injection is a relatively frequent effect (18%) with a small fraction of patients presenting considerable extravasations ranging from 1% to a maximum of 22% of the injected dose. A criterion based on the extravasated volume and maximum concentration was established in order to identify this fraction of patients that might be corrected for paravenous injection effect. Conclusions: The authors propose the use of a manual ROI based method for estimating the effectively administered FDG dose and then correct SUV quantification in those patients fulfilling the proposed criterion.

  18. SU-E-I-07: An Improved Technique for Scatter Correction in PET

    SciTech Connect (OSTI)

    Lin, S; Wang, Y; Lue, K; Lin, H; Chuang, K

    2014-06-01

    Purpose: In positron emission tomography (PET), the single scatter simulation (SSS) algorithm is widely used for scatter estimation in clinical scans. However, bias usually occurs at the essential steps of scaling the computed SSS distribution to real scatter amounts by employing the scatter-only projection tail. The bias can be amplified when the scatter-only projection tail is too small, resulting in incorrect scatter correction. To this end, we propose a novel scatter calibration technique to accurately estimate the amount of scatter using pre-determined scatter fraction (SF) function instead of the employment of scatter-only tail information. Methods: As the SF depends on the radioactivity distribution and the attenuating material of the patient, an accurate theoretical relation cannot be devised. Instead, we constructed an empirical transformation function between SFs and average attenuation coefficients based on a serious of phantom studies with different sizes and materials. From the average attenuation coefficient, the predicted SFs were calculated using empirical transformation function. Hence, real scatter amount can be obtained by scaling the SSS distribution with the predicted SFs. The simulation was conducted using the SimSET. The Siemens Biograph 6 PET scanner was modeled in this study. The Software for Tomographic Image Reconstruction (STIR) was employed to estimate the scatter and reconstruct images. The EEC phantom was adopted to evaluate the performance of our proposed technique. Results: The scatter-corrected image of our method demonstrated improved image contrast over that of SSS. For our technique and SSS of the reconstructed images, the normalized standard deviation were 0.053 and 0.182, respectively; the root mean squared errors were 11.852 and 13.767, respectively. Conclusion: We have proposed an alternative method to calibrate SSS (C-SSS) to the absolute scatter amounts using SF. This method can avoid the bias caused by the insufficient tail information and therefore improve the accuracy of scatter estimation.

  19. Wakefield Simulation of CLIC PETS Structure Using Parallel 3D Finite Element Time-Domain Solver T3P

    SciTech Connect (OSTI)

    Candel, A.; Kabel, A.; Lee, L.; Li, Z.; Ng, C.; Schussman, G.; Ko, K.; Syratchev, I.; /CERN

    2009-06-19

    In recent years, SLAC's Advanced Computations Department (ACD) has developed the parallel 3D Finite Element electromagnetic time-domain code T3P. Higher-order Finite Element methods on conformal unstructured meshes and massively parallel processing allow unprecedented simulation accuracy for wakefield computations and simulations of transient effects in realistic accelerator structures. Applications include simulation of wakefield damping in the Compact Linear Collider (CLIC) power extraction and transfer structure (PETS).

  20. Aromatase imaging with [N-methyl-C-11]vorozole PET in healthy men and women

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Biegon, Anat; Fowler, Joanna S.; Alexoff, David L.; Kim, Sung Won; Logan, Jean; Pareto, Deborah; Schlyer, David; Wang, Gene-Jack

    2015-02-19

    Aromatase, the last and obligatory enzyme catalyzing estrogen biosynthesis from androgenic precursors, can be labeled in vivo with ¹¹C-vorozole. Aromatase inhibitors are widely used in breast cancer and other endocrine conditions. The present study aims to provide baseline information defining aromatase distribution in healthy men and women, against which its perturbation in pathological situations can be studied. Methods: ¹¹C-vorozole (111-296 MBq/subject) was injected I.V in 13 men and 20 women (age range 23 to 67). PET data were acquired over a 90 minute period. Each subject had 4 scans, 2/day separated by 2-6 weeks, including brain and torso or pelvismore » scans. Young women were scanned at 2 discrete phases of the menstrual cycle (midcycle and late luteal). Men and postmenopausal women were also scanned following pretreatment with a clinical dose of the aromatase inhibitor letrozole (“blocking” studies). Time activity curves were obtained and standard uptake values (SUV) calculated for major organs including brain, heart, lungs, liver, kidneys, spleen, muscle, bone and male and female reproductive organs (penis, testes, uterus, ovaries). Organ and whole body radiation exposures were calculated using Olinda software. Results: Liver uptake was higher than all other organs, but was not blocked by pretreatment with letrozole. Mean SUVs in men were higher than in women, and brain uptake was blocked by letrozole. Male brain SUVs were also higher than all other organs (ranging from 0.48±0.05 in lungs to 1.5±0.13 in kidneys). Mean ovarian SUVs (3.08±0.7) were comparable to brain levels and higher than all other organs. Furthermore, ovarian SUVs In young women around the time of ovulation (midcycle) were significantly higher than those measured in the late luteal phase, while aging and cigarette smoking reduced ¹¹C-vorozole uptake. Conclusions: PET with ¹¹C-vorozole is useful for assessing physiological changes in estrogen synthesis capacity in the human body. Baseline levels in breasts, lungs and bones are low, supporting further investigation of this tracer as a new tool for detection of aromatase-overexpressing primary tumors or metastases in these organs and optimization of treatment in cancer and other disorders in which aromatase inhibitors are useful.« less

  1. Evaluation of the Dopamine Hypothesis of ADHD with PET Brain Imaging

    ScienceCinema (OSTI)

    Swanson, James [University of California, Irvine, California, United States

    2010-09-01

    The Dopamine (DA) Hypothesis of ADHD (Wender, 1971; Levy, 1990) suggests that abnormalities in the synaptic mechanisms of DA transmission may be disrupted, and specific abnormalities in DA receptors and DA transporters (DAT) have been proposed (see Swanson et al, 1998). Early studies with small samples (e.g., n = 6, Dougherty et al, 1999) used single photon emission tomography (SPECT) and the radioligand (123I Altropane) to test a theory that ADHD may be caused by an over expression of DAT and reported 'a 70% increase in age-corrected dopamine transporter density in patients with attention deficit hyperactivity disorder compared with healthy controls' and suggested that treatment with stimulant medication decreased DAT density in ADHD patients and corrected an underlying abnormality (Krause et al, 2000). The potential importance of these findings was noted by Swanson (1999): 'If true, this is a major finding and points the way for new investigations of the primary pharmacological treatment for ADHD (with the stimulant drugs - e.g., methylphenidate), for which the dopamine transporter is the primary site of action. The potential importance of this finding demands special scrutiny'. This has been provided over the past decade using Positron Emission Tomography (PET). Brain imaging studies were conducted at Brookhaven National Laboratory (BNL) in a relatively large sample of stimulant-naive adults assessed for DAT (11C cocaine) density and DA receptors (11C raclopride) availability. These studies (Volkow et al, 2007; Volkow et al, 2009) do not confirm the hypothesis of increased DAT density and suggest the opposite (i.e., decreased rather than increased DAT density), and follow-up after treatment (Wang et al, 2010) does not confirm the hypothesis that therapeutic doses of methylphenidate decrease DAT density and suggests the opposite (i.e., increased rather than decreased DAT density). The brain regions implicated by these PET imaging studies also suggest that a motivation deficit may contribute as much as an attention deficit to the manifestation of behaviors that underlie the symptoms of ADHD.

  2. Radiolabeled Peptide Scaffolds for PET/SPECT - Optical in Vivo Imaging of Carbohydrate-Lectin Interactions

    SciTech Connect (OSTI)

    Deutscher, Susan

    2014-09-30

    The objective of this research is to develop phage display-selected peptides into radio- and fluoresecently- labeled scaffolds for the multimodal imaging of carbohydrate-lectin interactions. While numerous protein and receptor systems are being explored for the development of targeted imaging agents, the targeting and analysis of carbohydrate-lectin complexes in vivo remains relatively unexplored. Antibodies, nanoparticles, and peptides are being developed that target carbohydrate-lectin complexes in living systems. However, antibodies and nanoparticles often suffer from slow clearance and toxicity problems. Peptides are attractive alternative vehicles for the specific delivery of radionuclides or fluorophores to sites of interest in vivo, although, because of their size, uptake and retention may be less than antibodies. We have selected high affinity peptides that bind a specific carbohydrate-lectin complex involved in cell-cell adhesion and cross-linking using bacteriophage (phage) display technologies (1,2). These peptides have allowed us to probe the role of these antigens in cell adhesion. Fluorescent versions of the peptides have been developed for optical imaging and radiolabeled versions have been used in single photon emission computed tomography (SPECT) and positron emission tomography (PET) in vivo imaging (3-6). A benefit in employing the radiolabeled peptides in SPECT and PET is that these imaging modalities are widely used in living systems and offer deep tissue sensitivity. Radiolabeled peptides, however, often exhibit poor stability and high kidney uptake in vivo. Conversely, optical imaging is sensitive and offers good spatial resolution, but is not useful for deep tissue penetration and is semi-quantitative. Thus, multimodality imaging that relies on the strengths of both radio- and optical- imaging is a current focus for development of new in vivo imaging agents. We propose a novel means to improve the efficacy of radiolabeled and fluorescently labeled peptides, including our lectin/carbohydrate- targeting peptides, by displaying the targeting epitopes on small ~29 amino acid cyclic plant protein scaffolds known as cyclotides. Cyclotides are extremely stable molecules with long serum half-lives and low kidney uptake (7). More than one copy of the peptide can be engineered into the cyclotide loops, thus increasing the avidity of the peptide construct for its target.

  3. Aromatase imaging with [N-methyl-C-11]vorozole PET in healthy men and women

    SciTech Connect (OSTI)

    Biegon, Anat; Fowler, Joanna S.; Alexoff, David L.; Kim, Sung Won; Logan, Jean; Pareto, Deborah; Schlyer, David; Wang, Gene-Jack

    2015-02-19

    Aromatase, the last and obligatory enzyme catalyzing estrogen biosynthesis from androgenic precursors, can be labeled in vivo with C-vorozole. Aromatase inhibitors are widely used in breast cancer and other endocrine conditions. The present study aims to provide baseline information defining aromatase distribution in healthy men and women, against which its perturbation in pathological situations can be studied. Methods: C-vorozole (111-296 MBq/subject) was injected I.V in 13 men and 20 women (age range 23 to 67). PET data were acquired over a 90 minute period. Each subject had 4 scans, 2/day separated by 2-6 weeks, including brain and torso or pelvis scans. Young women were scanned at 2 discrete phases of the menstrual cycle (midcycle and late luteal). Men and postmenopausal women were also scanned following pretreatment with a clinical dose of the aromatase inhibitor letrozole (blocking studies). Time activity curves were obtained and standard uptake values (SUV) calculated for major organs including brain, heart, lungs, liver, kidneys, spleen, muscle, bone and male and female reproductive organs (penis, testes, uterus, ovaries). Organ and whole body radiation exposures were calculated using Olinda software. Results: Liver uptake was higher than all other organs, but was not blocked by pretreatment with letrozole. Mean SUVs in men were higher than in women, and brain uptake was blocked by letrozole. Male brain SUVs were also higher than all other organs (ranging from 0.480.05 in lungs to 1.50.13 in kidneys). Mean ovarian SUVs (3.080.7) were comparable to brain levels and higher than all other organs. Furthermore, ovarian SUVs In young women around the time of ovulation (midcycle) were significantly higher than those measured in the late luteal phase, while aging and cigarette smoking reduced C-vorozole uptake. Conclusions: PET with C-vorozole is useful for assessing physiological changes in estrogen synthesis capacity in the human body. Baseline levels in breasts, lungs and bones are low, supporting further investigation of this tracer as a new tool for detection of aromatase-overexpressing primary tumors or metastases in these organs and optimization of treatment in cancer and other disorders in which aromatase inhibitors are useful.

  4. Aromatase imaging with [N-methyl-C-11]vorozole PET in healthy men and women

    SciTech Connect (OSTI)

    Biegon, Anat; Fowler, Joanna S.; Alexoff, David L.; Kim, Sung Won; Logan, Jean; Pareto, Deborah; Schlyer, David; Wang, Gene-Jack

    2015-02-19

    Aromatase, the last and obligatory enzyme catalyzing estrogen biosynthesis from androgenic precursors, can be labeled in vivo with ¹¹C-vorozole. Aromatase inhibitors are widely used in breast cancer and other endocrine conditions. The present study aims to provide baseline information defining aromatase distribution in healthy men and women, against which its perturbation in pathological situations can be studied. Methods: ¹¹C-vorozole (111-296 MBq/subject) was injected I.V in 13 men and 20 women (age range 23 to 67). PET data were acquired over a 90 minute period. Each subject had 4 scans, 2/day separated by 2-6 weeks, including brain and torso or pelvis scans. Young women were scanned at 2 discrete phases of the menstrual cycle (midcycle and late luteal). Men and postmenopausal women were also scanned following pretreatment with a clinical dose of the aromatase inhibitor letrozole (“blocking” studies). Time activity curves were obtained and standard uptake values (SUV) calculated for major organs including brain, heart, lungs, liver, kidneys, spleen, muscle, bone and male and female reproductive organs (penis, testes, uterus, ovaries). Organ and whole body radiation exposures were calculated using Olinda software. Results: Liver uptake was higher than all other organs, but was not blocked by pretreatment with letrozole. Mean SUVs in men were higher than in women, and brain uptake was blocked by letrozole. Male brain SUVs were also higher than all other organs (ranging from 0.48±0.05 in lungs to 1.5±0.13 in kidneys). Mean ovarian SUVs (3.08±0.7) were comparable to brain levels and higher than all other organs. Furthermore, ovarian SUVs In young women around the time of ovulation (midcycle) were significantly higher than those measured in the late luteal phase, while aging and cigarette smoking reduced ¹¹C-vorozole uptake. Conclusions: PET with ¹¹C-vorozole is useful for assessing physiological changes in estrogen synthesis capacity in the human body. Baseline levels in breasts, lungs and bones are low, supporting further investigation of this tracer as a new tool for detection of aromatase-overexpressing primary tumors or metastases in these organs and optimization of treatment in cancer and other disorders in which aromatase inhibitors are useful.

  5. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies

    SciTech Connect (OSTI)

    Williams, Jason M.; Rani, Sudheer D.; Li, Xia; Whisenant, Jennifer G.; Abramson, Richard G.; Arlinghaus, Lori R.; Lee, Tzu-Cheng; MacDonald, Lawrence R.; Partridge, Savannah C.; Kang, Hakmook; Linden, Hannah M.; Kinahan, Paul E.; Yankeelov, Thomas E.

    2015-07-15

    Purpose: Previous studies have demonstrated how imaging of the breast with patients lying prone using a supportive positioning device markedly facilitates longitudinal and/or multimodal image registration. In this contribution, the authors primary objective was to determine if there are differences in the standardized uptake value (SUV) derived from [{sup 18}F]fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) in breast tumors imaged in the standard supine position and in the prone position using a specialized positioning device. Methods: A custom positioning device was constructed to allow for breast scanning in the prone position. Rigid and nonrigid phantom studies evaluated differences in prone and supine PET. Clinical studies comprised 18F-FDG-PET of 34 patients with locally advanced breast cancer imaged in the prone position (with the custom support) followed by imaging in the supine position (without the support). Mean and maximum values (SUV{sub peak} and SUV{sub max}, respectively) were obtained from tumor regions-of-interest for both positions. Prone and supine SUV were linearly corrected to account for the differences in 18F-FDG uptake time. Correlation, BlandAltman, and nonparametric analyses were performed on uptake time-corrected and uncorrected data. Results: SUV from the rigid PET breast phantom imaged in the prone position with the support device was 1.9% lower than without the support device. In the nonrigid PET breast phantom, prone SUV with the support device was 5.0% lower than supine SUV without the support device. In patients, the median (range) difference in uptake time between prone and supine scans was 16.4 min (13.430.9 min), which was significantlybut not completelyreduced by the linear correction method. SUV{sub peak} and SUV{sub max} from prone versus supine scans were highly correlated, with concordance correlation coefficients of 0.91 and 0.90, respectively. Prone SUV{sub peak} and SUV{sub max} were significantly lower than supine in both original and uptake time-adjusted data across a range of index times (P < < 0.0001, Wilcoxon signed rank test). Before correcting for uptake time differences, BlandAltman analyses revealed proportional bias between prone and supine measurements (SUV{sub peak} and SUV{sub max}) that increased with higher levels of FDG uptake. After uptake time correction, this bias was significantly reduced (P < 0.01). Significant prone-supine differences, with regard to the spatial distribution of lesions relative to isocenter, were observed between the two scan positions, but this was poorly correlated with the residual (uptake time-corrected) prone-supine SUV{sub peak} difference (P = 0.78). Conclusions: Quantitative 18F-FDG-PET/CT of the breast in the prone position is not deleteriously affected by the support device but yields SUV that is consistently lower than those obtained in the standard supine position. SUV differences between scans arising from FDG uptake time differences can be substantially reduced, but not removed entirely, with the current correction method. SUV from the two scan orientations is quantitatively different and should not be assumed equivalent or interchangeable within the same subject. These findings have clinical relevance in that they underscore the importance of patient positioning while scanning as a clinical variable that must be accounted for with longitudinal PET measurement, for example, in the assessment of treatment response.

  6. Synthesis of reduced graphene oxide/ZnO nanorods composites on graphene coated PET flexible substrates

    SciTech Connect (OSTI)

    Huang, Lei, E-mail: leihuang@shnu.edu.cn; Guo, Guilue; Liu, Yang; Chang, Quanhong; Shi, Wangzhou

    2013-10-15

    Graphical abstract: - Highlights: ZnO nanorods synthesized on CVD-graphene and rGO surfaces, respectively. ZnO/CVD-graphene and ZnO/rGO form a distinctive porous 3D structure. rGO/ZnO nanostructures possibility in energy storage devices. - Abstract: In this work, reduced graphene oxide (rGO)/ZnO nanorods composites were synthesized on graphene coated PET flexible substrates. Both chemical vapor deposition (CVD) graphene and reduced graphene oxide (rGO) films were prepared following by hydrothermal growth of vertical aligned ZnO nanorods. Reduced graphene sheets were then spun coated on the ZnO materials to form a three dimensional (3D) porous nanostructure. The morphologies of the ZnO/CVD graphene and ZnO/rGO were investigated by SEM, which shows that the ZnO nanorods grown on rGO are larger in diameters and have lower density compared with those grown on CVD graphene substrate. As a result of fact, the rough surface of nano-scale ZnO on rGO film allows rGO droplets to seep into the large voids of ZnO nanorods, then to form the rGO/ZnO hierarchical structure. By comparison of the different results, we conclude that rGO/ZnO 3D nanostructure is more desirable for the application of energy storage devices.

  7. Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging

    DOE Patents [OSTI]

    Mease, Ronnie C. (Fairfax, VA); Mausner, Leonard F. (Stony Brook, NY); Srivastava, Suresh C. (Setauket, NY)

    1995-06-27

    A simple method for the synthesis of 1,4,7,10-tetraazacyclododecane N,N'N",N'"-tetraacetic acid and 1,4,8,11-tetraazacyclotetradecane N,N',N",N'"-tetraacetic acid involves cyanomethylating 1,4,7,10-tetraazacyclododecane or 1,4,8,11-tetraazacyclotetradecane to form a tetranitrile and hydrolyzing the tetranitrile. These macrocyclic compounds are functionalized through one of the carboxylates and then conjugated to various biological molecules including monoclonal antibodies. The resulting conjugated molecules are labeled with radiometals for SPECT and PET imaging and for radiotherapy.

  8. Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, SPECT and PET imaging

    DOE Patents [OSTI]

    Mease, R.C.; Mausner, L.F.; Srivastava, S.C.

    1995-06-27

    A simple method for the synthesis of 1,4,7,10-tetraazacyclododecane N,N{prime}N{double_prime},N{prime}{double_prime}-tetraacetic acid and 1,4,8,11-tetraazacyclotetradecane N,N{prime},N{double_prime},N{prime}{double_prime}-tetraacetic acid involves cyanomethylating 1,4,7,10-tetraazacyclododecane or 1,4,8,11-tetraazacyclotetradecane to form a tetranitrile and hydrolyzing the tetranitrile. These macrocyclic compounds are functionalized through one of the carboxylates and then conjugated to various biological molecules including monoclonal antibodies. The resulting conjugated molecules are labeled with radiometals for SPECT and PET imaging and for radiotherapy. 4 figs.

  9. Wakefield Computations for the CLIC PETS using the Parallel Finite Element Time-Domain Code T3P

    SciTech Connect (OSTI)

    Candel, A; Kabel, A.; Lee, L.; Li, Z.; Ng, C.; Schussman, G.; Ko, K.; Syratchev, I.; /CERN

    2009-06-19

    In recent years, SLAC's Advanced Computations Department (ACD) has developed the high-performance parallel 3D electromagnetic time-domain code, T3P, for simulations of wakefields and transients in complex accelerator structures. T3P is based on advanced higher-order Finite Element methods on unstructured grids with quadratic surface approximation. Optimized for large-scale parallel processing on leadership supercomputing facilities, T3P allows simulations of realistic 3D structures with unprecedented accuracy, aiding the design of the next generation of accelerator facilities. Applications to the Compact Linear Collider (CLIC) Power Extraction and Transfer Structure (PETS) are presented.

  10. SU-E-J-104: Single Photon Image From PET with Insertable SPECT Collimator for Boron Neutron Capture Therapy: A Feasibility Study

    SciTech Connect (OSTI)

    Jung, J; Yoon, D; Suh, T

    2014-06-01

    Purpose: The aim of our proposed system is to confirm the feasibility of extraction of two types of images from one positron emission tomography (PET) module with an insertable collimator for brain tumor treatment during the BNCT. Methods: Data from the PET module, neutron source, and collimator was entered in the Monte Carlo n-particle extended (MCNPX) source code. The coincidence events were first compiled on the PET detector, and then, the events of the prompt gamma ray were collected after neutron emission by using a single photon emission computed tomography (SPECT) collimator on the PET. The obtaining of full width at half maximum (FWHM) values from the energy spectrum was performed to collect effective events for reconstructed image. In order to evaluate the images easily, five boron regions in a brain phantom were used. The image profiles were extracted from the region of interest (ROI) of a phantom. The image was reconstructed using the ordered subsets expectation maximization (OSEM) reconstruction algorithm. The image profiles and the receiver operating characteristic (ROC) curve were compiled for quantitative analysis from the two kinds of reconstructed image. Results: The prompt gamma ray energy peak of 478 keV appeared in the energy spectrum with a FWHM of 41 keV (6.4%). On the basis of the ROC curve in Region A to Region E, the differences in the area under the curve (AUC) of the PET and SPECT images were found to be 10.2%, 11.7%, 8.2% (center, Region C), 12.6%, and 10.5%, respectively. Conclusion: We attempted to acquire the PET and SPECT images simultaneously using only PET without an additional isotope. Single photon images were acquired using an insertable collimator on a PET detector. This research was supported by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information and Communication Technologies (ICT) and Future Planning (MSIP)(Grant No.2009 00420) and the Radiation Technology R and D program (Grant No.2013M2A2A7043498), Republic of Korea.

  11. FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Benz, Matthias R.; Czernin, Johannes; Tap, William D.; Eckardt, Jeffrey J.; Seeger, Leanne L.; Allen-Auerbach, Martin S.; Dry, Sarah M.; Phelps, Michael E.; Weber, Wolfgang A.; Eilber, Fritz C.

    2010-01-01

    Purpose . Tmore » he aim of this study was to prospectively evaluate whether FDG-PET allows an accurate assessment of histopathologic response to neoadjuvant treatment in adult patients with primary bone sarcomas. Methods . Twelve consecutive patients with resectable, primary high grade bone sarcomas were enrolled prospectively. FDG-PET/CT imaging was performed prior to the initiation and after completion of neoadjuvant treatment. Imaging findings were correlated with histopathologic response. Results . Histopathologic responders showed significantly more pronounced decreases in tumor FDG-SUVmax from baseline to late follow up than non-responders ( 64 ± 19 % versus 29 ± 30 %, resp.; P = .03 ). Using a 60% decrease in tumor FDG-uptake as a threshold for metabolic response correctly classified 3 of 4 histopathologic responders and 7 of 8 histopathologic non-responders as metabolic responders and non-responders, respectively (sensitivity, 75%; specificity, 88%). Conclusion . These results suggest that changes in FDG-SUVmax at the end of neoadjuvant treatment can identify histopathologic responders and non-responders in adult primary bone sarcoma patients.« less

  12. SU-D-9A-04: Brain PET/CT Imaging On a Scanner with a Large Axial Field-Of-View

    SciTech Connect (OSTI)

    Park, M; Gerbaudo, V; Hamberg, L; Seaver, K; Kijewski, M

    2014-06-01

    Purpose: Large axial field-of-view (FOV) PET/CT scanners are valued for high sensitivity. Brain PET image quality may depend on the head position within the FOV. We investigated the precision of activity estimation for brain PET imaging when the brain was positioned at the end (END) and in the middle (CEN) of the FOV. The additional CT dose for the CEN position was recorded. Methods: An image quality (Jaszczak) phantom and a striatal phantom were filled with F-18 and positioned in END and CEN locations. For each phantom and each location, we acquired a ∼1-hr listmode PET, rebinned the data into 10 frames with equal number of coincidence events, and reconstructed each frame using an iterative algorithm. For the striatal phantom, END and CEN were compared by drawing on each image three regions of interest (ROI) in axially separated uniform areas. The standard deviation of the activity estimation within each ROI was averaged over the 10 images. The coefficient of variation (CV) for activity estimation was calculated at each position. Image quality was assessed by inspecting the resolution bar pattern in the Jaszczak phantom at two different head positions. Results: The CV was the lowest for ROIs near the center of the FOV. For slices near the end, not only was the CV highest, but also the resolution pattern was degraded. CTDIvol summarized in the dose report indicated that the CT dose was ∼ 10% higher for CEN as compared to END position. Conclusion: Positioning the brain in the middle of the FOV in a large FOV PET/CT scanner allows more precise measurement of tracer uptake and better image quality at the cost of increased CT dose. For the end location longer scan times may minimize image quality degradation without any additional CT dose.

  13. The new bern PET cyclotron, its research beam line, and the development of an innovative beam monitor detector

    SciTech Connect (OSTI)

    Braccini, Saverio

    2013-04-19

    The new Bern cyclotron laboratory aims at industrial radioisotope production for PET diagnostics and multidisciplinary research by means of a specifically conceived beam transfer line, terminated in a separate bunker. In this framework, an innovative beam monitor detector based on doped silica and optical fibres has been designed, constructed, and tested. Scintillation light produced by Ce and Sb doped silica fibres moving across the beam is measured, giving information on beam position, shape, and intensity. The doped fibres are coupled to commercial optical fibres, allowing the read-out of the signal far away from the radiation source. This general-purpose device can be easily adapted for any accelerator used in medical applications and is suitable either for low currents used in hadrontherapy or for currents up to a few {mu}A for radioisotope production, as well as for both pulsed and continuous beams.

  14. 3D inpatient dose reconstruction from the PET-CT imaging of {sup 90}Y microspheres for metastatic cancer to the liver: Feasibility study

    SciTech Connect (OSTI)

    Fourkal, E.; Veltchev, I.; Lin, M.; Meyer, J.; Koren, S.; Doss, M.; Yu, J. Q.

    2013-08-15

    Purpose: The introduction of radioembolization with microspheres represents a significant step forward in the treatment of patients with metastatic disease to the liver. This technique uses semiempirical formulae based on body surface area or liver and target volumes to calculate the required total activity for a given patient. However, this treatment modality lacks extremely important information, which is the three-dimensional (3D) dose delivered by microspheres to different organs after their administration. The absence of this information dramatically limits the clinical efficacy of this modality, specifically the predictive power of the treatment. Therefore, the aim of this study is to develop a 3D dose calculation technique that is based on the PET imaging of the infused microspheres.Methods: The Fluka Monte Carlo code was used to calculate the voxel dose kernel for {sup 90}Y source with voxel size equal to that of the PET scan. The measured PET activity distribution was converted to total activity distribution for the subsequent convolution with the voxel dose kernel to obtain the 3D dose distribution. In addition, dose-volume histograms were generated to analyze the dose to the tumor and critical structures.Results: The 3D inpatient dose distribution can be reconstructed from the PET data of a patient scanned after the infusion of microspheres. A total of seven patients have been analyzed so far using the proposed reconstruction method. Four patients underwent treatment with SIR-Spheres for liver metastases from colorectal cancer and three patients were treated with Therasphere for hepatocellular cancer. A total of 14 target tumors were contoured on post-treatment PET-CT scans for dosimetric evaluation. Mean prescription activity was 1.7 GBq (range: 0.583.8 GBq). The resulting mean maximum measured dose to targets was 167 Gy (range: 71311 Gy). Mean minimum dose to 70% of target (D70) was 68 Gy (range: 25155 Gy). Mean minimum dose to 90% of target (D90) was 53 Gy (range: 13125 Gy).Conclusions: A three-dimensional inpatient dose reconstruction method has been developed that is based on the PET/CT data of a patient treated with {sup 90}Y microspheres. It allows for a complete description of the absorbed dose by the tumor and critical structures. It represents the first step in building predictive models for treatment outcomes for patients receiving this therapeutic modality as well as it allows for better analysis of patients' dose response and will ultimately improve future treatment administration.

  15. SU-E-J-250: A Methodology for Active Bone Marrow Protection for Cervical Cancer Intensity-Modulated Radiotherapy Using 18F-FLT PET/CT Image

    SciTech Connect (OSTI)

    Ma, C; Yin, Y

    2014-06-01

    Purpose: The purpose of this study was to compare a radiation therapy treatment planning that would spare active bone marrow and whole pelvic bone marrow using 18F FLT PET/CT image. Methods: We have developed an IMRT planning methodology to incorporate functional PET imaging using 18F FLT/CT scans. Plans were generated for two cervical cancer patients, where pelvicactive bone marrow region was incorporated as avoidance regions based on the range: SUV>2., another region was whole pelvic bone marrow. Dose objectives were set to reduce the volume of active bone marrow and whole bone marraw. The volumes of received 10 (V10) and 20 (V20) Gy for active bone marrow were evaluated. Results: Active bone marrow regions identified by 18F FLT with an SUV>2 represented an average of 48.0% of the total osseous pelvis for the two cases studied. Improved dose volume histograms for identified bone marrow SUV volumes and decreases in V10(average 18%), and V20(average 14%) were achieved without clinically significant changes to PTV or OAR doses. Conclusion: Incorporation of 18F FLT/CT PET in IMRT planning provides a methodology to reduce radiation dose to active bone marrow without compromising PTV or OAR dose objectives in cervical cancer.

  16. SU-E-QI-17: Dependence of 3D/4D PET Quantitative Image Features On Noise

    SciTech Connect (OSTI)

    Oliver, J; Budzevich, M; Zhang, G; Latifi, K; Dilling, T; Balagurunathan, Y; Gu, Y; Grove, O; Feygelman, V; Gillies, R; Moros, E; Lee, H.

    2014-06-15

    Purpose: Quantitative imaging is a fast evolving discipline where a large number of features are extracted from images; i.e., radiomics. Some features have been shown to have diagnostic, prognostic and predictive value. However, they are sensitive to acquisition and processing factors; e.g., noise. In this study noise was added to positron emission tomography (PET) images to determine how features were affected by noise. Methods: Three levels of Gaussian noise were added to 8 lung cancer patients PET images acquired in 3D mode (static) and using respiratory tracking (4D); for the latter images from one of 10 phases were used. A total of 62 features: 14 shape, 19 intensity (1stO), 18 GLCM textures (2ndO; from grey level co-occurrence matrices) and 11 RLM textures (2ndO; from run-length matrices) features were extracted from segmented tumors. Dimensions of GLCM were 256256, calculated using 3D images with a step size of 1 voxel in 13 directions. Grey levels were binned into 256 levels for RLM and features were calculated in all 13 directions. Results: Feature variation generally increased with noise. Shape features were the most stable while RLM were the most unstable. Intensity and GLCM features performed well; the latter being more robust. The most stable 1stO features were compactness, maximum and minimum length, standard deviation, root-mean-squared, I30, V10-V90, and entropy. The most stable 2ndO features were entropy, sum-average, sum-entropy, difference-average, difference-variance, difference-entropy, information-correlation-2, short-run-emphasis, long-run-emphasis, and run-percentage. In general, features computed from images from one of the phases of 4D scans were more stable than from 3D scans. Conclusion: This study shows the need to characterize image features carefully before they are used in research and medical applications. It also shows that the performance of features, and thereby feature selection, may be assessed in part by noise analysis.

  17. Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic {beta}-cell mass

    SciTech Connect (OSTI)

    Cline, Gary W.; Zhao, Xiaojian; Jakowski, Amy B.; Soeller, Walter C.; Treadway, Judith L.

    2011-09-02

    Highlights: {yields} We screened G-protein coupled receptors for imaging pancreatic. {yields} Database mining and immunohistochemistry identified GPCRs enriched in {beta}-cells. {yields} In vitro and in vivo assays were used to determine exocrine vs endocrine specificity. {yields} GPCR candidates for imaging of {beta}-cell mass are Prokineticin-1R, mGluR5, and GLP-1R. -- Abstract: A critical unmet need exists for methods to quantitatively measure endogenous pancreatic {beta}-cell mass (BCM) for the clinical evaluation of therapies to prevent or reverse loss of BCM and diabetes progression. Our objective was to identify G-protein coupled receptors (GPCRs) that are expressed with a high degree of specificity to islet {beta}-cells for receptor-targeted imaging of BCM. GPCRs enriched in pancreatic islets relative to pancreas acinar and hepatic tissue were identified using a database screen. Islet-specific expression was confirmed by human pancreas immunohistochemistry (IHC). In vitro selectivity assessment was determined from the binding and uptake of radiolabeled ligands to the rat insulinoma INS-1 832/13 cell line and isolated rat islets relative to the exocrine pancreas cell-type, PANC-1. Tail-vein injections of radioligands into rats were used to determine favorable image criteria of in vivo biodistribution to the pancreas relative to other internal organs (i.e., liver, spleen, stomach, and lungs). Database and IHC screening identified four candidate receptors for further in vitro and in vivo evaluation for PET imaging of BCM: prokineticin-1 receptor (PK-1R), metabotropic glutamate receptor type-5 (mGluR5), neuropeptide Y-2 receptor (NPY-2R), and glucagon-like peptide 1 receptor (GLP-1R). In vitro specificity ratios gave the following receptor rank order: PK-1R > GLP-1R > NPY-2R > mGluR5. The biodistribution rank order of selectivity to the pancreas was found to be PK-1R > VMAT2 {approx} GLP-1R > mGluR5. Favorable islet selectivity and biodistribution characteristics suggest several GPCRs as potential targets for PET imaging of pancreatic BCM.

  18. Clinical Value of [{sup 11}C]Methionine PET for Stereotactic Radiation Therapy With Intensity Modulated Radiation Therapy to Metastatic Brain Tumors

    SciTech Connect (OSTI)

    Miwa, Kazuhiro; Department of Clinical Brain Sciences, Gifu University Graduate School of Medicine, Minokamo, Gifu ; Matsuo, Masayuki; Shinoda, Jun; Aki, Tatsuki; Yonezawa, Shingo; Department of Clinical Brain Sciences, Gifu University Graduate School of Medicine, Minokamo, Gifu ; Ito, Takeshi; Asano, Yoshitaka; Department of Clinical Brain Sciences, Gifu University Graduate School of Medicine, Minokamo, Gifu ; Yamada, Mikito; Yokoyama, Kazutoshi; Yamada, Jitsuhiro; Yano, Hirohito; Iwama, Toru

    2012-12-01

    Purpose: This study investigated the clinical impact of {sup 11}C-labeled methionine-positron emission tomography (MET-PET) for stereotactic radiation therapy with intensity modulated radiation therapy (SRT-IMRT) in metastatic brain tumors. Methods and Materials: Forty-two metastatic brain tumors were examined. All tumors were treated with SRT-IMRT using a helical tomotherapy system. Gross tumor volume (GTV) was defined and drawn on the stereotactic magnetic resonance (MR) image, taking into account the respective contributions of MR imaging and MET-PET. Planning target volume (PTV) encompassed the GTV-PET plus a 2-mm margin. SRT-IMRT was performed, keeping the dose for PTV at 25-35 Gy in 5 fractions. The ratio of the mean value of MET uptake to the contralateral normal brain (L/N ratio) was plotted for the PTV prior to SRT-IMRT, at 3 months following SRT-IMRT, and at 6 months following SRT-IMRT. Tumor characteristic changes of MET uptake before and after SRT-IMRT were evaluated quantitatively, comparing them with MRI examination. Results: Mean {+-} SD L/N ratios were 1.95 {+-} 0.83, 1.18 {+-} 0.21, and 1.12 {+-} 0.25 in the pre-SRT-IMRT group, in the 3 months post-SRT-IMRT group, and in the 6 months post-SRT-IMRT group, respectively. Differences in the mean L/N ratio between the pre-SRT-IMRT group and the 3-month post-SRT-IMRT group and between the pre-SRT-IMRT group and the 6 month post-SRT-IMRT group were statistically significant, irrespective of MRI examination. Conclusions: We showed examples of metastatic lesions demonstrating significant decreases in MET uptake following SRT-IMRT. MET-PET seems to have a potential role in providing additional information, although MRI remains the gold standard for diagnosis and follow-up after SRT-IMRT. The present study is a preliminary approach, but to more clearly define the impact of PET-based radiosurgical assessment, further experimental and clinical analyses are required.

  19. Mathematical modeling of positron emission tomography (PET) data to assess radiofluoride transport in living plants following petiolar administration

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Converse, Alexander K.; Ahlers, Elizabeth O.; Bryan, Tom W.; Hetue, Jackson D.; Lake, Katherine A.; Ellison, Paul A.; Engle, Jonathan W.; Barnhart, Todd E.; Nickles, Robert J.; Williams, Paul H.; et al

    2015-03-15

    Background: Ion transport is a fundamental physiological process that can be studied non-invasively in living plants with radiotracer imaging methods. Fluoride is a known phytotoxic pollutant and understanding its transport in plants after leaf absorption is of interest to those in agricultural areas near industrial sources of airborne fluoride. Here we report the novel use of a commercial, high-resolution, animal positron emission tomography (PET) scanner to trace a bolus of [¹⁸F]fluoride administered via bisected petioles of Brassica oleracea, an established model species, to simulate whole plant uptake of atmospheric fluoride. This methodology allows for the first time mathematical compartmental modelingmore » of fluoride transport in the living plant. Radiotracer kinetics in the stem were described with a single-parameter free- and trapped-compartment model and mean arrival times at different stem positions were calculated from the free-compartment time-activity curves. Results: After initiation of administration at the bisected leaf stalk, [¹⁸F] radioactivity climbed for approximately 10 minutes followed by rapid washout from the stem and equilibration within leaves. Kinetic modeling of transport in the stem yielded a trapping rate of 1.5 +/- 0.3%/min (mean +/- s.d., n = 3), velocity of 2.2 +/- 1.1 cm/min, and trapping fraction of 0.8 +/- 0.5%/cm. Conclusion: Quantitative assessment of physiologically meaningful transport parameters of fluoride in living plants is possible using standard positron emission tomography in combination with petiolar radiotracer administration. Movement of free fluoride was observed to be consistent with bulk flow in xylem, namely a rapid and linear change in position with respect to time. Trapping, likely in the apoplast, was observed. Future applications of the methods described here include studies of transport of other ions and molecules of interest in plant physiology.« less

  20. SU-E-QI-03: Compartment Modeling of Dynamic Brain PET - The Effect of Scatter and Random Corrections On Parameter Errors

    SciTech Connect (OSTI)

    Häggström, I; Karlsson, M; Larsson, A; Schmidtlein, C

    2014-06-15

    Purpose: To investigate the effects of corrections for random and scattered coincidences on kinetic parameters in brain tumors, by using ten Monte Carlo (MC) simulated dynamic FLT-PET brain scans. Methods: The GATE MC software was used to simulate ten repetitions of a 1 hour dynamic FLT-PET scan of a voxelized head phantom. The phantom comprised six normal head tissues, plus inserted regions for blood and tumor tissue. Different time-activity-curves (TACs) for all eight tissue types were used in the simulation and were generated in Matlab using a 2-tissue model with preset parameter values (K1,k2,k3,k4,Va,Ki). The PET data was reconstructed into 28 frames by both ordered-subset expectation maximization (OSEM) and 3D filtered back-projection (3DFBP). Five image sets were reconstructed, all with normalization and different additional corrections C (A=attenuation, R=random, S=scatter): Trues (AC), trues+randoms (ARC), trues+scatters (ASC), total counts (ARSC) and total counts (AC). Corrections for randoms and scatters were based on real random and scatter sinograms that were back-projected, blurred and then forward projected and scaled to match the real counts. Weighted non-linearleast- squares fitting of TACs from the blood and tumor regions was used to obtain parameter estimates. Results: The bias was not significantly different for trues (AC), trues+randoms (ARC), trues+scatters (ASC) and total counts (ARSC) for either 3DFBP or OSEM (p<0.05). Total counts with only AC stood out however, with an up to 160% larger bias. In general, there was no difference in bias found between 3DFBP and OSEM, except in parameter Va and Ki. Conclusion: According to our results, the methodology of correcting the PET data for randoms and scatters performed well for the dynamic images where frames have much lower counts compared to static images. Generally, no bias was introduced by the corrections and their importance was emphasized since omitting them increased bias extensively.

  1. {sup 18}F-FLT uptake kinetics in head and neck squamous cell carcinoma: A PET imaging study

    SciTech Connect (OSTI)

    Liu, Dan Fenwick, John D.; Chalkidou, Anastasia; Landau, David B.; Marsden, Paul K.

    2014-04-15

    Purpose: To analyze the kinetics of 3{sup ′}-deoxy-3{sup ′}-[F-18]-fluorothymidine (18F-FLT) uptake by head and neck squamous cell carcinomas and involved nodes imaged using positron emission tomography (PET). Methods: Two- and three-tissue compartment models were fitted to 12 tumor time-activity-curves (TACs) obtained for 6 structures (tumors or involved nodes) imaged in ten dynamic PET studies of 1 h duration, carried out for five patients. The ability of the models to describe the data was assessed using a runs test, the Akaike information criterion (AIC) and leave-one-out cross-validation. To generate parametric maps the models were also fitted to TACs of individual voxels. Correlations between maps of different parameters were characterized using Pearson'sr coefficient; in particular the phosphorylation rate-constants k{sub 3-2tiss} and k{sub 5} of the two- and three-tissue models were studied alongside the flux parameters K{sub FLT-2tiss} and K{sub FLT} of these models, and standardized uptake values (SUV). A methodology based on expectation-maximization clustering and the Bayesian information criterion (“EM-BIC clustering”) was used to distil the information from noisy parametric images. Results: Fits of two-tissue models 2C3K and 2C4K and three-tissue models 3C5K and 3C6K comprising three, four, five, and six rate-constants, respectively, pass the runs test for 4, 8, 10, and 11 of 12 tumor TACs. The three-tissue models have lower AIC and cross-validation scores for nine of the 12 tumors. Overall the 3C6K model has the lowest AIC and cross-validation scores and its fitted parameter values are of the same orders of magnitude as literature estimates. Maps ofK{sub FLT} and K{sub FLT-2tiss} are strongly correlated (r = 0.85) and also correlate closely with SUV maps (r = 0.72 for K{sub FLT-2tiss}, 0.64 for K{sub FLT}). Phosphorylation rate-constant maps are moderately correlated with flux maps (r = 0.48 for k{sub 3-2tiss} vs K{sub FLT-2tiss} and r = 0.68 for k{sub 5} vs K{sub FLT}); however, neither phosphorylation rate-constant correlates significantly with SUV. EM-BIC clustering reduces the parametric maps to a small number of levels—on average 5.8, 3.5, 3.4, and 1.4 for K{sub FLT-2tiss}, K{sub FLT}, k{sub 3-2tiss}, and k{sub 5.} This large simplification is potentially useful for radiotherapy dose-painting, but demonstrates the high noise in some maps. Statistical simulations show that voxel level noise degrades TACs generated from the 3C6K model sufficiently that the average AIC score, parameter bias, and total uncertainty of 2C4K model fits are similar to those of 3C6K fits, whereas at the whole tumor level the scores are lower for 3C6K fits. Conclusions: For the patients studied here, whole tumor FLT uptake time-courses are represented better overall by a three-tissue than by a two-tissue model. EM-BIC clustering simplifies noisy parametric maps, providing the best description of the underlying information they contain and is potentially useful for radiotherapy dose-painting. However, the clustering highlights the large degree of noise present in maps of the phosphorylation rate-constantsk{sub 5} and k{sub 3-2tiss}, which are conceptually tightly linked to cellular proliferation. Methods must be found to make these maps more robust—either by constraining other model parameters or modifying dynamic imaging protocols.

  2. Tumor Metabolism and Perfusion in Head and Neck Squamous Cell Carcinoma: Pretreatment Multimodality Imaging With {sup 1}H Magnetic Resonance Spectroscopy, Dynamic Contrast-Enhanced MRI, and [{sup 18}F]FDG-PET

    SciTech Connect (OSTI)

    Jansen, Jacobus F.A.; Schoeder, Heiko; Lee, Nancy Y.; Stambuk, Hilda E.; Wang Ya; Fury, Matthew G.; Patel, Senehal G.; Pfister, David G.; Shah, Jatin P.; Koutcher, Jason A.; Shukla-Dave, Amita

    2012-01-01

    Purpose: To correlate proton magnetic resonance spectroscopy ({sup 1}H-MRS), dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), and {sup 18}F-labeled fluorodeoxyglucose positron emission tomography ([{sup 18}F]FDG PET) of nodal metastases in patients with head and neck squamous cell carcinoma (HNSCC) for assessment of tumor biology. Additionally, pretreatment multimodality imaging was evaluated for its efficacy in predicting short-term response to treatment. Methods and Materials: Metastatic neck nodes were imaged with {sup 1}H-MRS, DCE-MRI, and [{sup 18}F]FDG PET in 16 patients with newly diagnosed HNSCC, before treatment. Short-term patient radiological response was evaluated at 3 to 4 months. Correlations among {sup 1}H-MRS (choline concentration relative to water [Cho/W]), DCE-MRI (volume transfer constant [K{sup trans}]; volume fraction of the extravascular extracellular space [v{sub e}]; and redistribution rate constant [k{sub ep}]), and [{sup 18}F]FDG PET (standard uptake value [SUV] and total lesion glycolysis [TLG]) were calculated using nonparametric Spearman rank correlation. To predict short-term responses, logistic regression analysis was performed. Results: A significant positive correlation was found between Cho/W and TLG ({rho} = 0.599; p = 0.031). Cho/W correlated negatively with heterogeneity measures of standard deviation std(v{sub e}) ({rho} = -0.691; p = 0.004) and std(k{sub ep}) ({rho} = -0.704; p = 0.003). Maximum SUV (SUVmax) values correlated strongly with MRI tumor volume ({rho} = 0.643; p = 0.007). Logistic regression indicated that std(K{sup trans}) and SUVmean were significant predictors of short-term response (p < 0.07). Conclusion: Pretreatment multimodality imaging using {sup 1}H-MRS, DCE-MRI, and [{sup 18}F]FDG PET is feasible in HNSCC patients with nodal metastases. Additionally, combined DCE-MRI and [{sup 18}F]FDG PET parameters were predictive of short-term response to treatment.

  3. Method for selective recovery of PET-usable quantities of [.sup.18 F] fluoride and [.sup.13 N] nitrate/nitrite from a single irradiation of low-enriched [.sup.18 O] water

    DOE Patents [OSTI]

    Ferrieri, Richard A.; Schlyer, David J.; Shea, Colleen

    1995-06-13

    A process for simultaneously producing PET-usable quantities of [.sup.13 N]NH.sub.3 and [.sup.18 F]F.sup.- for radiotracer synthesis is disclosed. The process includes producing [.sup.13 N]NO.sub.2.sup.- /NO.sub.3.sup.- and [.sup.18 F]F.sup.- simultaneously by exposing a low-enriched (20%-30%) [.sup.18 O]H.sub.2 O target to proton irradiation, sequentially isolating the [.sup.13 N]NO.sub.2.sup.- /NO.sub.3.sup.- and [.sup.18 F]F.sup.- from the [.sup.18 O]H.sub.2 O target, and reducing the [.sup.13 N]NO.sub.2.sup.- /NO.sub.3.sup.- to [.sup.13 N]NH.sub.3. The [.sup.13 N]NH.sub.3 and [.sup.18 F]F.sup.- products are then conveyed to a laboratory for radiotracer applications. The process employs an anion exchange resin for isolation of the isotopes from the [.sup.18 O]H.sub.2 O, and sequential elution of [.sup.13 N]NO.sub.2.sup.- /NO.sub.3.sup.- and [ .sup.18 F]F.sup.- fractions. Also the apparatus is disclosed for simultaneously producing PET-usable quantities of [.sup.13 N]NH.sub.3 and [.sup.18 F]F.sup.- from a single irradiation of a single low-enriched [.sup.18 O]H.sub.2 O target.

  4. Application of Two Phase (Liquid/Gas) Xenon Gamma-Camera for the Detection of Special Nuclear Material and PET Medical Imaging

    SciTech Connect (OSTI)

    McKinsey, Daniel Nicholas

    2013-08-27

    The McKinsey group at Yale has been awarded a grant from DTRA for the building of a Liquid Xenon Gamma Ray Color Camera (LXe-GRCC), which combines state-of-the-art detection of LXe scintillation light and time projection chamber (TPC) charge readout. The DTRA application requires a movable detector and hence only a single phase (liquid) xenon detector can be considered in this case. We propose to extend the DTRA project to applications that allow a two phase (liquid/gas) xenon TPC. This entails additional (yet minimal) hardware and extension of the research effort funded by DTRA. The two phase detector will have better energy and angular resolution. Such detectors will be useful for PET medical imaging and detection of special nuclear material in stationary applications (e.g. port of entry). The expertise of the UConn group in gas phase TPCs will enhance the capabilities of the Yale group and the synergy between the two groups will be very beneficial for this research project as well as the education and research projects of the two universities. The LXe technology to be used in this project has matured rapidly over the past few years, developed for use in detectors for nuclear physics and astrophysics. This technology may now be applied in a straightforward way to the imaging of gamma rays. According to detailed Monte Carlo simulations recently performed at Yale University, energy resolution of 1% and angular resolution of 3 degrees may be obtained for 1.0 MeV gamma rays, using existing technology. With further research and development, energy resolution of 0.5% and angular resolution of 1.3 degrees will be possible at 1.0 MeV. Because liquid xenon is a high density, high Z material, it is highly efficient for scattering and capturing gamma rays. In addition, this technology scales elegantly to large detector areas, with several square meter apertures possible. The Yale research group is highly experienced in the development and use of noble liquid detectors for astrophysics, most recently in the XENON10 experiment. The existing facilities at Yale are fully adequate for the completion of this project. The facilities of the UConn group at the LNS at Avery Point include a (clean) lab for detector development and this group recently delivered an Optical Readout TPC (O-TPC) for research in Nuclear Astrophysics at the TUNL in Duke University. The machine shop at UConn will be used (free of charge) for producing the extra hardware needed for this project including grids and frames.

  5. Method for selective recovery of PET-usable quantities of [{sup 18}F] fluoride and [{sup 13}N] nitrate/nitrite from a single irradiation of low-enriched [{sup 18}O] water

    DOE Patents [OSTI]

    Ferrieri, R.A.; Schlyer, D.J.; Shea, C.

    1995-06-13

    A process for simultaneously producing PET-usable quantities of [{sup 13}N]NH{sub 3} and [{sup 18}F]F{sup {minus}} for radiotracer synthesis is disclosed. The process includes producing [{sup 13}N]NO{sub 2}{sup {minus}}/NO{sub 3}{sup {minus}}and [{sup 18}F]F{sup {minus}} simultaneously by exposing a low-enriched (20%-30%) [{sup 18}O]H{sub 2}O target to proton irradiation, sequentially isolating the [{sup 13}N]NO{sub 2}{sup {minus}}/NO{sub 3}{sup {minus}} and [{sup 18}F]F{sup {minus}} from the [{sup 18}O]H{sub 2}O target, and reducing the [{sup 13}N]NO{sub 2}{sup {minus}}/NO{sub 3}{sup {minus}} to [{sup 13}N]NH{sub 3}. The [{sup 13}N]NH{sub 3} and [{sup 18}F]F{sup {minus}} products are then conveyed to a laboratory for radiotracer applications. The process employs an anion exchange resin for isolation of the isotopes from the [{sup 18}O]H{sub 2}O, and sequential elution of [{sup 13}N]NO{sub 2}{sup {minus}}/NO{sub 3}{sup {minus}} and [{sup 18}F]F{sup {minus}} fractions. Also the apparatus is disclosed for simultaneously producing PET-usable quantities of [{sup 13}N]NH{sub 3} and [{sup 18}F]F{sup {minus}} from a single irradiation of a single low-enriched [{sup 18}O]H{sub 2}O target. 2 figs.

  6. MO-G-17A-07: Improved Image Quality in Brain F-18 FDG PET Using Penalized-Likelihood Image Reconstruction Via a Generalized Preconditioned Alternating Projection Algorithm: The First Patient Results

    SciTech Connect (OSTI)

    Schmidtlein, CR; Beattie, B; Humm, J; Li, S; Wu, Z; Xu, Y; Zhang, J; Shen, L; Vogelsang, L; Feiglin, D; Krol, A

    2014-06-15

    Purpose: To investigate the performance of a new penalized-likelihood PET image reconstruction algorithm using the 1{sub 1}-norm total-variation (TV) sum of the 1st through 4th-order gradients as the penalty. Simulated and brain patient data sets were analyzed. Methods: This work represents an extension of the preconditioned alternating projection algorithm (PAPA) for emission-computed tomography. In this new generalized algorithm (GPAPA), the penalty term is expanded to allow multiple components, in this case the sum of the 1st to 4th order gradients, to reduce artificial piece-wise constant regions (“staircase” artifacts typical for TV) seen in PAPA images penalized with only the 1st order gradient. Simulated data were used to test for “staircase” artifacts and to optimize the penalty hyper-parameter in the root-mean-squared error (RMSE) sense. Patient FDG brain scans were acquired on a GE D690 PET/CT (370 MBq at 1-hour post-injection for 10 minutes) in time-of-flight mode and in all cases were reconstructed using resolution recovery projectors. GPAPA images were compared PAPA and RMSE-optimally filtered OSEM (fully converged) in simulations and to clinical OSEM reconstructions (3 iterations, 32 subsets) with 2.6 mm XYGaussian and standard 3-point axial smoothing post-filters. Results: The results from the simulated data show a significant reduction in the 'staircase' artifact for GPAPA compared to PAPA and lower RMSE (up to 35%) compared to optimally filtered OSEM. A simple power-law relationship between the RMSE-optimal hyper-parameters and the noise equivalent counts (NEC) per voxel is revealed. Qualitatively, the patient images appear much sharper and with less noise than standard clinical images. The convergence rate is similar to OSEM. Conclusions: GPAPA reconstructions using the 1{sub 1}-norm total-variation sum of the 1st through 4th-order gradients as the penalty show great promise for the improvement of image quality over that currently achieved with clinical OSEM reconstructions.

  7. Poster — Thur Eve — 03: Application of the non-negative matrix factorization technique to [{sup 11}C]-DTBZ dynamic PET data for the early detection of Parkinson's disease

    SciTech Connect (OSTI)

    Lee, Dong-Chang; Jans, Hans; McEwan, Sandy; Riauka, Terence; Martin, Wayne; Wieler, Marguerite

    2014-08-15

    In this work, a class of non-negative matrix factorization (NMF) technique known as alternating non-negative least squares, combined with the projected gradient method, is used to analyze twenty-five [{sup 11}C]-DTBZ dynamic PET/CT brain data. For each subject, a two-factor model is assumed and two factors representing the striatum (factor 1) and the non-striatum (factor 2) tissues are extracted using the proposed NMF technique and commercially available factor analysis software “Pixies”. The extracted factor 1 and 2 curves represent the binding site of the radiotracer and describe the uptake and clearance of the radiotracer by soft tissues in the brain, respectively. The proposed NMF technique uses prior information about the dynamic data to obtain sample time-activity curves representing the striatum and the non-striatum tissues. These curves are then used for “warm” starting the optimization. Factor solutions from the two methods are compared graphically and quantitatively. In healthy subjects, radiotracer uptake by factors 1 and 2 are approximately 35–40% and 60–65%, respectively. The solutions are also used to develop a factor-based metric for the detection of early, untreated Parkinson's disease. The metric stratifies healthy subjects from suspected Parkinson's patients (based on the graphical method). The analysis shows that both techniques produce comparable results with similar computational time. The “semi-automatic” approach used by the NMF technique allows clinicians to manually set a starting condition for “warm” starting the optimization in order to facilitate control and efficient interaction with the data.

  8. Adaptation of the modified BoucWen model to compensate for hysteresis in respiratory motion for the list-mode binning of cardiac SPECT and PET acquisitions: Testing using MRI

    SciTech Connect (OSTI)

    Dasari, Paul K. R.; Shazeeb, Mohammed Salman; Knik, Arda; Lindsay, Clifford; Mukherjee, Joyeeta M.; Johnson, Karen L.; King, Michael A.

    2014-11-01

    Purpose: Binning list-mode acquisitions as a function of a surrogate signal related to respiration has been employed to reduce the impact of respiratory motion on image quality in cardiac emission tomography (SPECT and PET). Inherent in amplitude binning is the assumption that there is a monotonic relationship between the amplitude of the surrogate signal and respiratory motion of the heart. This assumption is not valid in the presence of hysteresis when heart motion exhibits a different relationship with the surrogate during inspiration and expiration. The purpose of this study was to investigate the novel approach of using the BoucWen (BW) model to provide a signal accounting for hysteresis when binning list-mode data with the goal of thereby improving motion correction. The study is based on the authors previous observations that hysteresis between chest and abdomen markers was indicative of hysteresis between abdomen markers and the internal motion of the heart. Methods: In 19 healthy volunteers, they determined the internal motion of the heart and diaphragm in the superiorinferior direction during free breathing using MRI navigators. A visual tracking system (VTS) synchronized with MRI acquisition tracked the anteriorposterior motions of external markers placed on the chest and abdomen. These data were employed to develop and test the BoucWen model by inputting the VTS derived chest and abdomen motions into it and using the resulting output signals as surrogates for cardiac motion. The data of the volunteers were divided into training and testing sets. The training set was used to obtain initial values for the model parameters for all of the volunteers in the set, and for set members based on whether they were or were not classified as exhibiting hysteresis using a metric derived from the markers. These initial parameters were then employed with the testing set to estimate output signals. Pearsons linear correlation coefficient between the abdomen, chest, average of chest and abdomen markers, and BoucWen derived signals versus the true internal motion of the heart from MRI was used to judge the signals match to the heart motion. Results: The results show that the BoucWen model generated signals demonstrated strong correlation with the heart motion. This correlation was slightly larger on average than that of the external surrogate signals derived from the abdomen marker, and average of the abdomen and chest markers, but was not statistically significantly different from them. Conclusions: The results suggest that the proposed model has the potential to be a unified framework for modeling hysteresis in respiratory motion in cardiac perfusion studies and beyond.

  9. Advanced Instrumentation for Positron Emission Tomography [PET

    DOE R&D Accomplishments [OSTI]

    Derenzo, S. E.; Budinger, T. F.

    1985-04-01

    This paper summarizes the physical processes and medical science goals that underlay modern instrumentation design for Positron Emission Tomography. The paper discusses design factors such as detector material, crystalphototube coupling, shielding geometry, sampling motion, electronics design, time-of-flight, and the interrelationships with quantitative accuracy, spatial resolution, temporal resolution, maximum data rates, and cost.

  10. PET And Bioluminescent Imaging Aid Evaluation Of Stem Cells'...

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    interactive.snm.orgindex.cfm?PageID903&CFID27713770&CFTOKEN13840564 Submitted: Tuesday, December 4, 2007 - 12:00am...

  11. The Dog Days of Summer - Capitalizing on the Pet Market | Department...

    Office of Energy Efficiency and Renewable Energy (EERE) Indexed Site

    Leveraging Seasonal Opportunities for Marketing Energy Efficiency Hit the Road: Applying Lessons from National Campaigns to a Local Context (201) Strengthening the Front Lines: ...

  12. Very fast doped LaBr.sub.3 scintillators and time-of-flight PET

    DOE Patents [OSTI]

    Shah, Kanai S.

    2006-10-31

    The present invention concerns very fast scintillator materials capable of resolving the position of an annihilation event within a portion of a human body cross-section. In one embodiment, the scintillator material comprises LaBr.sub.3 doped with cerium. Particular attention is drawn to LaBr.sub.3 doped with a quantity of Ce that is chosen for improving the timing properties, in particular the rise time and resultant timing resolution of the scintillator, and locational capabilities of the scintillator.

  13. PET And Bioluminescent Imaging Aid Evaluation Of Stem Cells' Potential For

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    New Ways To Treat Disease (Society of Nuclear Medicine) | Jefferson Lab interactive.snm.org/index.cfm?PageID=903&CFID=27713770&CFTOKEN=13840564 Submitted: Tuesday, December 4, 2007 - 1

  14. Improved Production and Separation Technologies for Non-standard PET Radionuclides

    SciTech Connect (OSTI)

    Welch, Michael J. [Washington University, St. Louis, MO] [Washington University, St. Louis, MO (United States); Lapi, Suzanne [Washington University, St. Louis, MO] [Washington University, St. Louis, MO (United States)

    2012-12-01

    Brief summary of activity issues, concerns, successes: Project 1 is completed. We have optimized plating parameters with the new target bodies and slanted target plating system. The target station has been mounted on the end of the beamline, service lines have been nstalled to allow for helium and water cooling. We have routinely produced copper-64 using the new slanted target system in conjunction with our automated system. In project 2, we successfully fabricated and tested microfluidic extraction devices made out of two organic solvent-resistant polymers, thiolene and SIFEL. Initially, we developed analytical and computational models to describe the extraction process, and used the model to design the microfluidic devices. Then we optimized the microfabrication procedures to manufacture microreactors, followed by optimization of the operational parameters to obtain a stable aqueous-organic interface, which is critical for efficient extraction. When we tested the thiolene devices for extraction of copper-64, we observed very low extraction efficiencies (less than 5%) due to adhesion of copper to thiolene. However, we observed very high extraction efficiencies with SIFEL devices (greater than 95%), which are due to the high interfacial area for extraction and shorter diffusion lengths.

  15. PET: An Emerging Tool in the Fight Against Cancer |GE Global...

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    proud to say that much of the preclinical R&D work occurred right here at GE Global Research. In addition to x-ray, doctors can now tap into other imaging modalities, like MRI...

  16. T'

    Office of Legacy Management (LM)

    j: ;;I : T' j-jE: i t 1 ,iu" I;ts'J-F.; +X'l'W 20, ,57 I::anch T;3 cl:l:i xi ,.&A O.Cfice J su T>J...

  17. Lu1-xI3:Cex--A Scintillator for gamma ray spectroscopy and time-of-flight PET

    DOE Patents [OSTI]

    Shah, Kanai S.

    2009-03-17

    The present invention concerns very fast scintillator materials comprising lutetium iodide doped with Cerium Lu.sub.1-xI.sub.3:Ce.sub.x; LuI.sub.3:Ce). The LuI.sub.3 scintillator material has surprisingly good characteristics including high light output, high gamma ray stopping efficiency, fast response, low cost, good proportionality, and minimal afterglow that the material is useful for gamma ray spectroscopy, medical imaging, nuclear and high energy physics research, diffraction, non-destructive testing, nuclear treaty verification and safeguards, and geological exploration. The timing resolution of the scintillators of the present invention provide compositions capable of resolving the position of an annihilation event within a portion of a human body cross-section.

  18. 2013 Nuclear Workforce Development ...

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Practice in Nuclear Medicine Radiopharmacy Patient Care Medical Imaging & Computers Moderator: Deborah M. Gibbs, MEd, PET, CNMT Lead Nuclear Medicine PET Facility...

  19. Final Report for "Boron and Tin in Nuclear Medicien: The Development of Reactive Solid-State Reagents for PET and SPECT

    SciTech Connect (OSTI)

    George W. Kabalka

    2006-01-13

    The research program was directed at the use of functionalized organometallic reagents that would rapidly react with radiolabeled agents generated by a medical cyclotron or reactor. The radioisotopes included fluorine-18, oxgygen-15, nitrogen-13, carbon-11 and iodine-123; all short lived nuclides of importantce in nuclear medicine imaging studies utilizing emission tomography techniques. The early studies led to the development of extensive new isotope incorporation chemistry. These studies validated the feasibility of using reactive intermediates, such as the organoboranes, and acted as a catalyst for others to investigate organometallic agents based on mercury, tin, and silicon. A large number of radiolabeling techniques and radiopharmaceuticals were developed. These included agents for use in oncology, neurology, and metabolism. The research resulted in the generation of one hundred and one journal articles, eighty seven refereed published abstracts and forty one invited lectures. Thirteen postdoctoral students, fourteen graduate students, and twenty eight undergraduate students were trained in the scientific aspects of nuclear medicine imaging under the asupices of this grant.

  20. Lu.sub.1-xI.sub.3:Ce.sub.x-a scintillator for gamma-ray spectroscopy and time-of-flight pet

    DOE Patents [OSTI]

    Shah, Kanai S.

    2008-02-12

    The present invention includes very fast scintillator materials including lutetium iodide doped with Cerium (Lu.sub.1-xI.sub.3:Ce.sub.x; LuI.sub.3:Ce). The LuI.sub.3 scintillator material has surprisingly good characteristics including high light output, high gamma-ray stopping efficiency, fast response, low cost, good proportionality, and minimal afterglow that the material is useful for gamma-ray spectroscopy, medical imaging, nuclear and high energy physics research, diffraction, non-destructive testing, nuclear treaty verification and safeguards, and geological exploration.

  1. Lu.sub.1-xI.sub.3:Ce.sub.x--a scintillator for gamma ray spectroscopy and time-of-flight PET

    DOE Patents [OSTI]

    Shah, Kanai S.

    2007-02-06

    The present invention concerns very fast scintillator materials comprising lutetium iodide doped with Cerium (Lu.sub.1-xI.sub.3:Ce.sub.x; LuI.sub.3:Ce). The LuI.sub.3 scintillator material has surprisingly good characteristics including high light output, high gamma ray stopping efficiency, fast response, low cost, good proportionality, and minimal afterglow that the material is useful for gamma ray spectroscopy, medical imaging, nuclear and high energy physics research, diffraction, non-destructive testing, nuclear treaty verification and safeguards, and geological exploration. The timing resolution of the scintillators of the present invention provide compositions capable of resolving the position of an annihilation event within a portion of a human body cross-section.

  2. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging

    DOE Patents [OSTI]

    Mease, Ronnie C. (Coram, NY); Mausner, Leonard F. (Stony Brook, NY); Srivastava, Suresh C. (Setauket, NY)

    1994-01-01

    Cyclo agents useful in forming antibody-metal conjugates useful for diagnostic and therapeutic purposes. New compounds and processes of forming these compounds are disclosed including 4-haloacetamido-trans-1,2-diaminocyclohexyl polyaminocarboxylate and 4-isothiocyanato-trans-1,2-diamino cyclohexane-N,N,N',N'-tetra acetic acid.

  3. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and SPECT and PET imaging

    DOE Patents [OSTI]

    Mease, R.C.; Mausner, L.F.; Srivastava, S.C.

    1994-03-08

    Cyclo agents are described which are useful in forming antibody-metal conjugates which are used for diagnostic and therapeutic purposes. New compounds and processes of forming these compounds are disclosed including 4-haloacetamido-trans-1,2diaminocyclohexyl polyaminocarboxylate and 4-isothiocyanato-trans-1,2diamino cyclohexane-N,N,N',N'-tetra acetic acid. No Drawings

  4. Correction of MRI-induced geometric distortions in whole-body...

    Office of Scientific and Technical Information (OSTI)

    Title: Correction of MRI-induced geometric distortions in whole-body small animal PET-MRI Purpose: The fusion of positron emission tomography (PET) and magnetic resonance imaging ...

  5. Virent is Replacing Crude Oil

    Office of Energy Efficiency and Renewable Energy (EERE) Indexed Site

    Crude Oil Reformate BTX PX PTA PET resin Preform Bottle Naphtha Biomass Reformate BTX PX Virent PET fiber Textile Clothing BioFormPX Brand Supply chain innovation Opportunity ...

  6. LAKESHORE AVON BR ANT-EDEN ALD EN-LANC ASTER AU BURN W SH ELDON

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    81 § ¨ ¦ 81 LAKESHORE AVON BR ANT-EDEN ALD EN-LANC ASTER AU BURN W SH ELDON CALEDONIA HURON C REEK LEIC EST ER COL DEN ASH FORD INDIAN FALLS LAWTONS SAR DINIA RPD-037 -2 GLENWOOD PU LASKI PAVILION CON CORD COL LINS N ELM A ORC HARD PARK-H AMBU RG DANLEY CORNERS ST ILLWAT ER CHAFF EE-ARCAD E FAYETT E-WATERLOO LAKEVIEW JAVA SEN EC A W ELLER Y AU RORA E ZOAR BU FFALO TIOGA SILVER LAKE AKR ON ROM E RAT HBON E ALM A BET HANY WYOMING ULYSSES BR ANCH W SAN DY CREEK COL LINS BLOOMFIELD E LEBANON

  7. Correction of MRI-induced geometric distortions in whole-body small animal

    Office of Scientific and Technical Information (OSTI)

    PET-MRI (Journal Article) | SciTech Connect Correction of MRI-induced geometric distortions in whole-body small animal PET-MRI Citation Details In-Document Search Title: Correction of MRI-induced geometric distortions in whole-body small animal PET-MRI Purpose: The fusion of positron emission tomography (PET) and magnetic resonance imaging (MRI) data can be a challenging task in whole-body PET-MRI. The quality of the registration between these two modalities in large field-of-views (FOV) is

  8. Profiles in garbage: Polyethylene terephthalate

    SciTech Connect (OSTI)

    Miller, C.

    1997-11-01

    Polyethylene terephthalate (PET) is a plastic resin used primarily to make bottles. Soft drinks -- along with salad dressing, fruit juices, peanut butter, and other household and consumer products -- use PET bottles. PET also is used for film, sheeting for cups and food trays, oven-safe trays, and other uses. PET is a relatively new packaging resin, first commercialized in the early 1970s. Because it is an ``engineered`` resin, PET is more expensive than commodity resins such as high-density polyethylene (HDPE) and, for the same reason, it is usually the highest valued plastic recyclable.

  9. Impact of {sup 18}F-Fluorodeoxyglucose Positron Emission Tomography Before and After Definitive Radiation Therapy in Patients With Apparently Solitary Plasmacytoma

    SciTech Connect (OSTI)

    Kim, Paul J.; Hicks, Rodney J.; Wirth, Andrew; Ryan, Gail; Seymour, John F.; Prince, H. Miles

    2009-07-01

    Purpose: To evaluate the impact of {sup 18}F-fluorodeoxyglucose positron emission tomography (FDG-PET) on management of patients with apparently isolated plasmacytoma. Methods and Materials: Twenty-one patients with apparently solitary plasmacytoma who underwent FDG-PET for staging or restaging were identified from a central PET database. They were either candidates for or had received definitive radiation therapy (RT). Results: Seventeen patients had initial staging scans for bone (n = 11) or soft tissue (n = 6) plasmacytomas, and 11 had PET scans after RT. Only 1 of 14 known untreated sites of plasmacytoma was not identified on staging PET (lesion sensitivity = 93%). Three plasmacytomas were excised before PET. Staging PET influenced management in 6 of 17 patients (35%) by showing multiple myeloma (n = 1), discouraging RT after complete resection (n = 1), excluding plasmacytoma at a second site (n = 1), by increasing RT fields (n = 2), or by suggesting sarcoidosis (n = 1). Fifteen of 17 patients with initial staging PET scans received definitive RT. Restaging PET scans after RT showed complete metabolic response in 8 of 11 cases and progressive disease in 2. Two patients with either no response or partial metabolic response had late responses. Staging sestamibi and PET scans were concordant in five of six occasions (one sestamibi scan was false negative). Conclusions: FDG-PET has value for staging and RT planning in plasmacytoma and potentially could have a role in response-assessment after RT. Slow resolution of FDG uptake posttreatment does not necessarily imply an adverse prognosis.

  10. Synthesis of 4-substituted-trans-1,2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging

    DOE Patents [OSTI]

    Mease, Ronnie C.; Kolsky, Kathryn L.; Mausner, Leonard F.; Srivastava, Suresh C.

    1997-06-03

    Cyclohexyl chelating agents useful in forming antibody-metal conjugates useful for diagnostic and therapeutic purposes. New compounds and processes of forming these compounds are disclosed including 4-haloacetamido-trans-1,2-diaminocyclohexyl polyaminocarboxylate and 4-isothiocyanato-trans-1,2-diamino cyclohexane-N, N, N', N'-tetra acetic acid.

  11. Synthesis of 4-substituted-trans-1,2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and SPECT and PET imaging

    DOE Patents [OSTI]

    Mease, R.C.; Kolsky, K.L.; Mausner, L.F.; Srivastava, S.C.

    1997-06-03

    Cyclohexyl chelating agents useful in forming antibody-metal conjugates which are used for diagnostic and therapeutic purposes are synthesized. New compounds and processes of forming these compounds are disclosed including 4-haloacetamido-trans-1,2-diaminocyclohexyl polyaminocarboxylate and 4-isothiocyanato-trans-1,2-diamino cyclohexane-N,N,N{prime},N{prime}-tetra acetic acid.

  12. Protonation Studies of a Tungsten Dinitrogen Complex Supported by a Diphosphine Ligand Containing a Pendant Amine

    SciTech Connect (OSTI)

    Weiss, Charles J.; Egbert, Jonathan D.; Chen, Shentan; Helm, Monte L.; Bullock, R. Morris; Mock, Michael T.

    2014-05-12

    Treatment of trans-[W(N2)2(dppe)(PEtNMePEt)] (dppe = Ph2PCH2CH2PPh2; PEtNMePEt = Et2PCH2N(Me)CH2PEt2) with three equivalents of tetrafluoroboric acid (HBF4?Et2O) at -78 C generated the seven-coordinate tungsten hydride trans-[W(N2)2(H)(dppe)(PEtNMePEt)][BF4]. Depending on the temperature of the reaction, protonation of a pendant amine is also observed, affording trans-[W(N2)2(H)(dppe)(PEtNMe(H)PEt)][BF4]2, with formation of the hydrazido complex, [W(NNH2)(dppe)(PEtNMe(H)PEt)][BF4]2, as a minor product. Similar product mixtures were obtained using triflic acid (HOTf). Upon acid addition to the carbonyl analogue, cis-[W(CO)2(dppe)(PEtNMePEt)], the seven-coordinate carbonyl-hydride complex, trans-[W(CO)2(H)(dppe)(PEtN(H)MePEt)][OTf]2 was generated. The mixed diphosphine complex without the pendant amine in the ligand backbone, trans-[W(N2)2(dppe)(depp)] (depp = Et2P(CH2)3PEt2), was synthesized and treated with HBF4?Et2O, selectively generating a hydrazido complex, [W(NNH2)(F)(dppe)(depp)][BF4]. Computational analysis was used to probe proton affinity of three sites of protonation, the metal, pendant amine, and N2 ligand in these complexes. Room temperature reactions with 100 equivalents of HOTf produced NH4+ from reduction of the N2 ligand (electrons come from W). The addition of 100 equivalents HOTf to trans-[W(N2)2(dppe)(PEtNMePEt)] afforded 0.88 0.02 equivalents NH4+, while 0.36 0.02 equivalents of NH4+was formed upon treatment of trans-[W(N2)2(dppe)(depp)], the complex without the pendant amine. This work was supported as part of the Center for Molecular Electrocatalysis, an Energy Frontier Research Center funded by the U.S. Department of Energy Office of Science, Office of Basic Energy Sciences. Computational resources were provided by the National Energy Research Scientific Computing Center (NERSC) at Lawrence Berkeley National Laboratory. Pacific Northwest National Laboratory is operated by Battelle for DOE.

  13. Sheltering in Place | Y-12 National Security Complex

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    everyone inside (including pets). Close all doors and windows. Turn off and close all ventilation systems, including: Air conditioning Attic & exhaust fans Furnaces Fireplace...

  14. Environment/Health/Safety (EHS): Radiation Protection Group

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    facility BELLA facility BELLA facility BELLA NDCX NDCX Gretina Gamma particle device PET Scanner APEX APEX APEX LASER LASER Rifle, CO Rifle, CO The group: Authorizes work with...

  15. Isotopes

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    while LANL-produced germanium-68 is used to calibrate Positron Emission Tomography (PET) equipment used for a broad spectrum of diagnostic procedures. Some isotopes produced,...

  16. Positron emission tomography probes for imaging immune activation and selected cancers

    DOE Patents [OSTI]

    Radu, Caius G. (Los Angeles, CA); Witte, Owen N. (Los Angeles, CA); Nair-Gill, Evan David (Los Angeles, CA); Satyamurthy, Nagichettiar (Los Angeles, CA); Shu, Chengyi J. (Los Angeles, CA); Czernin, Johannes (Los Angeles, CA)

    2012-01-24

    Compounds for use as PET probes and methods for synthesizing and using these, comprising [.sup.18F]D-FAC and other cytosine and adenosine analogs.

  17. Multimodality Plant Imaging of Small Molecules

    SciTech Connect (OSTI)

    DeJesus, Onofre T.

    2015-03-12

    Positron emission tomography (PET) is a non-invasive imaging technique used to diagnose disease and monitor therapy. PET imaging has had tremendous impact in healthcare delivery resulting in improved outcomes and reduced costs. The discovery and development of PET is one of the achievements of the Department of Energys (DOE) support of the peaceful uses of the atom. This project is a logical extension of the use of the PET technique to live plant imaging to advance DOEs biological and environmental initiatives.

  18. 48x96 poster template

    Office of Scientific and Technical Information (OSTI)

    Elliptically Curved PET Crystals Introduction and Measurement Goals Spectroscopy provides valuable information about the temperature and density of a compressed pellet in a plasma. ...

  19. SEQUEDEX

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    diseases (whether arising from bacteria, parasites, or viruses; characterizing gut, oral and skin microbiomes of humans, livestock, and pets; metagenomics of soils, rivers,...

  20. Tongwei Group | Open Energy Information

    Open Energy Info (EERE)

    with animal feed as its core business, and it is also involved in industries such as chemistry, IT, bioengineering, international trade, pet food, building and real estate as...

  1. SSRL HEADLINES August 2008

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    variety of drinks. Staff talked, laughed, met each others' families and pets, played volleyball, practiced their golf chipping skills, and generally relaxed and had a good time....

  2. Picture of the Week: Hot cells for medical isotopes

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    the diagnosis of cardiac disease, calibration of PET scanners which in turn diagnose cancer, neurological disease, inflammatory diseases, trauma, and other circulatory diseases,...

  3. Platts 2nd Annual Renewable Chemicals Conference

    Annual Energy Outlook [U.S. Energy Information Administration (EIA)]

    Topsoe, INEOS Bio, Iogen, POET * Cane, Energy crops, Waste * Quality and standards * ... butyl rubber, PET Gevo, Butamax, Cathay, Green, Cobalt Adipic Acid nylon, polyurethane ...

  4. Municipal Solid Waste:

    U.S. Energy Information Administration (EIA) Indexed Site

    of the Department of Energy or any other organization. ... Journal of Energy Resources Technology, "NOx and N2O ... Paper PET Containers & packaging HDPE Textiles PVC ...

  5. Slide 1

    Broader source: Energy.gov (indexed) [DOE]

    field trial of exchange ('12). - Successful engagement with DOE Office of Science and Japan enabled project continuation during year of 0 appropriation. - J Mar Pet Geol (Jan....

  6. A Growing List | U.S. DOE Office of Science (SC)

    Office of Science (SC) Website

    Food sterilization Medical isotope production Simulation of cancer treatments Reliability testing of nuclear weapons Scanning of shipping containers Proposed combination of PET and ...

  7. America's Next Top Energy Innovator Challenge | Department of...

    Office of Energy Efficiency and Renewable Energy (EERE) Indexed Site

    ... SynchroPET's technology can be paired with an existing MRI machine for a simultaneous image. These advances will accelerate the creation of new pharmaceuticals to treat cancers, ...

  8. Integrated X-Ray Reflectivity Measurements for Elliptically Curved...

    Office of Scientific and Technical Information (OSTI)

    Facility (NIF) target chamber at Lawrence Livermore National Laboratory (LLNL). Figure 1 shows the arrangement of the elliptical PET crystals in the snout of a NIF target ...

  9. Integrated X-ray Reflectivity Measurements for Elliptically Curved...

    Office of Scientific and Technical Information (OSTI)

    The elliptically curved pentaerythritol (PET) crystals used in the Supersnout 2 X-ray spectrometer on the National Ignition Facility (NIF) at Lawrence Livermore National Laboratory ...

  10. T'

    Office of Legacy Management (LM)

    j: ;;I : T' j-jE: i t 1 \ ,iu" I;ts'J-F.; ~+X'l'W~ 20, ,$57 I::<c?:v: : ;T pl F ;, -j~eiss~;&el~~-;, ~~~:x!',~al engineer, ~cchnical Cr-anch T;3 cl:l:i xi ~,.&A O.Cfice !J su T>J 3x : sz\,T[jC; 03 NO&( Q>i SU~c$LJ.]~&jCT AT-32 \XTA ' ~~~A?~~IfR~ I&LfX l~LULJT~.Cll..Z~~~~C p" ,- ' \' , , i;l ,,"p' ,~~?;""r~~~~, >,a .;. .,-' $" Y' J pi\rSs;lcJj tJT ~~$TIC~~:3J, LEtCX~ C@>L?AllY Tf-j.! ' < nqiF1 lMc>\:$.:,.,. ::~;{li~tS.Lc, + J

  11. Aridity changes in the Tibetan Plateau in a warming climate

    SciTech Connect (OSTI)

    Gao, Yanhong; Li, Xia; Leung, Lai-Yung R.; Chen, Deliang; Xu, Jianwei

    2015-03-10

    Desertification in the Tibetan Plateau (TP) has drawn increasing attention in the recent decades. It has been postulated as a consequence of climate aridity due to the observed warming. This study quantifies the aridity changes in the TP and attributes the changes to different climatic factors. Using the ratio of P/PET (precipitation to potential evapotranspiration) as an aridity index to indicate changes in dryness and wetness in a given area, P/PET was calculated using observed records at 83 stations in the TP, with PET calculated using the Penman–Monteith (PM) algorithm. Spatial and temporal changes of P/PET in 1979-2011 are analyzed. Results show that stations located in the arid and semi-arid northwestern TP are becoming significantly wetter and stations in the semi-humid southeastern TP are becoming drier, though not significantly, in the recent three decades. The aridity change patterns are significantly correlated with precipitation, sunshine duration and diurnal temperature range changes at confidence level of 99.9% from two-tail t-test. Temporal correlations also confirm the significant correlation between aridity changes with the three variables, with precipitation being the most dominant driver of P/PET changes at interannual time scale. PET changes are insignificant but negatively correlated with P/PET in the cold season. In the warm season, however, correlation between PET changes and P/PET changes are significant at confidence level of 99.9% when the cryosphere melts near the surface. Significant correlation between wind speed changes and aridity changes occurs in limited locations and months. Consistency in the climatology pattern and linear trends in surface air temperature and precipitation calculated using station data, gridded data, and nearest grid-to-stations for the TP average and across sub-basins indicate the robustness of the trends despite the large spatial heterogeneity in the TP that challenge climate monitoring.

  12. Aridity changes in the Tibetan Plateau in a warming climate

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Gao, Yanhong; Li, Xia; Leung, Lai-Yung R.; Chen, Deliang; Xu, Jianwei

    2015-03-10

    Desertification in the Tibetan Plateau (TP) has drawn increasing attention in the recent decades. It has been postulated as a consequence of climate aridity due to the observed warming. This study quantifies the aridity changes in the TP and attributes the changes to different climatic factors. Using the ratio of P/PET (precipitation to potential evapotranspiration) as an aridity index to indicate changes in dryness and wetness in a given area, P/PET was calculated using observed records at 83 stations in the TP, with PET calculated using the Penman–Monteith (PM) algorithm. Spatial and temporal changes of P/PET in 1979-2011 are analyzed.more » Results show that stations located in the arid and semi-arid northwestern TP are becoming significantly wetter and stations in the semi-humid southeastern TP are becoming drier, though not significantly, in the recent three decades. The aridity change patterns are significantly correlated with precipitation, sunshine duration and diurnal temperature range changes at confidence level of 99.9% from two-tail t-test. Temporal correlations also confirm the significant correlation between aridity changes with the three variables, with precipitation being the most dominant driver of P/PET changes at interannual time scale. PET changes are insignificant but negatively correlated with P/PET in the cold season. In the warm season, however, correlation between PET changes and P/PET changes are significant at confidence level of 99.9% when the cryosphere melts near the surface. Significant correlation between wind speed changes and aridity changes occurs in limited locations and months. Consistency in the climatology pattern and linear trends in surface air temperature and precipitation calculated using station data, gridded data, and nearest grid-to-stations for the TP average and across sub-basins indicate the robustness of the trends despite the large spatial heterogeneity in the TP that challenge climate monitoring.« less

  13. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","2/2016","8/15/1990" ,"Release Date:","3/14/2016" ,"Next Release Date:","3/21/2016" ,"Excel File Name:","pet_pri_gnd_dcus_nus_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pri_gnd_dcus_nus_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  14. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1920" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_stoc_typ_d_nus_sae_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_stoc_typ_d_nus_sae_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  15. ,"Finished Motor Gasoline Refinery, Bulk Terminal, and Natural Gas Plant Stocks"

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1993" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_stoc_st_a_epm0f_str_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_stoc_st_a_epm0f_str_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  16. ,"U.S. Downstream Processing of Fresh Feed Input"

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1987" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_pnp_dwns_dc_nus_mbblpd_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_dwns_dc_nus_mbblpd_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  17. ,"U.S. Natural Gas Plant Field Production"

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_pnp_gp_dc_nus_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_gp_dc_nus_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  18. ,"U.S. Downstream Processing of Fresh Feed Input"

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1987" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_pnp_dwns_dc_nus_mbblpd_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_dwns_dc_nus_mbblpd_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  19. ,"U.S. Natural Gas Plant Field Production"

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_pnp_gp_dc_nus_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_gp_dc_nus_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016

  20. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    3,"Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_expc_a_ep00_eex_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_expc_a_ep00_eex_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  1. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    4,"Monthly","12/2015","1/15/1973" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_neti_a_ep00_imn_mbblpd_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_neti_a_ep00_imn_mbblpd_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov"

  2. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1986" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_pipe_dc_r20-r10_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_pipe_dc_r20-r10_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  3. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1986" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_ptb_dc_r20-r10_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_ptb_dc_r20-r10_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  4. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1986" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_tb_dc_r20-r10_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_tb_dc_r20-r10_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  5. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1993" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_pnp_pct_dc_nus_pct_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_pct_dc_nus_pct_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  6. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1985" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_pnp_unc_dcu_nus_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_unc_dcu_nus_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  7. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1993" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_stoc_typ_d_nus_skn_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_stoc_typ_d_nus_skn_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  8. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    60,"Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_stoc_typ_d_nus_skr_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_stoc_typ_d_nus_skr_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  9. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    2,"Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_expc_a_ep00_eex_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_expc_a_ep00_eex_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  10. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1870" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_exp_dc_nus-z00_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_exp_dc_nus-z00_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  11. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1910" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_imp_dc_nus-z00_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_imp_dc_nus-z00_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  12. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    3,"Annual",2015,"6/30/1973" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_neti_a_ep00_imn_mbblpd_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_neti_a_ep00_imn_mbblpd_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  13. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_netr_d_r10-z0p_vnr_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_netr_d_r10-z0p_vnr_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  14. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_pipe_dc_r20-r10_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_pipe_dc_r20-r10_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  15. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_ptb_dc_r20-r10_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_ptb_dc_r20-r10_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  16. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1936" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_res_a_eppr_im0_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_res_a_eppr_im0_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  17. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_tb_dc_r20-r10_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_tb_dc_r20-r10_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  18. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1993" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_pnp_pct_dc_nus_pct_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_pct_dc_nus_pct_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016

  19. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1936" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_pnp_refp_dc_nus_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_refp_dc_nus_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016

  20. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1913" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_stoc_typ_d_nus_sae_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_stoc_typ_d_nus_sae_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  1. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1993" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_stoc_typ_d_nus_skn_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_stoc_typ_d_nus_skn_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  2. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    56,"Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_stoc_typ_d_nus_skr_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_stoc_typ_d_nus_skr_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  3. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    59,"Monthly","12/2015","1/15/1963" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_sum_snd_a_ep00_mbblpd_m_cur.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_sum_snd_a_ep00_mbblpd_m_cur.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  4. THREE SBIR GRANTS AWARDED FOR SSL TECHNOLOGY | Department of...

    Energy Savers [EERE]

    using a PET Power Distribution System Summary: This Phase II project will demonstrate a novel approach to reducing cost of SSL ownership by 35% or more by simultaneously reducing...

  5. Isotopes Products

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    are saving lives, advancing cutting-edge research and keeping the U.S. safe. Products stress and rest Stress and rest Rb-82 PET images in a patient with dipyridamole...

  6. CX-001909: Categorical Exclusion Determination

    Broader source: Energy.gov [DOE]

    MRC Polyethylene Terephthalate (PET) Recycling FacilityCX(s) Applied: B5.1Date: 04/20/2010Location(s): Chicago, IllinoisOffice(s): Energy Efficiency and Renewable Energy, Golden Field Office

  7. Fermilab Today

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Hollywood Palms Employee Appreciation Day For more discounts, visit the employee discount Web page. In the News Crunch time for pet theory on dark matter From Nature, Jan. 21, 2015...

  8. Addiction Studies with Positron Emission Tomography

    ScienceCinema (OSTI)

    Joanna Fowler

    2010-01-08

    Brookhaven scientist Joanna Fowler describes Positron Emission Technology (PET) research at BNL which for the past 30 years has focused in the integration of basic research in radiotracer chemistry with the tools of neuroscience to develop new scientific

  9. Isotopomer analysis of free metabolites from hypoxia-responsive...

    Office of Scientific and Technical Information (OSTI)

    ... In brief, all E. coli BLR(DE3) pET30-GFP cultures were grown in M9 minimal 68 medium ... The first set of cultures was grown in 72 minimal medium containing 2% singly labeled 1- ...

  10. BERAC Meeting Minutes November 5-6, 1998 | U.S. DOE Office of...

    Office of Science (SC) Website

    ... few years. Much of our effort is in cancer imaging. We have a large program in studying the brain -- PET (positron emission tomography)--and also a strong radiochemistry effort. ...

  11. 6.20 Mapping Human Brain Function

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    0 612011 6.20 Mapping Human Brain Function Many mysteries of the human brain have been unraveled by positron emission tomography (PET), an imaging tool used worldwide to diagnose ...

  12. Awake Animal Imaging at BNL | U.S. DOE Office of Science (SC...

    Office of Science (SC) Website

    The first major project is the development of a PET instrument to image the brain of an awake External link rat. This will be a major advance in preclinical imaging of the brain in ...

  13. Microsoft PowerPoint - Das_2015_StaffScienceHighlight_ACSPhotonic...

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    obtained in a single step. Moreover, we report USC processing on TiO 2 ITO-coated polyethylene terephthalate (PET) substrates to realize flexible perovskite solar cells with PCE...

  14. Microsoft PowerPoint - Xiao_NanoLett-2013.pptx

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    of GaS nanosheet photodetectors made on SiO 2 Si substrates and flexible polyethylene terephthalate (PET) substrates exhibit a photo-responsivity at 254nm up to 4.2 AW...

  15. L-[METHYL-{sup 11}C] Methionine Positron Emission Tomography for Target Delineation in Malignant Gliomas: Impact on Results of Carbon Ion Radiotherapy

    SciTech Connect (OSTI)

    Mahasittiwat, Pawinee; Mizoe, Jun-etsu Hasegawa, Azusa; Ishikawa, Hiroyuki; Yoshikawa, Kyosan; Mizuno, Hideyuki; Yanagi, Takeshi; Takagi, Ryou D.D.S.; Pattaranutaporn, Pittayapoom; Tsujii, Hirohiko

    2008-02-01

    Purpose: To assess the importance of {sup 11}C-methionine (MET)-positron emission tomography (PET) for clinical target volume (CTV) delineation. Methods and Materials: This retrospective study analyzed 16 patients with malignant glioma (4 patients, anaplastic astrocytoma; 12 patients, glioblastoma multiforme) treated with surgery and carbon ion radiotherapy from April 2002 to Nov 2005. The MET-PET target volume was compared with gross tumor volume and CTV, defined by using computed tomography/magnetic resonance imaging (MRI). Correlations with treatment results were evaluated between positive and negative extended volumes (EVs) of the MET-PET target for CTV. Results: Mean volumes of the MET-PET targets, CTV1 (defined by means of high-intensity volume on T2-weighted MRI), and CTV2 (defined by means of contrast-enhancement volume on T1-weighted MRI) were 6.35, 264.7, and 117.7 cm{sup 3}, respectively. Mean EVs of MET-PET targets for CTV1 and CTV2 were 0.6 and 2.2 cm{sup 3}, respectively. The MET-PET target volumes were included in CTV1 and CTV2 in 13 (81.3%) and 11 patients (68.8%), respectively. Patients with a negative EV for CTV1 had significantly greater survival rate (p = 0.0069), regional control (p = 0.0047), and distant control time (p = 0.0267) than those with a positive EV. Distant control time also was better in patients with a negative EV for CTV2 than those with a positive EV (p = 0.0401). Conclusions: For patients with malignant gliomas, MET-PET has a possibility to be a predictor of outcome in carbon ion radiotherapy. Direct use of MET-PET fused to planning computed tomography will be useful and yield favorable results for the therapy.

  16. 2013 Nuclear Workforce Development Day

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Nuclear Workforce Development Day ∎ Tuesday, October 22, 2013 Nuclear Medicine Topics:  Pathways of Practice in Nuclear Medicine  Radiopharmacy  Patient Care  Medical Imaging & Computers Moderator: Deborah M. Gibbs, MEd, PET, CNMT Lead Nuclear Medicine / PET Facility Administrator Georgia Regents University Panel Members: Jim Corley, MS, RPh- Associate Professor Georgia Regents University George David, MS, FAAPM- Medical Physicist Georgia Regents University Dr. Gregory

  17. ega3322.tmp

    Office of Scientific and Technical Information (OSTI)

    s,, l,, BNL-68614 Automation for the Synthesis and Application of PET Radiopharmaceuticals David L. Alexoff, Department of Chemistry, Brookhaven Nfiticmal Laboratory, Upton, New York 11973-5000 Index Words: automation, laboratory robot, unit operations Introduction The development of automateds ystems supporting the production and application of PET radiopharmaceuticals has been an important focus of researchers since the first successes of using carbon-11 (Comar et al., 1979) and fluorine-18

  18. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    refoth_a_epm0_ptg_dpgal_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pri_refoth_a_epm0_ptg_dpgal_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"2/25/2016 9:01

  19. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    refmg_a_epm0_ptg_dpgal_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pri_refmg_a_epm0_ptg_dpgal_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"2/25/2016 8:57

  20. Impact of [{sup 18}F] Fluorodeoxyglucose Positron Emission Tomography on Staging and Management of Early-Stage Follicular Non-Hodgkin Lymphoma

    SciTech Connect (OSTI)

    Wirth, Andrew Foo, Marcus; Seymour, John F.; MacManus, Michael P.; Hicks, Rodney J.

    2008-05-01

    Purpose: Accurate staging is critical to select patients with early-stage (I-II) follicular lymphoma (ESFL) suitable for involved-field radiotherapy (IFRT) and to define the radiotherapy portal. We evaluated the impact of fluorodeoxyglucose (FDG) PET on staging, treatment, and outcome for patients with ESFL on conventional staging. Methods and Materials: Forty-two patients with untreated ESFL (World Health Organization Grade I-IIIa, or 'low grade') following a minimum of physical examination, computerized tomography, and bone marrow examination (conventional assessment) and who had staging PET from June 1997 to June 2006 were studied retrospectively. Stage allocation was based on routine imaging reports. Disease sites, stage, and management plan were recorded based on conventional assessment or conventional assessment plus PET. Results: FDG avidity was demonstrated in 97% of patients in whom disease was evident on conventional assessment after biopsy. PET findings suggested a change of stage or management in 19 patients: 13 (31%) who were upstaged to Stage III-IV, altering ideal management from IFRT to systemic therapy, and 6 (14%) who had the involved field enlarged, including 4 upstaged from Stage I to II. Of these 19 cases, PET findings were considered true positive in 8 patients, indeterminate in 10, and false positive in only 1 patient. Conclusions: Our data confirm that ESFL is usually FDG-avid. In routine practice, PET has the potential to upstage and thereby alter management in a high proportion of patients with apparent ESFL.

  1. SU-E-J-148: Evaluating Tumor Response with a Commercially Available Deformable Registration System

    SciTech Connect (OSTI)

    Bowling, J; Ramsey, C [Thompson Cancer Survival Center, Knoxville, TN (United States)

    2014-06-01

    Purpose: The purpose of this study is to present a method for evaluating the response to treatment using a commercially available deformable image registration software package (Velocity Medical Systems) and repeat PET/CT imaging. This technique can be used to identify volumes that are risk for tumor recurrence. Methods: Response to treatment was evaluated using PET/CT images acquired prior-to and post-treatment for radiation therapy patients treated with concurrent chemotherapy. Velocity (Version 3.0.1) was used to deform the initial PET/CT to the post treatment PET/CT. The post-treatment PET images were then subtracted from the pre-treatment PET images. The resulting re-sampled image is a three-dimensional SUV difference map that shows pixels with increasing SUV values. SUV values increases greater than 2.5 in the post treatment images were identified for additional follow-up. Results: A total of 5 Lung patients were analyzed as part of this study. One lung patient in the cohort had an SUV increase of +3.28 that was identified using the SUV difference map. This volume of increased uptake was located outside the treatment field and adjacent to the 35 Gy isodose line. The remaining four patients all had SUV decreases inside the planning target volume, and no unexpected areas of increase outside the irradiated volumes. All five patients were analyzed using standard tools inside the Velocity application. Conclusion: The response to treatment can easily be measured using serial PET/CT images and a commercially available deformable image registration. This provides both the radiation oncologists and medical oncologists with a quantitative assessment of their treatment to use in patient follow-up.

  2. Tumor Volume Combined With Number of Positive Lymph Node Stations Is a More Important Prognostic Factor Than TNM Stage for Survival of Non-Small-Cell Lung Cancer Patients Treated With (Chemo)radiotherapy

    SciTech Connect (OSTI)

    Dehing-Oberije, Cary [Department of Radiotherapy, University Hospital Maastricht, University Maastricht, MAASTRO Clinic, Research Institute Growth and Development (GROW), Maastricht (Netherlands)], E-mail: cary.dehing@maastro.nl; Ruysscher, Dirk de; Weide, Hiska van der [Department of Radiotherapy, University Hospital Maastricht, University Maastricht, MAASTRO Clinic, Research Institute Growth and Development (GROW), Maastricht (Netherlands); Hochstenbag, Monique [Department of Pulmonology, University Hospital Maastricht, Maastricht (Netherlands); Bootsma, Gerben [Department of Pulmonology, Atrium Medical Centre, Heerlen (Netherlands); Geraedts, Wiel [Department of Pulmonology, Maasland Hospital, Sittard (Netherlands); Pitz, Cordula [Department of Pulmonology, Laurentius Hospital, Roermond (Netherlands); Simons, Jean [Department of Pulmonology, Sint Jans Hospital, Weert (Netherlands); Teule, Jaap [Department of Nuclear Medicine, University Hospital Maastricht, Maastricht (Netherlands); Rahmy, Ali [Department of Nuclear Medicine, Atrium Medical Centre, Heerlen (Netherlands); Thimister, Paul [Department of Nuclear Medicine, Maasland Hospital, Sittard (Netherlands); Steck, Harald [Siemens Medical Solutions, Malvern, PA (United States); Lambin, Philippe [Department of Radiotherapy, University Hospital Maastricht, University Maastricht, MAASTRO Clinic, Research Institute Growth and Development (GROW), Maastricht (Netherlands)

    2008-03-15

    Purpose: The current tumor, node, metastasis system needs refinement to improve its ability to predict survival of patients with non-small-cell lung cancer (NSCLC) treated with (chemo)radiation. In this study, we investigated the prognostic value of tumor volume and N status, assessed by using fluorodeoxyglucose-positron emission tomography (PET). Patients and Methods: Clinical data from 270 consecutive patients with inoperable NSCLC Stages I-IIIB treated radically with (chemo)radiation were collected retrospectively. Diagnostic imaging was performed using either integrated PET-computed tomography or computed tomography and PET separately. The Kaplan-Meier method, as well as Cox regression, was used to analyze data. Results: Univariate survival analysis showed that number of positive lymph node stations (PLNSs), as well as N stage on PET, was associated significantly with survival. The final multivariate Cox model consisted of number of PLNSs, gross tumor volume (i.e., volume of the primary tumor plus lymph nodes), sex, World Health Organization performance status, and equivalent radiation dose corrected for time; N stage was no longer significant. Conclusions: Number of PLNSs, assessed by means of fluorodeoxyglucose-PET, was a significant factor for survival of patients with inoperable NSCLC treated with (chemo)radiation. Risk stratification for this group of patients should be based on gross tumor volume, number of PLNSs, sex, World Health Organization performance status, and equivalent radiation dose corrected for time.

  3. ,"U.S. Refinery Net Input"

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/2005" ,"Data 2","Alaskan Crude Oil Receipts",1,"Monthly","12/2015","1/15/1986" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_pnp_inpt2_dc_nus_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_inpt2_dc_nus_mbbl_m.htm" ,"Source:","Energy

  4. ,"U.S. Total Crude Oil and Products Imports"

    U.S. Energy Information Administration (EIA) Indexed Site

    0,"Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_impcus_a2_nus_ep00_im0_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcus_a2_nus_ep00_im0_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov"

  5. Molybdenum Hydride and Dihydride Complexes Bearing Diphosphine Ligands with a Pendant Amine: Formation of Complexes With Bound Amines

    SciTech Connect (OSTI)

    Zhang, Shaoguang; Bullock, R. Morris

    2015-07-06

    CpMo(CO)(PNP)H complexes (PNP = (R2PCH2)2NMe, R = Et or Ph) were synthesized by displacement of two CO ligands of CpMo(CO)3H by the PNP ligand; these complexes were characterized by IR and variable temperature 1H and 31P NMR spectroscopy. CpMo(CO)(PNP)H complexes are formed as mixture of cis and trans-isomers. Both cis-CpMo(CO)(PEtNMePEt)H and trans-CpMo(CO)(PPhNMePPh)H were analyzed by single crystal X-ray diffraction. Electrochemical oxidation of CpMo(CO)(PEtNMePEt)H and CpMo(CO)(PPhNMePPh)H in CH3CN are both irreversible at slow scan rates and quasi-reversible at higher scan rates, with E1/2 = -0.36 V (vs. Cp2Fe+/0) for CpMo(CO)(PEtNMePEt)H and E1/2 = -0.18 V for CpMo(CO)(PPhNMePPh)H. Hydride abstraction from CpMo(CO)(PNP)H with [Ph3C]+[A]- (A = B(C6F5)4 or BArF4; [ArF = 3,5-bis(trifluoromethyl)phenyl]) afforded “tuck-in” [CpMo(CO)(κ3-PNP)]+ complexes that feature the amine bound to the metal. Displacement of the κ3 Mo-N bond by CD3CN gives [CpMo(CO)(PNP)(CD3CN)]+. The kinetics of this reaction were studied by NMR spectroscopy, providing the activation parameters ΔH‡ = 22.1 kcal/mol, ΔS‡ = 1.89 cal/(mol·K), Ea = 22.7 kcal/mol. Protonation of CpMo(CO)(PEtNMePEt)H affords [CpMo(CO)(κ2-PEtNMePEt)(H)2]+ as a Mo dihydride complex, which loses H2 to generate [CpMo(CO)(κ3-PEtNMePEt)]+ at room temperature. CpMo(CO)(dppp)H (dppp = 1,2-bis(diphenylphosphino)propane) was studied as a Mo diphosphine analogue without a pendant amine, and the product of protonation of this complex gives [CpMo(CO)(dppp)(H)2]+. Our results show that the pendant amine has a strong driving force to form stable “tuck-in” [CpMo(CO)(κ3-PNP)]+ complexes, and also promotes hydrogen elimination from [CpMo(CO)(PNP)(H)2]+ complexes by formation of Mo-N dative bond. We thank the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences for support. Pacific Northwest National Laboratory is operated by Battelle for the U.S. Department of Energy. We thank Monte Helm, Elliott Hulley and Deanna Miller for help on the crystallography, and Ming Fang for assistance on the electrochemical experiments.

  6. ,"U.S. Blender Net Production"

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/2005" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_pnp_refp3_dc_nus_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_refp3_dc_nus_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016

  7. ,"U.S. Refinery Net Input"

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/2005" ,"Data 2","Alaskan Crude Oil Receipts",1,"Annual",2015,"6/30/1986" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_pnp_inpt2_dc_nus_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_inpt2_dc_nus_mbbl_a.htm" ,"Source:","Energy Information Administration"

  8. ,"U.S. Refinery Net Production"

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1993" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_pnp_refp2_dc_nus_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_pnp_refp2_dc_nus_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016

  9. ,"U.S. Total Crude Oil and Products Imports"

    U.S. Energy Information Administration (EIA) Indexed Site

    1,"Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_impcus_a2_nus_ep00_im0_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcus_a2_nus_ep00_im0_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  10. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    6,"Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_impcp_a2_r10_ep00_ip0_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a2_r10_ep00_ip0_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov"

  11. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_impcp_a2_r20_ep00_ip0_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a2_r20_ep00_ip0_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov"

  12. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    0,"Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_impcp_a2_r30_ep00_ip0_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a2_r30_ep00_ip0_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov"

  13. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    1,"Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_impcp_a2_r50_ep00_ip0_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a2_r50_ep00_ip0_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov"

  14. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_netr_d_r10-z0p_vnr_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_netr_d_r10-z0p_vnr_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  15. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    5,"Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_impcp_a1_z00_ep00_ip0_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a1_z00_ep00_ip0_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov"

  16. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    7,"Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_impcp_a2_r10_ep00_ip0_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a2_r10_ep00_ip0_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  17. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_impcp_a2_r20_ep00_ip0_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a2_r20_ep00_ip0_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  18. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    1,"Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_impcp_a2_r30_ep00_ip0_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a2_r30_ep00_ip0_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  19. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_impcp_a2_r40_ep00_ip0_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a2_r40_ep00_ip0_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  20. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    0,"Annual",2015,"6/30/1981" ,"Release Date:","3/11/2016" ,"Next Release Date:","8/31/2016" ,"Excel File Name:","pet_move_impcp_a2_r50_ep00_ip0_mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcp_a2_r50_ep00_ip0_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202)

  1. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    1,"Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_move_impcus_a1_z00_ep00_im0_mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_impcus_a1_z00_ep00_im0_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov"

  2. An XPS study on the chemical bond structure at the interface between SiO{sub x}N{sub y} and N doped polyethylene terephthalate

    SciTech Connect (OSTI)

    Ding Wanyu [School of Materials Science and Engineering, Dalian Jiaotong University, Dalian 116028 (China); Key Laboratory of Materials Modification by Laser, Ion and Electron Beams, Ministry of Education, Dalian University of Technology, Dalian 116024 (China); Li Li; Zhang Lina; Chai Weiping [School of Materials Science and Engineering, Dalian Jiaotong University, Dalian 116028 (China); Ju Dongying [Department of Material Science and Engineering, Saitama Institute of Technology, Fukaya 369-0293 (Japan); Peng Shou [China Triumph International Engineering Co., Ltd., 2000 Zhongshanbei Road, 200063 Shanghai (China)

    2013-03-14

    The super-thin silicon oxynitride (SiO{sub x}N{sub y}) films were deposited onto the N doped polyethylene terephthalate (PET) surface. Varying the N doping parameters, the different chemical bond structures were obtained at the interface between the SiO{sub x}N{sub y} film and the PET surface. X-ray photoelectron spectra results showed that at the initial stage of SiO{sub x}N{sub y} film growth, the C=N bonds could be broken and C-N-Si crosslink bonds could be formed at the interface of SiO{sub x}N{sub y}/PET, which C=N bonds could be formed onto the PET surface during the N doping process. At these positions, the SiO{sub x}N{sub y} film could be crosslinked well onto the PET surface. Meanwhile, the doped N could crosslink the [SiO{sub 4}] and [SiN{sub 4}] tetrahedrons, which could easily form the dense layer structure at the initial stage of SiO{sub x}N{sub y} film growth, instead of the ring and/or chain structures of [SiO{sub 4}] tetrahedrons crosslinked by O. Finally, from the point of applying SiO{sub x}N{sub y}/PET complex as the substrate, the present work reveals a simple way to crosslink them, as well as the crosslink model and physicochemical mechanism happened at the interface of complex.

  3. Getting Inside Plants | Jefferson Lab

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Getting Inside Plants Seeing Green - This image of a rose leaf was captured with a plant imaging system that is based on the same technology used to conduct PET scans in humans. The ultimate goal of the plant imaging program is to see how plants will respond to rising levels of carbon dioxide in the atmosphere. Getting Inside Plants PET scans have been used for decades to help doctors diagnose disease in people - from cancers to heart problems. Now, the technology is returning to one of its

  4. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    mbblpd_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_cons_psup_dc_nus_mbblpd_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016 2:54:27 PM" "Back to Contents","Data 1: U.S. Product Supplied for Crude Oil and Petroleum Products"

  5. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    mbblpd_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_exp_dc_nus-z00_mbblpd_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016 2:56:04 PM" "Back to Contents","Data 1: U.S. Exports of Crude Oil and Petroleum Products"

  6. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    mbblpd_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_imp_dc_nus-z00_mbblpd_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016 3:35:39 PM" "Back to Contents","Data 1: U.S. Imports of Crude Oil and Petroleum Products"

  7. High-speed digitization readout of silicon photomultipliers for time of flight positron emission tomography

    SciTech Connect (OSTI)

    Ronzhin, A.; Los, S.; Martens, M.; Ramberg, E.; Kim, H.; Chen, C.; Kao, C.; Niessen, K.; Zatserklyaniy, A.; Mazzillo, M.; Carbone, B.; /SGS Thomson, Catania

    2011-02-01

    We report on work to develop a system with about 100 picoseconds (ps) time resolution for time of flight positron emission tomography [TOF-PET]. The chosen photo detectors for the study were Silicon Photomultipliers (SiPM's). This study was based on extensive experience in studying timing properties of SiPM's. The readout of these devices used the commercial high speed digitizer DRS4. We applied different algorithms to get the best time resolution of 155 ps Guassian (sigma) for a LYSO crystal coupled to a SiPM. We consider the work as a first step in building a prototype TOF-PET module. The field of positron-emission-tomography (PET) has been rapidly developing. But there are significant limitations in how well current PET scanners can reconstruct images, related to how fast data can be acquired, how much volume they can image, and the spatial and temporal resolution of the generated photons. Typical modern scanners now include multiple rings of detectors, which can image a large volume of the patient. In this type of scanner, one can treat each ring as a separate detector and require coincidences only within the ring, or treat the entire region viewed by the scanner as a single 3 dimensional volume. This 3d technique has significantly better sensitivity since more photon pair trajectories are accepted. However, the scattering of photons within the volume of the patient, and the effect of random coincidences limits the technique. The advent of sub-nanosecond timing resolution detectors means that there is potentially much better rejection of scattered photon events and random coincidence events in the 3D technique. In addition, if the timing is good enough, then the origin of photons pairs can be determined better, resulting in improved spatial resolution - so called 'Time-of-Flight' PET, or TOF-PET. Currently a lot of activity has occurred in applications of SiPMs for TOF-PET. This is due to the devices very good time resolution, low profile, lack of high voltage needed, and their non-sensitivity to magnetic fields. While investigations into this technique have begun elsewhere, we feel that the extensive SiPM characterization and data acquisition expertise of Fermilab, and the historical in-depth research of PET imaging at University of Chicago will combine to make significant strides in this field. We also benefit by a working relationship with the SiPM producer STMicroelectronics (STM).

  8. MO-C-BRE-01: The WMIS-AAPM Joint Symposium: Advances in Molecular Imaging

    SciTech Connect (OSTI)

    Contag, C; Pogue, B; Lewis, J

    2014-06-15

    This joint symposium of the World Molecular Imaging Society (WMIS) and the AAPM includes three luminary speakers discussing work in new paradigms of molecular imaging in cancer (Contag), applications of optical imaging technologies to radiation therapy (Pogue) and an update on PET imaging as a surrogate biomarker for cancer progression and response to therapy. Learning Objectives: Appreciate the current trends in molecular and systems imaging. Understand how optical imaging technologies, and particularly Cerenkov detectors, can be used in advancing radiation oncology. Stay current on new PET tracers - and targets - of interest in cancer treatment.

  9. Pretreatment Staging Positron Emission Tomography/Computed Tomography in Patients With Inflammatory Breast Cancer Influences Radiation Treatment Field Designs

    SciTech Connect (OSTI)

    Walker, Gary V.; Niikura, Naoki; Yang Wei; Rohren, Eric; Valero, Vicente; Woodward, Wendy A.; Alvarez, Ricardo H.; Lucci, Anthony; Ueno, Naoto T.; Buchholz, Thomas A.

    2012-08-01

    Purpose: Positron emission tomography/computed tomography (PET/CT) is increasingly being utilized for staging of inflammatory breast cancer (IBC). The purpose of this study was to define how pretreatment PET/CT studies affected postmastectomy radiation treatment (PMRT) planning decisions for IBC. Methods and Materials: We performed a retrospective analysis of 62 patients diagnosed with IBC between 2004 and 2009, who were treated with PMRT in our institution and who had a staging PET/CT within 3 months of diagnosis. Patients received a baseline physical examination, staging mammography, ultrasonographic examination of breast and draining lymphatics, and chest radiography; most patients also had a bone scan (55 patients), liver imaging (52 patients), breast MRI (46 patients), and chest CT (25 patients). We compared how PET/CT findings affected PMRT, assuming that standard PMRT would target the chest wall, level III axilla, supraclavicular fossa, and internal mammary chain (IMC). Any modification of target volumes, field borders, or dose prescriptions was considered a change. Results: PET/CT detected new areas of disease in 27 of the 62 patients (44%). The areas of additional disease included the breast (1 patient), ipsilateral axilla (1 patient), ipsilateral supraclavicular (4 patients), ipsilateral infraclavicular (1 patient), ipsilateral IMC (5 patients), ipsilateral subpectoral (3 patients), mediastinal (8 patients), other distant/contralateral lymph nodes (15 patients), or bone (6 patients). One patient was found to have a non-breast second primary tumor. The findings of the PET/CT led to changes in PMRT in 11 of 62 patients (17.7%). These changes included additional fields in 5 patients, adjustment of fields in 2 patients, and higher doses to the supraclavicular fossa (2 patients) and IMC (5 patients). Conclusions: For patients with newly diagnosed IBC, pretreatment PET/CT provides important information concerning involvement of locoregional lymph nodes, mediastinal lymph nodes, and unsuspected sites of distant metastasis. This information is important in the design of radiotherapy treatment fields and, therefore, we recommend that PET/CT be a component of initial staging for IBC.

  10. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_cons_psup_dc_nus_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016 2:54:26 PM" "Back to Contents","Data 1: U.S. Product Supplied for Crude Oil and Petroleum Products"

  11. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_exp_dc_nus-z00_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016 2:56:03 PM" "Back to Contents","Data 1: U.S. Exports of Crude Oil and Petroleum Products"

  12. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    mbbl_m.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_move_imp_dc_nus-z00_mbbl_m.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016 3:35:17 PM" "Back to Contents","Data 1: U.S. Imports of Crude Oil and Petroleum Products"

  13. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    mbblpd_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_crd_crpdn_adc_mbblpd_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016 2:54:42 PM" "Back to Contents","Data 1: Crude Oil Production"

  14. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    mbbl_a.xls" ,"Available from Web Page:","http://www.eia.gov/dnav/pet/pet_crd_crpdn_adc_mbbl_a.htm" ,"Source:","Energy Information Administration" ,"For Help, Contact:","infoctr@eia.gov" ,,"(202) 586-8800",,,"3/9/2016 2:54:41 PM" "Back to Contents","Data 1: Crude Oil Production"

  15. Citizens Advisory Board's Eco Fair Blends Fun and Facts for Schoolchildren

    Office of Environmental Management (EM)

    near Paducah Site | Department of Energy Citizens Advisory Board's Eco Fair Blends Fun and Facts for Schoolchildren near Paducah Site Citizens Advisory Board's Eco Fair Blends Fun and Facts for Schoolchildren near Paducah Site June 1, 2012 - 12:00pm Addthis Lone Oak Middle School sixth-graders pet a mallard hen at the third annual Eco Fair May 15 in West Kentucky Wildlife Management Area. Lone Oak Middle School sixth-graders pet a mallard hen at the third annual Eco Fair May 15 in West

  16. New Barrier Coating Materials for PV Module Backsheets: Preprint

    SciTech Connect (OSTI)

    Barber, G. D.; Jorgensen, G. J.; Terwilliger, K.; Glick, S. H.; Pern, J.; McMahon, T. J.

    2002-05-01

    This conference paper describes the high moisture barrier high resistivity coatings on polyethylene terepthalate (PET) have been fabricated and characterized for use in PV module back sheet applications. These thin film barriers exhibit water vapor transmission rates (WVTR) as low as 0.1 g/m2-day at 37.8 C and have shown excellent adhesion (> 10 N/mm) to both ethylene vinyl acetate (EVA) and PET even after filtered xenon arc lamp UV exposure. The WVTR and adhesion values for this construction are compared to and shown to be superior to candidate polymeric backsheet materials.

  17. 453rd Brookhaven Lecture

    ScienceCinema (OSTI)

    Richard Ferrieri

    2010-09-01

    In this lecture titled "Striving Towards Energy Sustainability: How Will Plants Play a Role in Our Future?" Richard Ferrieri discusses how radiotracers and positron emission tomography (PET imaging) are providing a new look into plant processes that could lead to more renewable biofuels.

  18. Systems for increasing the sensitivity of gamma-ray imagers

    DOE Patents [OSTI]

    Mihailescu, Lucian; Vetter, Kai M.; Chivers, Daniel H.

    2012-12-11

    Systems that increase the position resolution and granularity of double sided segmented semiconductor detectors are provided. These systems increase the imaging resolution capability of such detectors, either used as Compton cameras, or as position sensitive radiation detectors in imagers such as SPECT, PET, coded apertures, multi-pinhole imagers, or other spatial or temporal modulated imagers.

  19. Methods for increasing the sensitivity of gamma-ray imagers

    DOE Patents [OSTI]

    Mihailescu, Lucian (Pleasanton, CA); Vetter, Kai M. (Alameda, CA); Chivers, Daniel H. (Fremont, CA)

    2012-02-07

    Methods are presented that increase the position resolution and granularity of double sided segmented semiconductor detectors. These methods increase the imaging resolution capability of such detectors, either used as Compton cameras, or as position sensitive radiation detectors in imagers such as SPECT, PET, coded apertures, multi-pinhole imagers, or other spatial or temporal modulated imagers.

  20. Determination of the effects caused by different polymers on coal fluidity during carbonization using high-temperature {sup 1}H NMR and rheometry

    SciTech Connect (OSTI)

    Miguel Castro Diaz; Lucky Edecki; Karen M. Steel; John W. Patrick; Colin E. Snape

    2008-01-15

    The effects of blending polyethylene (PE), polystyrene (PS), poly(ethyleneterephthalate) (PET), a flexible polyurethane (FPU), and a car shredded fluff waste (CSF) on fluidity development of a bituminous coal during carbonization have been studied by means of high-torque, small-amplitude controlled-strain rheometry and in situ high-temperature {sup 1}H NMR spectroscopy. The most detrimental effects were caused by PET and PS, which completely destroyed the fluidity of the coal. The CSF had a deleterious effect on coal fluidity similar to that of PET, although the deleterious effect on the viscoelastic properties of the coal were less pronounced than those of PET and PS. On the contrary, the addition of 10 wt % PE caused a slight reduction in the concentration of fluid hydrogen and an increase in the minimum complex viscosity, and the addition of 10 wt % FPU reduced the concentration of fluid hydrogen without changing the viscoelastic properties of the coal. Although these results suggest that these two plastics could potentially be used as additives in coking blends without compromising coke porosity, it was found that the semicoke strengths were reduced by adding 2 wt % FPU and 5 wt % PE. Therefore, it is unlikely that more than 2 wt % of a plastic waste could be added to a coal blend without deterioration in coke quality. 35 refs., 11 figs., 3 tabs.

  1. High resolution scintillation detector with semiconductor readout

    DOE Patents [OSTI]

    Levin, Craig S.; Hoffman, Edward J.

    2000-01-01

    A novel high resolution scintillation detector array for use in radiation imaging such as high resolution Positron Emission Tomography (PET) which comprises one or more parallelepiped crystals with at least one long surface of each crystal being in intimate contact with a semiconductor photodetector such that photons generated within each crystal by gamma radiation passing therethrough is detected by the photodetector paired therewith.

  2. Quantitative Clinical Evaluation of a Simultaneous PETI MRI Breast Imaging System

    SciTech Connect (OSTI)

    Schlyer D. J.; Schlyer, D.J.

    2013-04-03

    A prototype simultaneous PET-MRI breast scanner has been developed for conducting clinical studies with the goal of obtaining high resolution anatomical and functional information in the same scan which can lead to faster and better diagnosis, reduction of unwanted biopsies, and better patient care.

  3. Recyclability assessment of nano-reinforced plastic packaging

    SciTech Connect (OSTI)

    Sánchez, C.; Hortal, M.; Aliaga, C.; Devis, A.; Cloquell-Ballester, V.A.

    2014-12-15

    Highlights: • The study compares the recyclability of polymers with and without nanoparticles. • Visual appearance, material quality and mechanical properties are evaluated. • Minor variations in mechanical properties in R-PE and R-PP with nanoparticles. • Slight degradation of R-PET which affect mechanical properties. • Colour deviations in recycled PE, PP and PET in ranges higher that 0.3 units. - Abstract: Packaging is expected to become the leading application for nano-composites by 2020 due to the great advantages on mechanical and active properties achieved with these substances. As novel materials, and although there are some current applications in the market, there is still unknown areas under development. One key issue to be addressed is to know more about the implications of the nano-composite packaging materials once they become waste. The present study evaluates the extrusion process of four nanomaterials (Layered silicate modified nanoclay (Nanoclay1), Calcium Carbonate (CaCO{sub 3}), Silver (Ag) and Zinc Oxide (ZnO) as part of different virgin polymer matrices of polyethylene (PE), Polypropylene (PP) and Polyethyleneterephtalate (PET). Thus, the following film plastic materials: (PE–Nanoclay1, PE–CaCO{sub 3}, PP–Ag, PET–ZnO, PET–Ag, PET–Nanoclay1) have been processed considering different recycling scenarios. Results on recyclability show that for PE and PP, in general terms and except for some minor variations in yellowness index, tensile modulus, tensile strength and tear strength (PE with Nanoclay1, PP with Ag), the introduction of nanomaterial in the recycling streams for plastic films does not affect the final recycled plastic material in terms of mechanical properties and material quality compared to conventional recycled plastic. Regarding PET, results show that the increasing addition of nanomaterial into the recycled PET matrix (especially PET–Ag) could influence important properties of the recycled material, due to a slight degradation of the polymer, such as increasing pinholes, degradation fumes and elongation at break. Moreover, it should be noted that colour deviations were visible in most of the samples (PE, PP and PET) in levels higher than 0.3 units (limit perceivable by the human eye). The acceptance of these changes in the properties of recycled PE, PP and PET will depend on the specific applications considered (e.g. packaging applications are more strict in material quality that urban furniture or construction products)

  4. Outcomes of Positron Emission Tomography-Staged Clinical N3 Breast Cancer Treated With Neoadjuvant Chemotherapy, Surgery, and Radiotherapy

    SciTech Connect (OSTI)

    Park, Hae Jin; Shin, Kyung Hwan; Cho, Kwan Ho; Park, In Hae; Lee, Keun Seok; Ro, Jungsil; Jung, So-Youn; Lee, Seeyoun; Kim, Seok Won; Kang, Han-Sung; Chie, Eui Kyu; Ha, Sung Whan

    2011-12-01

    Purpose: To evaluate the treatment outcome and efficacy of regional lymph node irradiation after neoadjuvant chemotherapy (NCT) and surgery in positron emission tomography (PET)-positive clinical N3 (cN3) breast cancer patients. Methods and Materials: A total of 55 patients with ipsilateral infraclavicular (ICL), internal mammary (IMN), or supraclavicular (SCL) lymph node involvement in the absence of distant metastases, as revealed by an initial PET scan, were retrospectively analyzed. The clinical nodal stage at diagnosis (2002 AJCC) was cN3a in 14 patients (26%), cN3b in 12 patients (22%), and cN3c in 29 patients (53%). All patients were treated with NCT, followed by mastectomy or breast-conserving surgery and subsequent radiotherapy (RT) with curative intent. Results: At the median follow-up of 38 months (range, 9-80 months), 20 patients (36%) had developed treatment failures, including distant metastases either alone or combined with locoregional recurrences that included one ipsilateral breast recurrence (IBR), six regional failures (RF), and one case of combined IBR and RF. Only 3 patients (5.5%) exhibited treatment failure at the initial PET-positive clinical N3 lymph node. The 5-year locoregional relapse-free survival, disease-free survival (DFS), and overall survival rates were 80%, 60%, and 79%, respectively. RT delivered to PET-positive IMN regions in cN3b patients and at higher doses ({>=}55 Gy) to SCL regions in cN3c patients was not associated with improved 5-year IMN/SCL relapse-free survival or DFS. Conclusion: NCT followed by surgery and RT, including the regional lymph nodes, resulted in excellent locoregional control for patients with PET-positive cN3 breast cancer. The primary treatment failure in this group was due to distant metastasis rather than RF. Neither higher-dose RT directed at PET-positive SCL nodes nor coverage of PET-positive IMN nodes was associated with additional gains in locoregional control or DFS.

  5. Optimal Timing for Assessment of Tumor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer: Do All Patients Benefit From Waiting Longer Than 6 Weeks?

    SciTech Connect (OSTI)

    Perez, Rodrigo O.; Angelita and Joaquim Gama Institute, Sao Paulo ; Habr-Gama, Angelita; Sao Juliao, Guilherme P.; Gama-Rodrigues, Joaquim; Sousa, Afonso H.S.; Campos, Fabio Guilherme; Imperiale, Antonio R.; Lynn, Patricio B.; Proscurshim, Igor; Nahas, Sergio Carlos; Ono, Carla Rachel; Buchpiguel, Carlos Alberto; Department of Radiology and Nuclear Medicine, Hospital do Coracao, Sao Paulo

    2012-12-01

    Purpose: To estimate the metabolic activity of rectal cancers at 6 and 12 weeks after completion of chemoradiation therapy (CRT) by 2-[fluorine-18] fluoro-2-deoxy-D-glucose-labeled positron emission tomography/computed tomography ([{sup 18}FDG]PET/CT) imaging and correlate with response to CRT. Methods and Materials: Patients with cT2-4N0-2M0 distal rectal adenocarcinoma treated with long-course neoadjuvant CRT (54 Gy, 5-fluouracil-based) were prospectively studied ( (ClinicalTrials.org) identifier (NCT00254683)). All patients underwent 3 PET/CT studies (at baseline and 6 and 12 weeks from CRT completion). Clinical assessment was at 12 weeks. Maximal standard uptake value (SUVmax) of the primary tumor was measured and recorded at each PET/CT study after 1 h (early) and 3 h (late) from {sup 18}FDG injection. Patients with an increase in early SUVmax between 6 and 12 weeks were considered 'bad' responders and the others as 'good' responders. Results: Ninety-one patients were included; 46 patients (51%) were 'bad' responders, whereas 45 (49%) patients were 'good' responders. 'Bad' responders were less likely to develop complete clinical response (6.5% vs. 37.8%, respectively; P=.001), less likely to develop significant histological tumor regression (complete or near-complete pathological response; 16% vs. 45%, respectively; P=.008) and exhibited greater final tumor dimension (4.3 cm vs. 3.3 cm; P=.03). Decrease between early (1 h) and late (3 h) SUVmax at 6-week PET/CT was a significant predictor of 'good' response (accuracy of 67%). Conclusions: Patients who developed an increase in SUVmax after 6 weeks were less likely to develop significant tumor downstaging. Early-late SUVmax variation at 6-week PET/CT may help identify these patients and allow tailored selection of CRT-surgery intervals for individual patients.

  6. An experimental investigation on the mechanical properties of the interface between large-sized graphene and a flexible substrate

    SciTech Connect (OSTI)

    Xu, Chaochen; Guo, Jiangang Song, Haibin; Xie, Haimei; Xue, Tao; Qin, Qinghua; Wu, Sen

    2015-04-28

    In this paper, the interfacial mechanical properties of large-sized monolayer graphene attached to a flexible polyethylene terephthalate (PET) substrate are investigated. Using a micro-tensile test and Raman spectroscopy, in situ measurements are taken to obtain the full-field deformation of graphene subjected to a uniaxial tensile loading and unloading cycle. The results of the full-field deformation are subsequently used to identify the status of the interface between the graphene and the substrate as one of perfect adhesion, one showing slide or partial debonding, and one that is fully debonded. The interfacial stress/strain transfer and the evolution of the interface from one status to another during the loading and unloading processes are discussed and the mechanical parameters, such as interfacial strength and interfacial shear strength, are obtained quantitatively demonstrating a relatively weak interface between large-sized graphene and PET.

  7. Production and characterization of a composite insulation material from waste polyethylene teraphtalates

    SciTech Connect (OSTI)

    Kurtulmus, Erhan; Karaboyac?, Mustafa; Yigitarslan, Sibel

    2013-12-16

    The pollution of polyethylene teraphtalate (PET) is in huge amounts due to the most widely usage as a packaging material in several industries. Regional pumice has several desirable characteristics such as porous structure, low-cost and light-weight. Considering the requirements approved by the Ministry of Public Works on isolation, composite insulation material consisting of PET and pumice was studied. Sheets of composites differing both in particle size of pumice and composition of polymer were produced by hot-molding technique. Characterization of new composite material was achieved by measuring its weight, density, flammability, endurance against both to common acids and bases, and to a force applied, heat insulation and water adsorption capacity. The results of the study showed that produced composite material is an alternative building material due to its desirable characteristics; low weight, capability of low heat conduction.

  8. Compact conscious animal positron emission tomography scanner

    DOE Patents [OSTI]

    Schyler, David J. (Bellport, NY); O'Connor, Paul (Bellport, NY); Woody, Craig (Setauket, NY); Junnarkar, Sachin Shrirang (Sound Beach, NY); Radeka, Veljko (Bellport, NY); Vaska, Paul (Sound Beach, NY); Pratte, Jean-Francois (Stony Brook, NY); Volkow, Nora (Chevy Chase, MD)

    2006-10-24

    A method of serially transferring annihilation information in a compact positron emission tomography (PET) scanner includes generating a time signal for an event, generating an address signal representing a detecting channel, generating a detector channel signal including the time and address signals, and generating a composite signal including the channel signal and similarly generated signals. The composite signal includes events from detectors in a block and is serially output. An apparatus that serially transfers annihilation information from a block includes time signal generators for detectors in a block and an address and channel signal generator. The PET scanner includes a ring tomograph that mounts onto a portion of an animal, which includes opposing block pairs. Each of the blocks in a block pair includes a scintillator layer, detection array, front-end array, and a serial encoder. The serial encoder includes time signal generators and an address signal and channel signal generator.

  9. [{sup 13}N] Ammonia Cardiac Program At West Virginia University Health Sciences

    SciTech Connect (OSTI)

    Armbruster, John M.

    2011-06-01

    Due to the shortage of the more traditional cardiac imagining isotopes, specifically, Technicium-99, the Cardiologists at WVU have had to look to alternative imagining techniques such as PET. This has led to a dramatic increase in the use of [{sup 13}N] Ammonia PET scans at the Health Sciences Center. The patient load has gone from one to two patients one day a week to typically two to three patients, two days a week, with occasional add-on in-house patients; each patient typically requiring two target irradiations. In this paper, we will discuss the process that is being used to meet this increased demand from the production of the isotope through the final result.

  10. Positron emission tomography wrist detector

    DOE Patents [OSTI]

    Schlyer, David J. (Bellport, NY); O'Connor, Paul (Bellport, NY); Woody, Craig (Setauket, NY); Junnarkar, Sachin Shrirang (Sound Beach, NY); Radeka, Veljko (Bellport, NY); Vaska, Paul (Sound Beach, NY); Pratte, Jean-Francois (Stony Brook, NY)

    2006-08-15

    A method of serially transferring annihilation information in a compact positron emission tomography (PET) scanner includes generating a time signal representing a time-of-occurrence of an annihilation event, generating an address signal representing a channel detecting the annihilation event, and generating a channel signal including the time and address signals. The method also includes generating a composite signal including the channel signal and another similarly generated channel signal concerning another annihilation event. An apparatus that serially transfers annihilation information includes a time signal generator, address signal generator, channel signal generator, and composite signal generator. The time signal is asynchronous and the address signal is synchronous to a clock signal. A PET scanner includes a scintillation array, detection array, front-end array, and a serial encoder. The serial encoders include the time signal generator, address signal generator, channel signal generator, and composite signal generator.

  11. Compatibility of refrigerants and lubricants with electrical sheet insulation under retrofit conditions

    SciTech Connect (OSTI)

    Doerr, R.G.; Waite, T.D.

    1996-11-01

    To determine whether exposure to the original refrigerant/mineral oil would affect compatibility of sheet insulation with alternative refrigerant/lubricant after retrofit, sheet insulation was exposed at elevated temperature to the original refrigerant and mineral oil for 500 hours, followed by exposure to the alternative refrigerant and lubricant for 500 hours. Most of the sheet insulation materials exposed to the alternative refrigerant and lubricant (after an initial exposure to the original refrigerant and mineral oil) appeared to be compatible with the alternative refrigerant and lubricant. The only concern was delamination and blistering of the sheet insulation containing Nomex, especially after removal of absorbed refrigerant at high temperature. This was attributed to incompatibility of the adhesive and not to the Nomex itself. Embrittlement of the polyethylene terephthalate (PET) sheet was initially observed, but 2048 subsequent tests under extremely dry conditions showed that embrittlement of the PET materials was attributed to moisture present during the exposure.

  12. Cyclotron Produced Radionuclides for Diagnosis and Therapy of Human Neoplasms

    SciTech Connect (OSTI)

    Steven Larson MD

    2009-09-21

    This project funded since 1986 serves as a core project for cancer research throughout MSKCC, producing key radiotracers as well as basic knowledge about thel physics of radiation decay and imaging, for nuclear medicine applications to cancer diagnosis and therapy. In recent years this research application has broadened to include experiments intended to lead to an improved understanding of cancer biology and into the discovery and testing of new cancer drugs. Advances in immune based radiotargeting form the basis for this project. Both antibody and cellular based immune targeting methods have been explored. The multi-step targeting methodologies (MST) developed by NeoRex (Seattle,Washington), have been adapted for use with positron emitting isotopes and PET allowing the quantification and optimization of targeted delivery. In addition, novel methods for radiolabeling immune T-cells with PET tracers have advanced our ability to track these cells of prolonged period of time.

  13. U.S. Department of Energy National Nuclear Security Administration

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    National Nuclear Security Administration Nevada Field Office Nevada National Security Site (NNSS) Prohibited Items (per policy dated December 15, 2014) The following items/personnel are prohibited within the boundaries of the Nevada National Security Site: * NON-DRIVING PERSONNEL (team drivers acceptable in delivery vehicles) * PETS (police canine and service animals acceptable) * CHEMICAL IRRITANTS (including mace and pepper spray in excess of two [2] fluid ounces) * AMMUNITION, EXPLOSIVES

  14. Cluster computing software for GATE simulations

    SciTech Connect (OSTI)

    Beenhouwer, Jan de; Staelens, Steven; Kruecker, Dirk; Ferrer, Ludovic; D'Asseler, Yves; Lemahieu, Ignace; Rannou, Fernando R.

    2007-06-15

    Geometry and tracking (GEANT4) is a Monte Carlo package designed for high energy physics experiments. It is used as the basis layer for Monte Carlo simulations of nuclear medicine acquisition systems in GEANT4 Application for Tomographic Emission (GATE). GATE allows the user to realistically model experiments using accurate physics models and time synchronization for detector movement through a script language contained in a macro file. The downside of this high accuracy is long computation time. This paper describes a platform independent computing approach for running GATE simulations on a cluster of computers in order to reduce the overall simulation time. Our software automatically creates fully resolved, nonparametrized macros accompanied with an on-the-fly generated cluster specific submit file used to launch the simulations. The scalability of GATE simulations on a cluster is investigated for two imaging modalities, positron emission tomography (PET) and single photon emission computed tomography (SPECT). Due to a higher sensitivity, PET simulations are characterized by relatively high data output rates that create rather large output files. SPECT simulations, on the other hand, have lower data output rates but require a long collimator setup time. Both of these characteristics hamper scalability as a function of the number of CPUs. The scalability of PET simulations is improved here by the development of a fast output merger. The scalability of SPECT simulations is improved by greatly reducing the collimator setup time. Accordingly, these two new developments result in higher scalability for both PET and SPECT simulations and reduce the computation time to more practical values.

  15. Simplified one-pot synthesis of [.sup.18F]SFB for radiolabeling

    DOE Patents [OSTI]

    Olma, Sebastian; Shen, Clifton Kwang-Fu

    2015-08-04

    A non-aqueous single pot synthesis of [.sup.18F]SFB is set forth. The [.sup.18F]SFB produced with this method is then used, for example, to label a peptide or an engineered antibody fragment (diabody) targeting human epidermal growth factor receptor 2 (HER2) as representative examples of labeled compounds for use as an injectable composition to locate abnormal tissue, specifically tumors within an animal or human using a PET scan.

  16. Simplified one-pot synthesis of [.sup.18F]SFB for radiolabeling

    DOE Patents [OSTI]

    Olma, Sebastian; Shen, Clifton Kwang-Fu

    2013-07-16

    A non-aqueous single pot synthesis of [.sup.18F]SFB is set forth. The [.sup.18F]SFB produced with this method is then used, for example, to label a peptide or an engineered antibody fragment (diabody) targeting human epidermal growth factor receptor 2 (HER2) as representative examples of labeled compounds for use as an injectable composition to locate abnormal tissue, specifically tumors within an animal or human using a PET scan.

  17. Production of selenium-72 and arsenic-72

    DOE Patents [OSTI]

    Phillips, Dennis R.

    1994-01-01

    Methods and apparatus for producing selenium-72, separating it from its daughter isotope arsenic-72, and generating multiple portions of a solution containing arsenic-72 from a reusable parent substance comprised of selenium-72. The invention provides apparatus which can be located at a site where arsenic-72 is used, for purposes such as PET imaging, to produce arsenic-72 as needed, since the half-life of arsenic-72 is very short.

  18. Production of selenium-72 and arsenic-72

    DOE Patents [OSTI]

    Phillips, D.R.

    1994-12-06

    Methods and apparatus are described for producing selenium-72, separating it from its daughter isotope arsenic-72, and generating multiple portions of a solution containing arsenic-72 from a reusable parent substance comprised of selenium-72. The invention provides apparatus which can be located at a site where arsenic-72 is used, for purposes such as PET imaging, to produce arsenic-72 as needed, since the half-life of arsenic-72 is very short. 2 figures.

  19. Production of selenium-72 and arsenic-72

    DOE Patents [OSTI]

    Phillips, Dennis R.

    1995-01-01

    Methods and apparatus for producing selenium-72, separating it from its daughter isotope arsenic-72, and generating multiple portions of a solution containing arsenic-72 from a reusable parent substance comprised of selenium-72. The invention provides apparatus which can be located at a site where arsenic-72 is used, for purposes such as PET imaging, to produce arsenic-72 as needed, since the half-life of arsenic-72 is very short.

  20. New Methods in Motion Tracking to Generate Motion-Corrected Tomographic

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Images - Energy Innovation Portal Energy Analysis Energy Analysis Find More Like This Return to Search New Methods in Motion Tracking to Generate Motion-Corrected Tomographic Images Oak Ridge National Laboratory Contact ORNL About This Technology Publications: PDF Document Publication 11-G00250_1918.pdf (887 KB) Technology Marketing SummaryHigh quality three-dimensional images from conventional MRI, CT, PET, or SPECT scans require that the subject being imaged remain stationary during the

  1. Labeled ALPHA4BETA2 ligands and methods therefor

    DOE Patents [OSTI]

    Mukherjee, Jogeshwar; Pichika, Ramaiah; Potkin, Steven; Leslie, Frances; Chattopadhyay, Sankha

    2013-02-19

    Contemplated compositions and methods are employed to bind in vitro and in vivo to an .alpha.4.beta.2 nicotinic acetylcholine receptor in a highly selective manner. Where such compounds are labeled, compositions and methods employing such compounds can be used for PET and SPECT analysis. Alternatively, and/or additionally contemplated compounds can be used as antagonists, partial agonists or agonists in the treatment of diseases or conditions associated with .alpha.4.beta..beta.2 dysfunction.

  2. September 2015 Most Viewed Documents for Biology And Medicine | OSTI, US

    Office of Scientific and Technical Information (OSTI)

    Dept of Energy, Office of Scientific and Technical Information September 2015 Most Viewed Documents for Biology And Medicine Measuring dopamine release in the human brain with PET Volkow, N.D. [Brookhaven National Lab., Upton, NY (United States)]|[State Univ. of New York at Stony Brook, Stony Brook, NY (United States). Dept. of Psychiatry]; Fowler, J.S.; Logan, J.; Wang, G.J. [Brookhaven National Lab., Upton, NY (United States)] (1995) 168 Drug Retention Times Center for Human Reliability

  3. Open Data Winners from the SXSW Eco Hackathon | Department of Energy

    Office of Energy Efficiency and Renewable Energy (EERE) Indexed Site

    Open Data Winners from the SXSW Eco Hackathon Open Data Winners from the SXSW Eco Hackathon October 25, 2012 - 5:43pm Addthis The developers of HOMEee at SXSW. This android application helps homeowners track regular maintenance and opportunities for energy efficiency in a fun way, treating your home like a digital pet that gets happier as you make smarter energy choices. | Photo by Ian Kalin. The developers of HOMEee at SXSW. This android application helps homeowners track regular maintenance

  4. Positron emission tomography and optical tissue imaging

    DOE Patents [OSTI]

    Falen, Steven W. (Carmichael, CA); Hoefer, Richard A. (Newport News, VA); Majewski, Stanislaw (Yorktown, VA); McKisson, John (Hampton, VA); Kross, Brian (Yorktown, VA); Proffitt, James (Newport News, VA); Stolin, Alexander (Newport News, VA); Weisenberger, Andrew G. (Yorktown, VA)

    2012-05-22

    A mobile compact imaging system that combines both PET imaging and optical imaging into a single system which can be located in the operating room (OR) and provides faster feedback to determine if a tumor has been fully resected and if there are adequate surgical margins. While final confirmation is obtained from the pathology lab, such a device can reduce the total time necessary for the procedure and the number of iterations required to achieve satisfactory resection of a tumor with good margins.

  5. December 2015 Most Viewed Documents for Biology And Medicine | OSTI, US

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Dept of Energy, Office of Scientific and Technical Information December 2015 Most Viewed Documents for Biology And Medicine Measuring dopamine release in the human brain with PET Volkow, N.D. [Brookhaven National Lab., Upton, NY (United States)]|[State Univ. of New York at Stony Brook, Stony Brook, NY (United States). Dept. of Psychiatry]; Fowler, J.S.; Logan, J.; Wang, G.J. [Brookhaven National Lab., Upton, NY (United States)] (1995) 160 Drug Retention Times Center for Human Reliability

  6. Frequently Asked Questions About Southwesterns Vegetation Management Strategy

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Vegetation Management Program - Frequently Asked Questions Question. Why does Southwestern have to keep its transmission corridor clear of trees? Answer. Southwestern's vegetation management goals are to promote safety, provide for main- tenance access, and ensure electric system reliability. Trees or other vegetation near a trans- mission line can conduct electricity and increase the chance of unintentional contact with people and pets. If electricity flows through a tree to the ground, that

  7. Sheltering in Place | U.S. DOE Office of Science (SC)

    Office of Science (SC) Website

    Sheltering in Place Emergency Information Emergency Information Home Public Notifications Emergency Vocabulary Sheltering in Place Evacuation ISC Home Sheltering in Place Print Text Size: A A A FeedbackShare Page If you are advised to shelter-in-place by local news or our website, please follow these instructions: Bring everyone inside (including pets). Close all doors and windows. Turn off and close all ventilation systems, including: Air conditioning Attic & exhaust fans Furnaces Fireplace

  8. Jefferson Lab: Research Highlights

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Medical Imaging Public Interest Nuclear Physics Accelerator FEL Medical Imaging Engineering Archive print version Highlights Awake Animal SPECT Project Large Field of View Positron Emission Mammography Imaging Devices Pre-Clinical and Clinical Evaluation of High Resolution, Mobile Gamma Camera and Positron Imaging Devices Gamma Camera for a SPECT/Optical Small Animal Imaging System A Positron Emission Mammography Imager for a PEM/PET Biopsy Device Triple Modality Small Animal Planar Imaging

  9. NEVADA FIELD OFFICE PROHIBITED ARTICLES ON NEVADA NATIONAL SECURITY SITE

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    NEVADA FIELD OFFICE PROHIBITED ARTICLES ON NEVADA NATIONAL SECURITY SITE PUBLIC TOURS The following items are prohibited on the Nevada National Security Site public tours. If you have any of these items on your person, please return them to your vehicle. Tour escorts are required to do random checks. * Cameras/Camcorders * Cellular phones * Bluetooth enable devices * Portable Data Storage Devices * Computers * Recording Devices * Weapons * Explosives * Pets & Animals * Ammunition * PDA,

  10. Isotopes for cancer and cardiac care

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Isotopes for cancer Isotopes for cancer and cardiac care Eva Birnbaum is interviewed on KSFR radio on the Lab's Isotope Program February 4, 2016 hot cell facility A worker uses remote manipulator arms to handle a highly radioactive target inside the Lab's radiochemistry hot cell facility. Isotopes from Los Alamos are used for the diagnosis of cardiac disease, for the calibration of PET scanners which in turn diagnose cancer, neurological disease, inflammatory diseases, trauma, and other

  11. 2007 - 12 | Jefferson Lab

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    December 2007 Mon, 12/17/2007 - 1:00am Laser turns 50 (Inside Business) Fri, 12/14/2007 - 1:00am GOVERNOR INVESTS IN HIGHER EDUCATION (Daily Press) Wed, 12/05/2007 - 1:00am Transparent Nuclei (focus.aps.org) Tue, 12/04/2007 - 1:00am PET And Bioluminescent Imaging Aid Evaluation Of Stem Cells' Potential For New Ways To Treat Disease (Society of Nuclear Medicine

  12. DOE/SC-ARM-13-024 Science Plan

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    4 Science Plan Biogenic Aerosols - Effects on Clouds and Climate (BAECC) T Petäjä December 2013 DISCLAIMER This report was prepared as an account of work sponsored by the U.S. Government. Neither the United States nor any agency thereof, nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would

  13. NREL: Measurements and Characterization - X-Ray and UV Photoelectron

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Spectroscopy X-Ray and UV Photoelectron Spectroscopy Example of graph made with cluster tool; plots counts (Y-axis) vs. binding energy (X-axis) for PET Carbon 1S. High-resolution XPS spectra of carbon 1s from polyethylene terephthalate backsheet material, showing excellent quantitative agreement between measured and predicted peak area ratios. Subtle differences in polymer functionality are assessed by deviations from stoichiometry. In photoemission techniques, we use either X-rays or

  14. June 2015 Most Viewed Documents for Biology And Medicine | OSTI, US Dept of

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Energy, Office of Scientific and Technical Information June 2015 Most Viewed Documents for Biology And Medicine Measuring dopamine release in the human brain with PET Volkow, N.D. [Brookhaven National Lab., Upton, NY (United States)]|[State Univ. of New York at Stony Brook, Stony Brook, NY (United States). Dept. of Psychiatry]; Fowler, J.S.; Logan, J.; Wang, G.J. [Brookhaven National Lab., Upton, NY (United States)] (1995) 115 Dose and volume specification for reporting interstitial therapy

  15. Social Media and Messages that Matter - Top Tips and Tools | Department

    Energy Savers [EERE]

    of Energy Social Media and Messages that Matter - Top Tips and Tools Social Media and Messages that Matter - Top Tips and Tools Better Buildings Residential Network Peer Exchange Call Series: Social Media and Messages that Matter - Top Tips and Tools, call slides and discussion summary. PDF icon Call Slides and Discussion Summary More Documents & Publications The Dog Days of Summer - Capitalizing on the Pet Market Hit the Road: Applying Lessons from National Campaigns to a Local Context

  16. Training Your Thermostat to Save Money... and Energy! | Department of

    Office of Energy Efficiency and Renewable Energy (EERE) Indexed Site

    Energy Training Your Thermostat to Save Money... and Energy! Training Your Thermostat to Save Money... and Energy! June 25, 2012 - 6:14pm Addthis Kristin Swineford Communication Specialist, Weatherization and Intergovernmental Programs Many of us know that during the summer, temperatures aren't the only thing skyrocketing -- our energy bills usually also reach record highs due to the cooling measures required to keep ourselves, our pets, and even some of our household items comfortable.

  17. Petition for Advance Waiver of Patent Rights | Department of Energy

    Energy Savers [EERE]

    Advance Waiver of Patent Rights Petition for Advance Waiver of Patent Rights This the DOE form to petition for advance waiver of DOE patent rights under regulation 10 C.F.R. PART 784. PDF icon Advance Waiver Petition More Documents & Publications Petition for Identified Waiver of Patent Rights Format-PetForAdvanceWaivers.pdf Identified Patent Waiver W(I)2008-005

  18. Petition for Identified Waiver of Patent Rights | Department of Energy

    Energy Savers [EERE]

    Identified Waiver of Patent Rights Petition for Identified Waiver of Patent Rights This the DOE form to petition for an identified waiver of DOE patent rights under regulation 10 C.F.R. PART 784. PDF icon Identified Waiver Petition More Documents & Publications Petition for Advance Waiver of Patent Rights Format-PetForAdvanceWaivers.pdf Identified Patent Waiver W(I)2009-001

  19. DOE - Office of Legacy Management -- Visitors Center

    Office of Legacy Management (LM)

    Ohio > Fernald > Visitors Center > Visitors Center Fernald Preserve, Ohio Visitors Center Fernald Visitors Center Visitors Center Directions Event Calendar Community Meeting Room, Program Shelter, and Resource Room Program/Speaker Request Brochures Fact Sheets Technical Papers BioBlitz Geocaching Pets Policy The Fernald Preserve Visitors Center is a 10,000-square-foot green building that celebrates the rich and varied history of the Fernald site. Information on the site's natural,

  20. Cloning and expression of soluble truncated variants of Borrelia OspA, OspB and Vmp7

    DOE Patents [OSTI]

    Dunn, J.J.; Barbour, A.G.

    1996-11-05

    A method is provided for preparing soluble recombinant variations of Borrelia lipoproteins such as Borrelia burgdorferi outer surface protein A (OspA) and outer surface protein B (OspB), and B. hermsii variable major protein 7 (Vmp7). The method includes synthesizing a set of oligonucleotide primers, amplifying the template DNA utilizing the PCR, purifying the amplification products, cloning the amplification products into a suitable expression vector, transforming a suitable host utilizing the cloned expression vector, cultivating the transformed host for protein production and subsequently isolating and purifying the resulting protein. Also provided are soluble, recombinant variations of Borrelia burgdorferi outer surface protein A (OspA), outer surface protein B (OspB), and B. hermsii variable major protein 7 (Vmp7). The expression vectors harboring DNA encoding the recombinant variations, pET9-OspA, pET9-OspB and pET9-Vmp7, as well as the E. coli host BL21(DE3)/pLysS transformed with each of these vectors, are also disclosed. 38 figs.

  1. Cloning and expression of soluble truncated variants of Borrelia OspA, OspB and Vmp7

    DOE Patents [OSTI]

    Dunn, John J.; Barbour, Alan G.

    1996-11-05

    A method is provided herein for preparing soluble recombinant variations of Borrelia lipoproteins such as Borrelia burgdorferi outer surface protein A (OspA) and outer surface protein B (OspB), and B. hermsii variable major protein 7 (Vmp7). The method includes synthesizing a set of oligonucleotide primers, amplifying the template DNA utilizing the PCR, purifying the amplification products, cloning the amplification products into a suitable expression vector, transforming a suitable host utilizing the cloned expression vector, cultivating the transformed host for protein production and subsequently isolating and purifying the resulting protein. Also provided are soluble, recombinant variations of Borrelia burgdorferi outer surface protein A (OspA), outer surface protein B (OspB), and B. hermsii variable major protein 7 (Vmp7). The expression vectors harboring DNA encoding the recombinant variations, pET9-OspA, pET9-OspB and pET9-Vmp7, as well as the E. coli host BL21(DE3)/pLysS transformed with each of these vectors, are also disclosed.

  2. Monoamine oxidase: Radiotracer chemistry and human studies

    SciTech Connect (OSTI)

    Fowler, Joanna S.; Logan, Jean; Shumay, Elena; Alia-Klein, Nelly; Wang, Gene-Jack; Volkow, Nora D.

    2015-03-01

    Monoamine oxidase (MAO) oxidizes amines from both endogenous and exogenous sources thereby regulating the concentration of neurotransmitter amines such as serot onin, norepinephrine and dopamine as well as many xenobiotics. MAO inhibitor drugs are used in the treatment of Parkinsons disease and in depression stimulating the development of radiotracer tools to probe the role of MAO in normal human biology and in disease. Over the past 30 since the first radiotracers were developed and the first PET images of MAO in humans were carried out, PET studies of brain MAO in healthy volunteers and in patients have identified different variables which have contributed to different MAO levels in brain and in peripheral organs. MAO radiotracers and PET have also been used to study the current and developing MAO inhibitor drugs including the selection of doses for clinical trials. In this article, we describe (1) the development of MAO radiotracers; (2) human studies including the relationship of brain MAO levels to genotype, personality, neurological and psychiatric disorders; (3) examples of the use of MAO radiotracers in drug research and development. We will conclude with outstanding needs to improve the radiotracers which are currently used and possible new applications.

  3. Iterative reconstruction using a Monte Carlo based system transfer matrix for dedicated breast positron emission tomography

    SciTech Connect (OSTI)

    Saha, Krishnendu; Straus, Kenneth J.; Glick, Stephen J.; Chen, Yu.

    2014-08-28

    To maximize sensitivity, it is desirable that ring Positron Emission Tomography (PET) systems dedicated for imaging the breast have a small bore. Unfortunately, due to parallax error this causes substantial degradation in spatial resolution for objects near the periphery of the breast. In this work, a framework for computing and incorporating an accurate system matrix into iterative reconstruction is presented in an effort to reduce spatial resolution degradation towards the periphery of the breast. The GATE Monte Carlo Simulation software was utilized to accurately model the system matrix for a breast PET system. A strategy for increasing the count statistics in the system matrix computation and for reducing the system element storage space was used by calculating only a subset of matrix elements and then estimating the rest of the elements by using the geometric symmetry of the cylindrical scanner. To implement this strategy, polar voxel basis functions were used to represent the object, resulting in a block-circulant system matrix. Simulation studies using a breast PET scanner model with ring geometry demonstrated improved contrast at 45% reduced noise level and 1.5 to 3 times resolution performance improvement when compared to MLEM reconstruction using a simple line-integral model. The GATE based system matrix reconstruction technique promises to improve resolution and noise performance and reduce image distortion at FOV periphery compared to line-integral based system matrix reconstruction.

  4. Monoamine oxidase: Radiotracer chemistry and human studies

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Fowler, Joanna S.; Logan, Jean; Shumay, Elena; Alia-Klein, Nelly; Wang, Gene-Jack; Volkow, Nora D.

    2015-03-01

    Monoamine oxidase (MAO) oxidizes amines from both endogenous and exogenous sources thereby regulating the concentration of neurotransmitter amines such as serot onin, norepinephrine and dopamine as well as many xenobiotics. MAO inhibitor drugs are used in the treatment of Parkinson’s disease and in depression stimulating the development of radiotracer tools to probe the role of MAO in normal human biology and in disease. Over the past 30 since the first radiotracers were developed and the first PET images of MAO in humans were carried out, PET studies of brain MAO in healthy volunteers and in patients have identified different variablesmore » which have contributed to different MAO levels in brain and in peripheral organs. MAO radiotracers and PET have also been used to study the current and developing MAO inhibitor drugs including the selection of doses for clinical trials. In this article, we describe (1) the development of MAO radiotracers; (2) human studies including the relationship of brain MAO levels to genotype, personality, neurological and psychiatric disorders; (3) examples of the use of MAO radiotracers in drug research and development. We will conclude with outstanding needs to improve the radiotracers which are currently used and possible new applications.« less

  5. Monoamine oxidase: Radiotracer chemistry and human studies

    SciTech Connect (OSTI)

    Fowler, Joanna S.; Logan, Jean; Shumay, Elena; Alia-Klein, Nelly; Wang, Gene-Jack; Volkow, Nora D.

    2015-03-01

    Monoamine oxidase (MAO) oxidizes amines from both endogenous and exogenous sources thereby regulating the concentration of neurotransmitter amines such as serot onin, norepinephrine and dopamine as well as many xenobiotics. MAO inhibitor drugs are used in the treatment of Parkinson’s disease and in depression stimulating the development of radiotracer tools to probe the role of MAO in normal human biology and in disease. Over the past 30 since the first radiotracers were developed and the first PET images of MAO in humans were carried out, PET studies of brain MAO in healthy volunteers and in patients have identified different variables which have contributed to different MAO levels in brain and in peripheral organs. MAO radiotracers and PET have also been used to study the current and developing MAO inhibitor drugs including the selection of doses for clinical trials. In this article, we describe (1) the development of MAO radiotracers; (2) human studies including the relationship of brain MAO levels to genotype, personality, neurological and psychiatric disorders; (3) examples of the use of MAO radiotracers in drug research and development. We will conclude with outstanding needs to improve the radiotracers which are currently used and possible new applications.

  6. Radiation Therapy in Primary Mediastinal B-Cell Lymphoma With Positron Emission Tomography Positivity After Rituximab Chemotherapy

    SciTech Connect (OSTI)

    Filippi, Andrea Riccardo; Piva, Cristina; Giunta, Francesca; Bellò, Marilena; Chiappella, Annalisa; Caracciolo, Daniele; Zotta, Michela; Douroukas, Anastasios; Ragona, Riccardo; Vitolo, Umberto; Bisi, Gianni; Ricardi, Umberto

    2013-10-01

    Purpose: To investigate the role of radiation therapy (RT) in patients affected with primary mediastinal B-cell lymphoma (PMBCL) with residual {sup 18}fluorodeoxyglucose positron emission tomography ({sup 18}FDG-PET)-positive disease after rituximab chemotherapy (R-CT). Methods and Materials: Thirty-seven patients treated with R-CT and RT, all with {sup 18}FDG-PET scan at diagnosis and before RT, were included. All {sup 18}FDG-PET scans were reviewed, and responses were classified according to the Deauville 5-point scoring system. Outcomes measures were overall survival (OS) and progression-free survival (PFS), estimated for the whole cohort and for subgroups according to {sup 18}FDG-PET score after R-CT. Results: The median follow-up time was 40.9 months. Three patients were assigned to Deauville score 1 (8.1%), 9 to score 2 (24.3%), 7 to score 3 (19%), 14 to score 4 (37.8%), and 4 to score 5 (10.8%). After RT, all patients with score 3-4 experienced a complete response (CR). Among patients with score 5, 1 was in CR (25%), 2 had persistent positivity (50%), and 1 showed progressive disease (25%). A total of 4 patients experienced progression or relapse: 1 of 33 (3%) with scores 1-4, and 3 of 4 (75%) with score 5. The 3-year OS and PFS of the whole cohort were 89.8% and 88.7%, respectively. OS was significantly different between scores 1-3 and scores 4-5 (100% vs 77% at 3 years, P<.05). Patients with a score of 5 had a significantly worse outcome than did all other patients (OS at 2 years, 33.3% vs 100%). Conclusions: Approximately 50% of PMBCL patients show residual disease at {sup 18}FDG-PET scan after R-CT. RT is able to convert to CR approximately 85% of these patients, but those with a Deauville score of 5 (10%) appear at high risk of progression and death, and they might be candidates for intensified programs.

  7. Postradiation Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer

    SciTech Connect (OSTI)

    Murphy, James D.; La, Trang H.; Chu, Karen; Quon, Andrew; Fischbein, Nancy J.; Maxim, Peter G.; Graves, Edward E.; Loo, Billy W.; Le, Quynh-Thu

    2011-06-01

    Purpose: To explore the prognostic value of metabolic tumor volume measured on postradiation {sup 18}F-fluorodeoxyglucose positron emission tomography (PET) imaging in patients with head-and-neck cancer. Methods and Materials: Forty-seven patients with head-and-neck cancer who received pretreatment and posttreatment PET/computed tomography (CT) imaging along with definitive chemoradiotherapy were included in this study. The PET/CT parameters evaluated include the maximum standardized uptake value, metabolic tumor volume (MTV{sub 2.0}-MTV{sub 4.0}; where MTV{sub 2.0} refers to the volume above a standardized uptake value threshold of 2.0), and integrated tumor volume. Kaplan-Meier and Cox regression models were used to test for association between PET endpoints and disease-free survival and overall survival. Results: Multiple postradiation PET endpoints correlated significantly with outcome; however, the most robust predictor of disease progression and death was MTV{sub 2.0}. An increase in MTV{sub 2.0} of 21cm{sup 3} (difference between 75th and 25th percentiles) was associated with an increased risk of disease progression (hazard ratio [HR]= 2.5, p = 0.0001) and death (HR = 2.0, p = 0.003). In patients with nonnasopharyngeal carcinoma histology (n = 34), MTV{sub 2.0} <18 cm{sup 3} and MTV{sub 2.0} {>=}18 cm{sup 3} yielded 2-year disease-free survival rates of 100% and 63%, respectively (p = 0.006) and 2-year overall survival rates of 100% and 81%, respectively (p = 0.009). There was no correlation between MTV{sub 2.0} and disease-free survival or overall survival with nasopharyngeal carcinoma histology (n = 13). On multivariate analysis, only postradiation MTV{sub 2.0} was predictive of disease-free survival (HR = 2.47, p = 0.0001) and overall survival (HR = 1.98, p = 0.003). Conclusions: Postradiation metabolic tumor volume is an adverse prognostic factor in head-and-neck cancer. Biomarkers such as MTV are important for risk stratification and will be valuable in the future with risk-adapted therapies.

  8. DEVELOPMENT OF AUTOMATED SOFTWARE PROGRAM FOR THE ANALYSIS OF ALZHEIMER'S DISEASE BETA-AMYLOID SCANS

    SciTech Connect (OSTI)

    Mariotti, Jack; Zubal, George

    2013-12-18

    Study goal: A Phase 1 evaluation of the kinetics, clearance and cerebral distribution of one novel peripheral benzodiazepine receptors(PBR)positron emission tomography (PET) imaging agent, 18F-PBR-111 following intravenous administration in healthy volunteers and Alzheimer's disease (AD) patients. Short title: Evaluation of PET imaging with PBR-111 in HV and AD subjects Proof of Mechanism. Primary Objective: To evaluate the cerebral distribution of PBR-111 positron emission tomography (PET) for detection/exclusion of microglial activation in patients with Alzheimer's disease subjects compared to healthy volunteers. Secondary objectives: - To assess the dynamic uptake and washout of [18F]PBR-111, a potential imaging bio-marker for inflammatory changes in brain, using positron emission tomography in subjects with Alzheimer's disease (AD) and healthy volunteers (HV). - To perform blood metabolite characterization of [18F]PBR-111 in subjects with AD and HV to determine the nature of metabolites in assessment of [18F]-PBR-111 as a PET brain imaging agent. Name of radioactive drug substance: PBR-111 Dose(s): The applied PBR-111 radioactive dose will be up to 5.0 mCi, diluted in a maximum of 10 ml of saline. The radioligand will be administered as a slow intravenous bolus injection (i.e., 6 sec/ml) into a large vein (e.g., antecubital vein). Route of administration: Intravenous injection Duration of treatment: Single administration of a diagnostic agent Indication: PBR-111 positron emission tomography (PET) imaging has the potential to detect microglial activation. In the presence of PBR-111 uptake (representative of microglial activation), inflammation in the brain can be detected. Diagnosis and main criteria for inclusion: Study participants will be HVs and patients diagnosed with probable AD. HVs must be 18 years of age (at least four subjects 50 years of age) and have no evidence of cognitive impairment or other neurologic disease by medical history. The lack of cognitive impairment will also be based on a Clinical Dementia Rating (CDR) of 0. Patients with probable AD must be 50 years of age and must fulfill the National Institute of Neurological and Communicative Disorders and Stroke, Alzheimer's Disease and Related Disorders Association [NINCDS-ADRDA] criteria for probable AD. The CDR score must be 1.0 and 2.0 and have a modified Hachinski of 4. All HVs and all patients with probable AD must be able to comply with all study procedures. Study design: This is a Phase 1, open-label, single-center, non-randomized single dose study to assess the kinetics, clearance and cerebral distribution of PBR-111 PET imaging in detecting microglial activation in the brain in patients with probable AD compared to HVs. All aspects related to image acquisition, processing, and visual as well as quantitative evaluation will be developed, optimized, and validated (where required). Each subject will be required to visit the study center during the screening phase and on the PBR-111 PET imaging day (baseline). A telephone follow-up visit will be performed 7 days (± 3 days) after PBR-111 PET administration. At the screening visit, each subject (or caregiver in the case of AD subjects) will be asked to provide written informed consent or assent. During the screening phase (maximum duration of 60 days) subject medical, neurological, and surgical history, clinical assessments, and a neuro-psychiatric evaluation will be performed on all eligible subjects. Subjects will be allowed to leave the center after all evaluations have been completed. During this period an MRI of the brain will be performed during the screening period. If an MRI of the brain has been performed within six months of the imaging visit using the methods described in the protocol, and there has been no medically significant events in the interim, the previous MRI may be used. During the PBR-111 PET imaging day, all subjects will receive a single intravenous injection of PBR-111 and scanning will be performed over a 3.5 hour period. Each subject will have a telephone follow-up 7 days (± 3 days) thereafter to assess for adverse events. Methodology: - Assessments to provide clinical characterization of the AD subjects will be performed. - After administration of PBR-111, images will be generated with state-of-the-art PET imaging. Images will be assessed quantitatively for the presence of microglial activation by a nuclear physician blinded to clinical data. - Total radioactivity and estimation of the fraction of radioactivity associated to the un-metabolized tracer will be determined. In addition, the metabolite patterns of PBR-111 are determined in venous plasma and arterial samples based on high-performance liquid chromatography (HPLC) analyses. - Arterial sampling will be acquired in the initial two AD and two HV subjects and modeling will be assessed to determine if additional arterial sampling is necessary.

  9. Pretreatment [{sup 18}F]-fluoro-2-deoxy-glucose Positron Emission Tomography Maximum Standardized Uptake Value as Predictor of Distant Metastasis in Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy: Rethinking the Role of Positron Emission Tomography in Personalizing Treatment Based on Risk Status

    SciTech Connect (OSTI)

    Nair, Vimoj J.; MacRae, Robert; Sirisegaram, Abby; Pantarotto, Jason R.

    2014-02-01

    Purpose: The aim of this study was to determine whether the preradiation maximum standardized uptake value (SUV{sub max}) of the primary tumor for [{sup 18}F]-fluoro-2-deoxy-glucose positron emission tomography (FDG-PET) has a prognostic significance in patients with Stage T1 or T2N0 non-small cell lung cancer (NSCLC) treated with curative radiation therapy, whether conventional or stereotactic body radiation therapy (SBRT). Methods and Materials: Between January 2007 and December 2011, a total of 163 patients (180 tumors) with medically inoperable histologically proven Stage T1 or T2N0 NSCLC and treated with radiation therapy (both conventional and SBRT) were entered in a research ethics board approved database. All patients received pretreatment FDG-PET / computed tomography (CT) at 1 institution with consistent acquisition technique. The medical records and radiologic images of these patients were analyzed. Results: The overall survival at 2 years and 3 years for the whole group was 76% and 67%, respectively. The mean and median SUV{sub max} were 8.1 and 7, respectively. Progression-free survival at 2 years with SUV{sub max} <7 was better than that of the patients with tumor SUV{sub max} ?7 (67% vs 51%; P=.0096). Tumors with SUV{sub max} ?7 were associated with a worse regional recurrence-free survival and distant metastasis-free survival. In the multivariate analysis, SUV{sub max} ?7 was an independent prognostic factor for distant metastasis-free survival. Conclusion: In early-stage NSCLC managed with radiation alone, patients with SUV{sub max} ?7 on FDG-PET / CT scan have poorer outcomes and high risk of progression, possibly because of aggressive biology. There is a potential role for adjuvant therapies for these high-risk patients with intent to improve outcomes.

  10. Silicon-Polymer Encapsulation of High-Level Calcine Waste for Transportation or Disposal

    SciTech Connect (OSTI)

    G. G. Loomis; C. M. Miller; J. A. Giansiracusa; R. Kimmel; S. V. Prewett

    2000-01-01

    This report presents the results of an experimental study investigating the potential uses for silicon-polymer encapsulation of High Level Calcine Waste currently stored within the Idaho Nuclear Technology and Engineering Center (INTEC) at the Idaho National Engineering and Environmental Laboratory (INEEL). The study investigated two different applications of silicon polymer encapsulation. One application uses silicon polymer to produce a waste form suitable for disposal at a High Level Radioactive Waste Disposal Facility directly, and the other application encapsulates the calcine material for transportation to an offsite melter for further processing. A simulated waste material from INTEC, called pilot scale calcine, which contained hazardous materials but no radioactive isotopes was used for the study, which was performed at the University of Akron under special arrangement with Orbit Technologies, the originators of the silicon polymer process called Polymer Encapsulation Technology (PET). This document first discusses the PET process, followed by a presentation of past studies involving PET applications to waste problems. Next, the results of an experimental study are presented on encapsulation of the INTEC calcine waste as it applies to transportation or disposal of calcine waste. Results relating to long-term disposal include: (1) a characterization of the pilot calcine waste; (2) Toxicity Characteristic Leaching Procedure (TCLP) testing of an optimum mixture of pilot calcine, polysiloxane and special additives; and, (3) Material Characterization Center testing MCC-1P evaluation of the optimum waste form. Results relating to transportation of the calcine material for a mixture of maximum waste loading include: compressive strength testing, 10-m drop test, melt testing, and a Department of Transportation (DOT) oxidizer test.

  11. Polysiloxane Encapsulation of High Level Calcine Waste for Transportation or Disposal

    SciTech Connect (OSTI)

    Loomis, Guy George

    2000-03-01

    This report presents the results of an experimental study investigating the potential uses for silicon-polymer encapsulation of High Level Calcine Waste currently stored within the Idaho Nuclear Technology and Engineering Center (INTEC) at the Idaho National Engineering and Environmental Laboratory (INEEL). The study investigated two different applications of silicon polymer encapsulation. One application uses silicon polymer to produce a waste form suitable for disposal at a High Level Radioactive Waste Disposal Facility directly, and the other application encapsulates the calcine material for transportation to an offsite melter for further processing. A simulated waste material from INTEC, called pilot scale calcine, which contained hazardous materials but no radioactive isotopes was used for the study, which was performed at the University of Akron under special arrangement with Orbit Technologies, the originators of the silicon polymer process called Polymer Encapsulation Technology (PET). This document first discusses the PET process, followed by a presentation of past studies involving PET applications to waste problems. Next, the results of an experimental study are presented on encapsulation of the INTEC calcine waste as it applies to transportation or disposal of calcine waste. Results relating to long-term disposal include: 1) a characterization of the pilot calcine waste; 2) Toxicity Characteristic Leaching Procedure (TCLP) testing of an optimum mixture of pilot calcine, polysiloxane and special additives; and, 3) Material Characterization Center testing MCC-1P evaluation of the optimum waste form. Results relating to transportation of the calcine material for a mixture of maximum waste loading include: compressive strength testing, 10-m drop test, melt testing, and a Department of Transportation (DOT) oxidizer test.

  12. Relationship of computed tomography perfusion and positron emission tomography to tumour progression in malignant glioma

    SciTech Connect (OSTI)

    Yeung, Timothy P C; Yartsev, Slav; Lee, Ting-Yim; Wong, Eugene; He, Wenqing; Fisher, Barbara; VanderSpek, Lauren L; Macdonald, David; Bauman, Glenn

    2014-02-15

    Introduction: This study aimed to explore the potential for computed tomography (CT) perfusion and 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) in predicting sites of future progressive tumour on a voxel-by-voxel basis after radiotherapy and chemotherapy. Methods: Ten patients underwent pre-radiotherapy magnetic resonance (MR), FDG-PET and CT perfusion near the end of radiotherapy and repeated post-radiotherapy follow-up MR scans. The relationships between these images and tumour progression were assessed using logistic regression. Cross-validation with receiver operating characteristic (ROC) analysis was used to assess the value of these images in predicting sites of tumour progression. Results: Pre-radiotherapy MR-defined gross tumour; near-end-of-radiotherapy CT-defined enhancing lesion; CT perfusion blood flow (BF), blood volume (BV) and permeability-surface area (PS) product; FDG-PET standard uptake value (SUV); and SUV:BF showed significant associations with tumour progression on follow-up MR imaging (P < 0.0001). The mean sensitivity (standard deviation), specificity and area under the ROC curve (AUC) of PS were 0.64 0.15, 0.74 0.07 and 0.72 0.12 respectively. This mean AUC was higher than that of the pre-radiotherapy MR-defined gross tumour and near-end-of-radiotherapy CT-defined enhancing lesion (both AUCs = 0.6 0.1, P ? 0.03). The multivariate model using BF, BV, PS and SUV had a mean AUC of 0.8 0.1, but this was not significantly higher than the PS only model. Conclusion: PS is the single best predictor of tumour progression when compared to other parameters, but voxel-based prediction based on logistic regression had modest sensitivity and specificity.

  13. Evaluation of plastic materials for range shifting, range compensation, and solid-phantom dosimetry in carbon-ion radiotherapy

    SciTech Connect (OSTI)

    Kanematsu, Nobuyuki; Koba, Yusuke; Ogata, Risa

    2013-04-15

    Purpose: Beam range control is the essence of radiotherapy with heavy charged particles. In conventional broad-beam delivery, fine range adjustment is achieved by insertion of range shifting and compensating materials. In dosimetry, solid phantoms are often used for convenience. These materials should ideally be equivalent to water. In this study, the authors evaluated dosimetric water equivalence of four common plastics, high-density polyethylene (HDPE), polymethyl methacrylate (PMMA), polyethylene terephthalate (PET), and polyoxymethylene (POM). Methods: Using the Bethe formula for energy loss, the Gottschalk formula for multiple scattering, and the Sihver formula for nuclear interactions, the authors calculated the effective densities of the plastics for these interactions. The authors experimentally measured variation of the Bragg peak of carbon-ion beams by insertion of HDPE, PMMA, and POM, which were compared with analytical model calculations. Results: The theoretical calculation resulted in slightly reduced multiple scattering and severely increased nuclear interactions for HDPE, compared to water and the other plastics. The increase in attenuation of carbon ions for 20-cm range shift was experimentally measured to be 8.9% for HDPE, 2.5% for PMMA, and 0.0% for POM while PET was theoretically estimated to be in between PMMA and POM. The agreement between the measurements and the calculations was about 1% or better. Conclusions: For carbon-ion beams, POM was dosimetrically indistinguishable from water and the best of the plastics examined in this study. The poorest was HDPE, which would reduce the Bragg peak by 0.45% per cm range shift, although with marginal superiority for reduced multiple scattering. Between the two clear plastics, PET would be superior to PMMA in dosimetric water equivalence.

  14. Plant maintenance and outage management issue, 2005

    SciTech Connect (OSTI)

    Agnihotri, Newal (ed.)

    2005-01-15

    The focus of the January-February issue is on plant maintenance and outage managment. Major articles/reports in this issue include: Dawn of a new era, by Joe Colvin, Nuclear Energy Institute (NEI); Plant profile: Beloyarsk NPP, Russia, by Nikolai Oshkanov, Beloyarsk NPP, Russia; Improving economic performance, by R. Spiegelberg-Planner, John De Mella, and Marius Condu, IAEA; A model for improving performance, by Pet Karns, MRO Software; ASME codes and standards, by Shannon Burke, ASME International; and, Refurbishment programs, by Craig S. Irish, Nuclear Logistics, Inc.

  15. ARM - Site Instruments

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Hyytiälä, FinlandInstruments Hyytiälä Deployment AMF Home Hyytiälä Home Experiment Planning Abstract and Related Campaigns Science Plan Deployment Operations Baseline Instruments and Data Plots at the Archive BAECC Instruments AMF2 Management and Operations Outreach News & Press BAECC Blog Backgrounder (PDF, 1.5MB) Poster (JPEG, 1.3MB) Education Flyer (English) (PDF, 1.3MB) Education Flyer (Finnish) (PDF, 1.3MB) Images Contacts Nicki Hickmon, AMF Operations Tuukka Petäjä, Principal

  16. ARM - Field Campaign - Biogenic Aerosols - Effects on Clouds and Climate:

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Extended Radiosonde IOP Extended Radiosonde IOP ARM Data Discovery Browse Data Related Campaigns Biogenic Aerosols - Effects on Clouds and Climate 2014.02.01, Petäjä, AMF Comments? We would love to hear from you! Send us a note below or call us at 1-888-ARM-DATA. Send Campaign : Biogenic Aerosols - Effects on Clouds and Climate: Extended Radiosonde IOP 2014.05.01 - 2014.08.31 Lead Scientist : Keri Nicoll For data sets, see below. Abstract Modified meteorological radiosondes have been

  17. Calibrating Curved Crystals Used for Plasma Spectroscopy

    SciTech Connect (OSTI)

    Haugh, M. J., Jacoby, K. D., Ross, P. W., Rochau, G. Wu, M., Regan, S. P., Barrios, M. A.

    2012-10-29

    The throughput and resolving power of an X-ray spectrometer that uses a curved crystal as the diffraction element is determined primarily by the crystal X-ray reflectivity properties. This poster presents a measurement technique for these crystal parameters using a simple diode source to produce a narrow spectral band. The results from measurements on concave elliptical polyethylene terephthalate (PET) crystals and convex potassium acid phthalate (KAP) crystals show large variations in the key parameters compared to those from the flat crystal.

  18. 4-fluoroalkyl-3-halophenyl nortropanes

    DOE Patents [OSTI]

    Goodman, Mark M. (Atlanta, GA); Chen, Ping (Indianapolis, IN)

    2002-06-04

    A series of compounds in the 4-fluoroalkyl-3-halophenyl nortropanes family are described as diagnostic and therapeutic agents for diseases associated with serotonin transporter dysfunction. These compounds bind to serotonin transporter protein with high affinity and selectivity. The invention provides methods of synthesis which incorporate radioisotopic halogens at a last step which permit high radiochemical yield and maximum usable product life. The radiolabeled compounds of the invention are useful as imaging agents for visualizing the location and density of serotonin transporter by PET and SPECT imaging.

  19. Fluoralkenyl nortropanes

    DOE Patents [OSTI]

    Goodman, Mark M. (Atlanta, GA); Chen, Ping (Indianapolis, IN)

    2002-02-05

    Provided are compounds of the following formula: ##STR1## wherein R is C2-C6 mono- or multi-unsaturated hydrocarbon having one or more ethylene, acetylene or allene groups, A is 18 or 19, and X is H or halogen. The compounds of the invention bind to dopamine transporter with high affinity and selectivity and are thus useful as diagnostic and therapeutic agents for diseases associated with dopamine transporter dysfunction. The radiolabeled compounds are useful as imaging agents for visualizing the location and density of dopamine transporter by PET imaging.

  20. 4-haloethenylphenyl tropane:serotonin transporter imaging agents

    DOE Patents [OSTI]

    Goodman, Mark M.; Martarello, Laurent

    2005-01-18

    A series of compounds in the 4-fluoroalkyl-3-halophenyl nortropanes and 4-haloethenylphenyl tropane families are described as diagnostic and therapeutic agents for diseases associated with serotonin transporter dysfunction. These compounds bind to serotonin transporter protein with high affinity and selectivity. The invention provides methods of synthesis which incorporate radioisotopic halogens at a last step which permit high radiochemical yield and maximum usable product life. The radiolabeled compounds of the invention are useful as imaging agents for visualizing the location and density of serotonin transporter by PET and SPECT imaging.

  1. Divalent fluoride doped cerium fluoride scintillator

    DOE Patents [OSTI]

    Anderson, David F. (630 Sylvan Pl., Batavia, IL 60510); Sparrow, Robert W. (28 Woodlawn Dr., Sturbridge, MA 01566)

    1991-01-01

    The use of divalent fluoride dopants in scintillator materials comprising cerium fluoride is disclosed. The preferred divalent fluoride dopants are calcium fluoride, strontium fluoride, and barium fluoride. The preferred amount of divalent fluoride dopant is less than about two percent by weight of the total scintillator. Cerium fluoride scintillator crystals grown with the addition of a divalent fluoride have exhibited better transmissions and higher light outputs than crystals grown without the addition of such dopants. These scintillators are useful in radiation detection and monitoring applications, and are particularly well suited for high-rate applications such as positron emission tomography (PET).

  2. DOE Research and Development Accomplishments Transcript - Fast Facts

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Fast Facts what has the DOE accomplished? decoded 3 of the chromosomes in your DNA developed battery that powered many spacecraft, including the lunar lander built a pre-Pong video game in 1958 won more than 80 Nobel prizes discovered 8 of the transuranium elements that are on the Periodic Table advanced medicine by contributing to the development of CAT, PET, and MRI scanners Did you know that DOE also discovered the path of carbon in photo-synthesis, which led to solar energy research found a

  3. DOE Research and Development Accomplishments Transcript - Visions of

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Success I Visions of Success I what has the DOE accomplished? decoded 3 of the chromosomes in your DNA developed batteries that power our spacecraft built a pre-Pong video game in 1958 won more than 80 Nobel prizes what else has DOE done? discovered 8 of the transuranium elements that are on the Periodic Table advanced medicine by contributing to the development of CAT, PET, and MRI scanners discovered the path of carbon in photosynthesis leading to solar energy research

  4. Pontotoc Co. Greene Co. Hale Co. OAK GROVE C OAL D EGAS CEDAR COVE

    Gasoline and Diesel Fuel Update (EIA)

    COAL D EGAS BLU E CREEK COAL DEGAS BR OOKWOOD C OAL D EGAS ST AR ROBIN SONS BEND COAL D EGAS BLU FF COR INNE MOU NDVILLE COAL D EGAS BLU EGU T CR EEK WH ITE OAK CREEK COAL DEGAS BEAVERT ON BLU FF FAYETTE W SN EAD S CREEK SPLU NGE PAR HAM N MUSGR OVE CR EEK MCCRAC KEN MOU NTAIN DAVIS C HAPEL BAC ON BLOOMING GROVE MT Z ION FAIRVIEW JASPER BLOWHORN CREEK MAPLE BRAN CH KEN NEDY COAL F IRE CR EEK MCGEE LAKE SILOAM MILLPOR T FERNBANK DAVIS C HAPEL NE DETROIT E BEANS F ERRY LEXIN GT ON PET ERSON COAL

  5. Pontotoc Co. Greene Co. Hale Co. OAK GROVE C OAL D EGAS CEDAR COVE COAL DEGAS

    Gasoline and Diesel Fuel Update (EIA)

    COAL DEGAS BLU E CREEK COAL DEGAS BR OOKWOOD C OAL D EGAS ST AR ROBIN SONS BEND COAL DEGAS BLU FF COR INNE MOU NDVILLE COAL DEGAS BLU EGU T CR EEK WH ITE OAK CREEK COAL DEGAS BEAVERT ON BLU FF FAYETTE W SN EAD S CREEK SPLU NGE PAR HAM N MUSGR OVE CR EEK MCCRAC KEN MOU NTAIN DAVIS C HAPEL BAC ON BLOOMING GROVE MT Z ION FAIRVIEW JASPER BLOWHORN CREEK MAPLE BRAN CH KEN NEDY COAL F IRE CR EEK MCGEE LAKE SILOAM MILLPOR T FERNBANK DAVIS C HAPEL NE DETROIT E BEANS F ERRY LEXIN GT ON PET ERSON COAL

  6. Isotopes Products

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Isotopes Products Isotopes Products Isotopes produced at Los Alamos National Laboratory are saving lives, advancing cutting-edge research and keeping the U.S. safe. Products stress and rest Stress and rest Rb-82 PET images in a patient with dipyridamole stress-inducible lateral wall and apical ischemia. (http://www.fac.org.ar/scvc/llave/image/machac/machaci.htm#f2,3,4) Strontium-82 is supplied to our customers for use in Sr-82/Rb-82 generator technologies. The generators in turn are supplied to

  7. 2007 | Jefferson Lab

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    December 2007 Mon, 12/17/2007 - 1:00am Laser turns 50 (Inside Business) Fri, 12/14/2007 - 1:00am GOVERNOR INVESTS IN HIGHER EDUCATION (Daily Press) Wed, 12/05/2007 - 1:00am Transparent Nuclei (focus.aps.org) Tue, 12/04/2007 - 1:00am PET And Bioluminescent Imaging Aid Evaluation Of Stem Cells' Potential For New Ways To Treat Disease (Society of Nuclear Medicine) November 2007 Fri, 11/16/2007 - 1:00am Scientists Help Teachers With Their Math and Science (EdWeek.org) Tue, 11/13/2007 - 1:00am Bush

  8. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    " ,"Click worksheet name or tab at bottom for data" ,"Worksheet Name","Description","# Of Series","Frequency","Latest Data for" ,"Data 1","Total Imports ",6,"Weekly","3/11/2016","2/8/1991" ,"Release Date:","3/16/2016" ,"Next Release Date:","3/23/2016" ,"Excel File Name:","pet_move_wkly_a_ep00_im0_mbblpd_w.xls"

  9. AMF Deployment, Hyytiala, Finland

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Finland Hyytiälä Deployment AMF Home Hyytiälä Home Experiment Planning Abstract and Related Campaigns Science Plan Deployment Operations Baseline Instruments and Data Plots at the Archive BAECC Instruments AMF2 Management and Operations Outreach News & Press BAECC Blog Backgrounder (PDF, 1.5MB) Poster (JPEG, 1.3MB) Education Flyer (English) (PDF, 1.3MB) Education Flyer (Finnish) (PDF, 1.3MB) Images Contacts Nicki Hickmon, AMF Operations Tuukka Petäjä, Principal Investigator AMF

  10. Synthesis and magnetic reversal of bi-conical Ni nanostructures

    SciTech Connect (OSTI)

    Biziere, N.; Lassalle Ballier, R.; Viret, M.

    2011-09-15

    Template synthesis in polyethylene terephthalate (PET) membranes has been used to grow hour glass shaped nickel nanowires with a constriction in the range of tens of nanometers at the center. Anisotropic magnetoresistance measurements have been performed on a single nanowire to follow magnetization reversal of the structure. The results are explained via 3D micromagnetic simulations showing the appearance of a complex vortex state close to the constriction whose propagation depends on the angle between the cone axis and the applied field. The interest of this original growth process for spintronics is discussed.

  11. Lawrence Berkeley Laboratory

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    e UNIVERSITY OF CALIFORNIA Presented at the International Workhop on Physics and Engineering in Computerized Multidimensional Imaging and Processing, Irvine, CA, April 4, 1986; and to be published in Journal of the SPIE RECENT DEVELOPMENTS IN POSITRON EMISSION TOMOGRAPHY (PET) INSTRUMENTATION S.E. Derenzo and T.F. Budinger April 1986 Prepared for the U.S. Department of Energy under Contract DE-AC03-76SF00098 DlSTRlBUTiON OF THIS DOCUMENT bs UMLtMlTEO LEGAL NOTICE This book was prepared as an

  12. Los Alamos ChamberFest

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    Los Alamos ChamberFest Los Alamos ChamberFest WHEN: Jun 13, 2015 10:00 AM - 3:00 PM WHERE: Central Park Square, Los Alamos CATEGORY: Community INTERNAL: Calendar Login Event Description ChamberFest is the annual Los Alamos Chamber of Commerce event featuring Chamber Members. It is an opportunity for businesses and nonprofits alike to showcase their products and services to the public. Entertainment will include music, a car show, pet activity area, and the always popular, kids activity area

  13. March 2015 Most Viewed Documents for Biology And Medicine | OSTI, US Dept

    Broader source: All U.S. Department of Energy (DOE) Office Webpages (Extended Search)

    of Energy, Office of Scientific and Technical Information 5 Most Viewed Documents for Biology And Medicine Measuring dopamine release in the human brain with PET Volkow, N.D. [Brookhaven National Lab., Upton, NY (United States)]|[State Univ. of New York at Stony Brook, Stony Brook, NY (United States). Dept. of Psychiatry]; Fowler, J.S.; Logan, J.; Wang, G.J. [Brookhaven National Lab., Upton, NY (United States)] (1995) 134 Drug Retention Times Center for Human Reliability Studies (2007) 114

  14. Workbook Contents

    U.S. Energy Information Administration (EIA) Indexed Site

    Stocks" ,"Click worksheet name or tab at bottom for data" ,"Worksheet Name","Description","# Of Series","Frequency","Latest Data for" ,"Data 1","U.S. Refinery Stocks",62,"Monthly","12/2015","1/15/1981" ,"Release Date:","2/29/2016" ,"Next Release Date:","3/31/2016" ,"Excel File Name:","pet_stoc_ref_dc_nus_mbbl_m.xls"

  15. Three SBIR Grants Awarded for Solid-State Lighting Technology | Department

    Office of Energy Efficiency and Renewable Energy (EERE) Indexed Site

    of Energy Three SBIR Grants Awarded for Solid-State Lighting Technology Three SBIR Grants Awarded for Solid-State Lighting Technology June 19, 2015 - 10:49am Addthis The U.S. Department of Energy Office of Science has awarded Three Small Business Innovation Research (SBIR) grants targeting advances in solid-state lighting (SSL) technology: VoltServer, Inc. (Phase II)-Low-Cost, High Efficiency Integration of SSL and Building Controls using a PET Power Distribution System MoJo Labs Inc.(Phase

  16. 427th Brookhaven Lecture

    ScienceCinema (OSTI)

    Gene-Jack Wang

    2010-09-01

    The increasing number of obese individuals in the U.S. and other countries world-wide adds urgency to the need to understand the mechanisms underlying pathological overeating. Research by the speaker and others at Brookhaven National Laboratory and elsewhere is compiling evidence that the brain circuits disrupted in obesity are similar to those involved in drug addiction. Using positron emission tomography (PET), the speaker and his colleagues have implicated brain dopamine in the normal and the pathological intake of food by humans.

  17. Four SBIR Grants Awarded for Solid-State Lighting Technology | Department

    Office of Environmental Management (EM)

    of Energy Four SBIR Grants Awarded for Solid-State Lighting Technology Four SBIR Grants Awarded for Solid-State Lighting Technology May 14, 2014 - 11:25am Addthis The U.S. Department of Energy Office of Science has awarded four Small Business Innovation Research (SBIR) grants targeting advances in solid-state lighting (SSL) technology: VoltServer, Inc. - Low-Cost, High Efficiency Integration of SSL and Building Controls using a PET Power Distribution System Innotec, Corp. - Integrating

  18. Four SBIR Grants Awarded for Solid-State Lighting Technology | Department

    Office of Environmental Management (EM)

    of Energy Four SBIR Grants Awarded for Solid-State Lighting Technology Four SBIR Grants Awarded for Solid-State Lighting Technology May 14, 2014 - 4:39pm Addthis The U.S. Department of Energy Office of Science has awarded four Small Business Innovation Research (SBIR) grants targeting advances in solid-state lighting (SSL) technology: VoltServer, Inc.-Low-Cost, High Efficiency Integration of SSL and Building Controls using a PET Power Distribution System Innotec, Corp.-Integrating Energy

  19. Carboranylporphyrins and uses thereof

    DOE Patents [OSTI]

    Wu, Haitao; Miura, Michiko

    2006-02-07

    The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-containing 5, 10, 15, 20-tetraphenylporphyrin compounds and methods for their use particularly in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT) for the treatment of tumors of the brain, head and neck, and surrounding tissue. The invention is also directed to using these carborane-containing tetraphenyl porphyrin compounds to methods of tumor imaging and/or diagnosis such as MRI, SPECT, or PET.

  20. Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof

    DOE Patents [OSTI]

    Miura, Michiko; Wu, Haitao

    2013-05-21

    The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity halogenated, carborane-containing 5,10,15,20-tetraphenylporphyrin compounds and methods for their use particularly in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT) for the treatment of tumors of the brain, head and neck, and surrounding tissue. The invention is also directed to using these halogenated, carborane-containing tetraphenylporphyrin compounds in methods of tumor imaging and/or diagnosis such as MRI, SPECT, or PET.

  1. Carboranylporphyrins and uses thereof

    DOE Patents [OSTI]

    Miura, Michiko; Renner, Mark W

    2012-10-16

    The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-containing porphyrin compounds with halide, amine, or nitro groups and methods for their use particularly in boron neutron capture therapy (BNCT), X-ray radiation therapy (XRT), and photodynamic therapy (PDT) for the treatment of tumors of the brain, head and neck, and surrounding tissue. The invention is also directed to using these carborane-containing porphyrin compounds in methods of tumor imaging and/or diagnosis such as MRI, SPECT, or PET.

  2. Carboranylporphyrins and uses thereof

    DOE Patents [OSTI]

    Wu, Haitao; Miura, Michiko

    2006-01-24

    The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-containing 5, 10, 15, 20-tetraphenylporphyrin compounds and methods for their use particularly in boron neutron capture therapy (BNCT) and photodynamic therapy (PDT) for the treatment of tumors of the brain, head, neck, and surrounding tissue. The invention is also directed to using these carborane-containing tetraphenyl porphyrin compounds to methods of tumor imaging and/or diagnosis such as MRI, SPECT, or PET.

  3. Carbonylporphyrins and uses thereof

    DOE Patents [OSTI]

    Miura, Michiko; Renner, Mark W

    2014-03-18

    The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-containing porphyrin compounds with halide, amine, or nitro groups and methods for their use particularly in boron neutron capture therapy (BNCT), X-ray radiation therapy (XRT), and photodynamic therapy (PDT) for the treatment of tumors of the brain, head and neck, and surrounding tissue. The invention is also directed to using these carborane-containing porphyrin compounds in methods of tumor imaging and/or diagnosis such as MRI, SPECT, or PET.

  4. Increasing the rate of hydrogen oxidation without increasing the overpotential: A bio-inspired iron molecular electrocatalyst with an outer coordination sphere proton relay

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Darmon, Jonathan M.; Kumar, Neeraj; Hulley, Elliott B.; Weiss, Charles J.; Raugei, Simone; Bullock, R. Morris; Helm, Monte L.

    2015-03-05

    Oxidation of hydrogen (H₂) to protons and electrons for energy production in fuel cells is catalyzed by platinum, but its low abundance and high cost present drawbacks to widespread adoption. Precisely controlled proton delivery and removal is critical in hydrogenase enzymes in nature that catalyze H₂ oxidation using earth-abundant metals (iron and nickel). Here we report a synthetic iron complex, (CpC5F4N)Fe(PEtN(CH2)3NMe2PEt)(Cl), that serves as a precatalyst for the oxidation of H₂, with turnover frequencies of 290 s⁻¹ in fluorobenzene, under 1 atm of H₂ using 1,4-diazabicyclo[2.2.2]octane (DABCO) as the exogenous base. The cooperative effect of the primary, secondary and outermore » coordination spheres for moving protons in this remarkably fast catalyst emphasizes the key role of pendant amines in mimicking the functionality of the proton pathway in the hydrogenase enzymes.« less

  5. Optical reaction cell and light source for 18F! fluoride radiotracer synthesis

    DOE Patents [OSTI]

    Ferrieri, Richard A. (Patchogue, NY); Schlyer, David (Bellport, NY); Becker, Richard J. (Islip, NY)

    1998-09-15

    Apparatus for performing organic synthetic reactions, particularly no-carrier-added nucleophilic radiofluorination reactions for PET radiotracer production. The apparatus includes an optical reaction cell and a source of broadband infrared radiant energy, which permits direct coupling of the emitted radiant energy with the reaction medium to heat the reaction medium. Preferably, the apparatus includes means for focusing the emitted radiant energy into the reaction cell, and the reaction cell itself is preferably configured to reflect transmitted radiant energy back into the reaction medium to further improve the efficiency of the apparatus. The apparatus is well suited to the production of high-yield syntheses of 2-.sup.18 F!fluoro-2-deoxy-D-glucose. Also provided is a method for performing organic synthetic reactions, including the manufacture of .sup.18 F!-labeled compounds useful as PET radiotracers, and particularly for the preparation of 2-.sup.18 F!fluoro-2-deoxy-D-glucose in higher yields than previously possible.

  6. Development of Advanced Polymeric Reflector for CSP Applications - Final Report

    SciTech Connect (OSTI)

    Treglio, Richard, T; Boyle, Keith, A; Henderson, Hildie

    2013-03-28

    This project attempted to deposit extremely thick and dense protective barrier onto a mirror film stack with a PET substrate. The target thickness was very high for thin film products; particularly since large areas and long production lengths of film are needed to make the final product economic. The technical investigations in this project centered on maintaining a quality barrier (i.e. dense film) while evaporating alumina with a high deposition rate onto a low cost PET substrate. The project found that the proposed configuration, particularly direct ion bombardment, provides too narrow a solution space to effectively and economically produce the ASRM attempted. The initial project goals were met when depositing on a limited width and at a modest rate. However, expanding to wide deposition at aggressive deposition rates did not produce consistent film quality. Economic viability drives the process to maximize deposition rate. The current system configuration has a limiting upper rate threshold that does not appear economically viable. For future work, alternate approaches seem needed to address the challenges encountered in the scale-up phase of this project.

  7. Multimodal Imaging of Alzheimer Pathophysiology in the Brain's Default Mode Network

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Shin, Jonghan; Kepe, Vladimir; Small, Gary W.; Phelps, Michael E.; Barrio, Jorge R.

    2011-01-01

    The spatial correlations between the brain's default mode network (DMN) and the brain regions known to develop pathophysiology in Alzheimer's disease (AD) have recently attracted much attention. In this paper, we compare results of different functional and structural imaging modalities, including MRI and PET, and highlight different patterns of anomalies observed within the DMN. Multitracer PET imaging in subjects with and without dementia has demonstrated that [C-11]PIB- and [F-18]FDDNP-binding patterns in patients with AD overlap within nodes of the brain's default network including the prefrontal, lateral parietal, lateral temporal, and posterior cingulate cortices, with the exception of the medial temporalmore » cortex (especially, the hippocampus) where significant discrepancy between increased [F-18]FDDNP binding and negligible [C-11]PIB-binding was observed. [F-18]FDDNP binding in the medial temporal cortex—a key constituent of the DMN—coincides with both the presence of amyloid and tau pathology, and also with cortical areas with maximal atrophy as demonstrated by T1-weighted MR imaging of AD patients.« less

  8. X-ray and gamma ray detector readout system

    DOE Patents [OSTI]

    Tumer, Tumay O (Riverside, CA); Clajus, Martin (Los Angeles, CA); Visser, Gerard (Bloomington, IN)

    2010-10-19

    A readout electronics scheme is under development for high resolution, compact PET (positron emission tomography) imagers based on LSO (lutetium ortho-oxysilicate, Lu.sub.2SiO.sub.5) scintillator and avalanche photodiode (APD) arrays. The key is to obtain sufficient timing and energy resolution at a low power level, less than about 30 mW per channel, including all required functions. To this end, a simple leading edge level crossing discriminator is used, in combination with a transimpedance preamplifier. The APD used has a gain of order 1,000, and an output noise current of several pA/ Hz, allowing bipolar technology to be used instead of CMOS, for increased speed and power efficiency. A prototype of the preamplifier and discriminator has been constructed, achieving timing resolution of 1.5 ns FWHM, 2.7 ns full width at one tenth maximum, relative to an LSO/PMT detector, and an energy resolution of 13.6% FWHM at 511 keV, while operating at a power level of 22 mW per channel. Work is in progress towards integration of this preamplifier and discriminator with appropriate coincidence logic and amplitude measurement circuits in an ASIC suitable for a high resolution compact PET instrument. The detector system and/or ASIC can also be used for many other applications for medical to industrial imaging.

  9. Microfluidic Radiometal Labeling Systems for Biomolecules

    SciTech Connect (OSTI)

    Reichert, D E; Kenis, P J. A.

    2011-12-29

    In a typical labeling procedure with radiometals, such as Cu-64 and Ga-68; a very large (~ 100-fold) excess of the non-radioactive reactant (precursor) is used to promote rapid and efficient incorporation of the radioisotope into the PET imaging agent. In order to achieve high specific activities, careful control of reaction conditions and extensive chromatographic purifications are required in order to separate the labeled compounds from the cold precursors. Here we propose a microfluidic approach to overcome these problems, and achieve high specific activities in a more convenient, semi-automated fashion and faster time frame. Microfluidic reactors, consisting of a network of micron-sized channels (typical dimensions in the range 10 â?? 300 ?¼m), filters, separation columns, electrodes and reaction loops/chambers etched onto a solid substrate, are now emerging as an extremely useful technology for the intensification and miniaturization of chemical processes. The ability to manipulate, process and analyze reagent concentrations and reaction interfaces in both space and time within the channel network of a microreactor provides the fine level of reaction control that is desirable in PET radiochemistry practice. These factors can bring radiometal labeling, specifically the preparation of radio-labeled biomolecules such as antibodies, much closer to their theoretical maximum specific activities.

  10. Simulation of the Two Stages Stretch-Blow Molding Process: Infrared Heating and Blowing Modeling

    SciTech Connect (OSTI)

    Bordival, M.; Schmidt, F. M.; Le Maoult, Y.; Velay, V. [CROMeP - Ecole des Mines d'Albi Carmaux - Campus Jarlard - 81013 Albi cedex 09 (France)

    2007-05-17

    In the Stretch-Blow Molding (SBM) process, the temperature distribution of the reheated perform affects drastically the blowing kinematic, the bottle thickness distribution, as well as the orientation induced by stretching. Consequently, mechanical and optical properties of the final bottle are closely related to heating conditions. In order to predict the 3D temperature distribution of a rotating preform, numerical software using control-volume method has been developed. Since PET behaves like a semi-transparent medium, the radiative flux absorption was computed using Beer Lambert law. In a second step, 2D axi-symmetric simulations of the SBM have been developed using the finite element package ABAQUS registered . Temperature profiles through the preform wall thickness and along its length were computed and applied as initial condition. Air pressure inside the preform was not considered as an input variable, but was automatically computed using a thermodynamic model. The heat transfer coefficient applied between the mold and the polymer was also measured. Finally, the G'sell law was used for modeling PET behavior. For both heating and blowing stage simulations, a good agreement has been observed with experimental measurements. This work is part of the European project ''APT{sub P}ACK'' (Advanced knowledge of Polymer deformation for Tomorrow's PACKaging)

  11. Compatibility of refrigerants and lubricants with motor materials under retrofit conditions

    SciTech Connect (OSTI)

    Doerr, R.; Waite, T.

    1995-01-12

    Motor materials were exposed to original refrigerants R-11, R-12, R-22 and R-502 in the presence of mineral oil for 500 hours. These same materials were then exposed to alternative refrigerants R-123, R-134a, R-407C (R-32/R-125/R-134a) and R-404A (R-125/R-143a/R-134a), respectively, in the presence of the appropriate lubricant for 500 hours. As a control, some samples were exposed to the original refrigerant/mineral oil for a total of 1,000 hours. These tests were conducted to determine whether exposure to the original refrigerant/mineral oil would affect compatibility of the motor materials with the alternative refrigerant/lubricant after retrofit. Motor materials exposed to the alternative refrigerant and lubricant (after an initial exposure to the original refrigerant and mineral oil) appeared to be compatible with the alternative refrigerant and lubricant. The only concerns were embrittlement of the polyethylene terephthalate (PET) sheet and sleeving insulations, and delamination and blistering of the Nomex sheet insulation in the R-22, R-502, and R-12. Embrittlement of the PET materials was attributed to moisture present during the exposure. Separation of the 475 varnish from metal surfaces in the R-123 was also a concern. The sheet and sleeving insulations were affected by the original refrigerant/mineral oil to a greater extent than by the alternative refrigerant and lubricant.

  12. Electrical properties and surface morphology of electron beam evaporated p-type silicon thin films on polyethylene terephthalate for solar cells applications

    SciTech Connect (OSTI)

    Ang, P. C.; Ibrahim, K.; Pakhuruddin, M. Z.

    2015-04-24

    One way to realize low-cost thin film silicon (Si) solar cells fabrication is by depositing the films with high-deposition rate and manufacturing-compatible electron beam (e-beam) evaporation onto inexpensive foreign substrates such as glass or plastic. Most of the ongoing research is reported on e-beam evaporation of Si films on glass substrates to make polycrystalline solar cells but works combining both e-beam evaporation and plastic substrates are still scarce in the literature. This paper studies electrical properties and surface morphology of 1 m electron beam evaporated Al-doped p-type silicon thin films on textured polyethylene terephthalate (PET) substrate for application as an absorber layer in solar cells. In this work, Si thin films with different doping concentrations (including an undoped reference) are prepared by e-beam evaporation. Energy dispersion X-ray (EDX) showed that the Si films are uniformly doped by Al dopant atoms. With increased Al/Si ratio, doping concentration increased while both resistivity and carrier mobility of the films showed opposite relationships. Root mean square (RMS) surface roughness increased. Overall, the Al-doped Si film with Al/Si ratio of 2% (doping concentration = 1.5710{sup 16} atoms/cm{sup 3}) has been found to provide the optimum properties of a p-type absorber layer for fabrication of thin film Si solar cells on PET substrate.

  13. High-Performance Flexible Perovskite Solar Cells by Using a Combination of Ultrasonic Spray-Coating and Low Thermal Budget Photonic Curing

    SciTech Connect (OSTI)

    Sanjib, Das; Yang, Bin; Gu, Gong; Joshi, Pooran C; Ivanov, Ilia N; Rouleau, Christopher; Aytug, Tolga; Geohegan, David B; Xiao, Kai

    2015-01-01

    Realizing the commercialization of high-performance and robust perovskite solar cells urgently requires the development of economically scalable processing techniques. Here we report a high-throughput ultrasonic spray-coating (USC) process capable of fabricating perovskite film-based solar cells on glass substrates with power conversion efficiency (PCE) as high as 13.04%. Perovskite films with high uniformity, crystallinity, and surface coverage are obtained in a single step. Moreover, we report USC processing on TiOx/ITO-coated polyethylene terephthalate (PET) substrates to realize flexible perovskite solar cells with PCE as high as 8.02% that are robust under mechanical stress. In this case, an optical curing technique was used to achieve a highly-conductive TiOx layer on flexible PET substrates for the first time. The high device performance and reliability obtained by this combination of USC processing with optical curing appears very promising for roll-to-roll manufacturing of high-efficiency, flexible perovskite solar cells.

  14. ACE3P Computations of Wakefield Coupling in the CLIC Two-Beam Accelerator

    SciTech Connect (OSTI)

    Candel, Arno; Li, Z.; Ng, C.; Rawat, V.; Schussman, G.; Ko, K.; Syratchev, I.; Grudiev, A.; Wuensch, W.

    2010-10-27

    The Compact Linear Collider (CLIC) provides a path to a multi-TeV accelerator to explore the energy frontier of High Energy Physics. Its novel two-beam accelerator concept envisions rf power transfer to the accelerating structures from a separate high-current decelerator beam line consisting of power extraction and transfer structures (PETS). It is critical to numerically verify the fundamental and higher-order mode properties in and between the two beam lines with high accuracy and confidence. To solve these large-scale problems, SLAC's parallel finite element electromagnetic code suite ACE3P is employed. Using curvilinear conformal meshes and higher-order finite element vector basis functions, unprecedented accuracy and computational efficiency are achieved, enabling high-fidelity modeling of complex detuned structures such as the CLIC TD24 accelerating structure. In this paper, time-domain simulations of wakefield coupling effects in the combined system of PETS and the TD24 structures are presented. The results will help to identify potential issues and provide new insights on the design, leading to further improvements on the novel CLIC two-beam accelerator scheme.

  15. Compact Beta Particle/Positron Imager for Plant Biology

    SciTech Connect (OSTI)

    Weisenberger, Andrew; Lee, Seung Joon; McKisson, John; Xi, Wenze; Zorn, Carl; Stolin, Alexander; Majewski, Stan; Majewski, Stanislaw; Howell, Calvin; Crowell, Alec

    2011-06-01

    The 11CO2 tracer is used to facilitate plant biology research towards optimization of plant productivity, biofuel development and carbon sequestration in biomass. Positron emission tomography (PET) imaging has been used to study carbon transport in live plants using 11CO2. Plants typically have very thin leaves resulting in little medium for the emitted positrons to undergo an annihilation event. For the emitted positron from 11C decay approximately 1mm of water equivalent material is needed for positron annihilation. Thus most of the positrons do not annihilate inside the leaf, resulting in limited sensitivity for PET imaging. To address this problem we have developed a compact beta-positive beta-minus particle (BPBM) imager for 11CO2 leaf imaging. The detector is based on a Hamamatsu H8500 position sensitive photomultiplier tube optically coupled via optical grease and a 3mm thick glass plate to a 0.5mm thick Eljin EJ-212 plastic scintillator. The detector is equipped with a flexible arm to allow its placement and orientation on the leaf of the plant of interest while maintaining the leaf's original orientation. We are planning to utilize the imaging device at the Duke University Phytotron to investigate dynamic carbon transport differences between invasive and native species.

  16. Associations between bacterial communities of house dust and infant gut

    SciTech Connect (OSTI)

    Konya, T.; Koster, B.; Maughan, H.; Escobar, M.; Azad, M.B.; Guttman, D.S.; Sears, M.R.; Becker, A.B.; Brook, J.R.; Takaro, T.K.; Kozyrskyj, A.L.; Scott, J.A.

    2014-05-01

    The human gut is host to a diverse and abundant community of bacteria that influence health and disease susceptibility. This community develops in infancy, and its composition is strongly influenced by environmental factors, notably perinatal anthropogenic exposures such as delivery mode (Cesarean vs. vaginal) and feeding method (breast vs. formula); however, the built environment as a possible source of exposure has not been considered. Here we report on a preliminary investigation of the associations between bacteria in house dust and the nascent fecal microbiota from 20 subjects from the Canadian Healthy Infant Longitudinal Development (CHILD) Study using high-throughput sequence analysis of portions of the 16S rRNA gene. Despite significant differences between the dust and fecal microbiota revealed by Nonmetric Multidimensional Scaling (NMDS) analysis, permutation analysis confirmed that 14 bacterial OTUs representing the classes Actinobacteria (3), Bacilli (3), Clostridia (6) and Gammaproteobacteria (2) co-occurred at a significantly higher frequency in matched duststool pairs than in randomly permuted pairs, indicating an association between these dust and stool communities. These associations could indicate a role for the indoor environment in shaping the nascent gut microbiota, but future studies will be needed to confirm that our findings do not solely reflect a reverse pathway. Although pet ownership was strongly associated with the presence of certain genera in the dust for dogs (Agrococcus, Carnobacterium, Exiguobacterium, Herbaspirillum, Leifsonia and Neisseria) and cats (Escherichia), no clear patterns were observed in the NMDS-resolved stool community profiles as a function of pet ownership.

  17. Optical reaction cell and light source for [18F] fluoride radiotracer synthesis

    DOE Patents [OSTI]

    Ferrieri, R.A.; Schlyer, D.; Becker, R.J.

    1998-09-15

    An apparatus is disclosed for performing organic synthetic reactions, particularly no-carrier-added nucleophilic radiofluorination reactions for PET radiotracer production. The apparatus includes an optical reaction cell and a source of broadband infrared radiant energy, which permits direct coupling of the emitted radiant energy with the reaction medium to heat the reaction medium. Preferably, the apparatus includes means for focusing the emitted radiant energy into the reaction cell, and the reaction cell itself is preferably configured to reflect transmitted radiant energy back into the reaction medium to further improve the efficiency of the apparatus. The apparatus is well suited to the production of high-yield syntheses of 2-[{sup 18}F]fluoro-2-deoxy-Dglucose. Also provided is a method for performing organic synthetic reactions, including the manufacture of [{sup 18}F]-labeled compounds useful as PET radiotracers, and particularly for the preparation of 2-[{sup 18}F]fluoro-2-deoxy-D-glucose in higher yields than previously possible. 4 figs.

  18. Optical reaction cell and light source for ›18F! fluoride radiotracer synthesis

    DOE Patents [OSTI]

    Ferrieri, Richard A.; Schlyer, David; Becker, Richard J.

    1998-09-15

    Apparatus for performing organic synthetic reactions, particularly no-carrier-added nucleophilic radiofluorination reactions for PET radiotracer production. The apparatus includes an optical reaction cell and a source of broadband infrared radiant energy, which permits direct coupling of the emitted radiant energy with the reaction medium to heat the reaction medium. Preferably, the apparatus includes means for focusing the emitted radiant energy into the reaction cell, and the reaction cell itself is preferably configured to reflect transmitted radiant energy back into the reaction medium to further improve the efficiency of the apparatus. The apparatus is well suited to the production of high-yield syntheses of 2-›.sup.18 F!fluoro-2-deoxy-D-glucose. Also provided is a method for performing organic synthetic reactions, including the manufacture of ›.sup.18 F!-labeled compounds useful as PET radiotracers, and particularly for the preparation of 2-›.sup.18 F!fluoro-2-deoxy-D-glucose in higher yields than previously possible.

  19. Space-resolved extreme ultraviolet spectroscopy free of high-energy neutral particle noise in wavelength range of 10130 on the large helical device

    SciTech Connect (OSTI)

    Huang, Xianli; Morita, Shigeru; Oishi, Tetsutarou; Goto, Motoshi; National Institute for Fusion Science, Toki 509-5292 Gifu ; Dong, Chunfeng

    2014-04-15

    A flat-field space-resolved extreme ultraviolet (EUV) spectrometer system working in wavelength range of 10130 has been constructed in the Large Helical Device (LHD) for profile measurements of bremsstrahlung continuum and line emissions of heavy impurities in the central column of plasmas, which are aimed at studies on Z{sub eff} and impurity transport, respectively. Until now, a large amount of spike noise caused by neutral particles with high energies (?180 keV) originating in neutral beam injection has been observed in EUV spectroscopy on LHD. The new system has been developed with an aim to delete such a spike noise from the signal by installing a thin filter which can block the high-energy neutral particles entering the EUV spectrometer. Three filters of 11 ?m thick beryllium (Be), 3.3 ?m thick polypropylene (PP), and 0.5 ?m thick polyethylene terephthalate (PET: polyester) have been examined to eliminate the spike noise. Although the 11 ?m Be and 3.3 ?m PP filters can fully delete the spike noise in wavelength range of ? ? 20 , the signal intensity is also reduced. The 0.5 ?m PET filter, on the other hand, can maintain sufficient signal intensity for the measurement and the spike noise remained in the signal is acceptable. As a result, the bremsstrahlung profile is successfully measured without noise at 20 even in low-density discharges, e.g., 2.9 10{sup 13} cm{sup ?3}, when the 0.5 ?m PET filter is used. The iron n = 32 L? transition array consisting of FeXVII to FeXXIV is also excellently observed with their radial profiles in wavelength range of 1018 . Each transition in the L? array can be accurately identified with its radial profile. As a typical example of the method a spectral line at 17.62 is identified as FeXVIII transition. Results on absolute intensity calibration of the spectrometer system, pulse height and noise count analyses of the spike noise between holographic and ruled gratings and wavelength response of the used filters are also presented with performance of the present spectrometer system.

  20. TU-F-12A-01: Quantitative Non-Linear Compartment Modeling of 89Zr- and 124I- Labeled J591 Monoclonal Antibody Kinetics Using Serial Non-Invasive Positron Emission Tomography Imaging in a Pre-Clinical Human Prostate Cancer Mouse Model

    SciTech Connect (OSTI)

    Fung, EK; Cheal, SM; Chalasani, S; Fareedy, SB; Punzalan, B; Humm, JL; Osborne, JR; Larson, SM; Zanzonico, PB; Otto, B; Bander, NH

    2014-06-15

    Purpose: To examine the binding kinetics of human IgG monoclonal antibody J591 which targets prostate-specific membrane antigen (PSMA) in a pre-clinical mouse cancer model using quantitative PET compartmental analysis of two radiolabeled variants. Methods: PSMA is expressed in normal human prostate, and becomes highly upregulated in prostate cancer, making it a promising therapeutic target. Two forms of J591, radiolabeled with either {sup 89}Zr or {sup 124}I, were prepared. {sup 89}Zr is a radiometal that becomes trapped in the cell upon internalization by the antigen-antibody complex, while radioiodine leaves the cell. Mice with prostate cancer xenografts underwent non-invasive serial imaging on a Focus 120 microPET up to 144 hours post-injection of J591. A non-linear compartmental model describing the binding and internalization of antibody in tumor xenograft was developed and applied to the PET-derived time-activity curves. The antibody-antigen association rate constant (ka), total amount of antigen per gram tumor (Ag-total), internalization rate of antibody-antigen complex, and efflux rate of radioisotope from tumor were fitted using the model. The surface-bound and the internalized activity were also estimated. Results: Values for ka, Ag-total, and internalization rate were found to be similar regardless of radiolabel payload used. The efflux rate, however, was ? 9-fold higher for {sup 124}I-J591 than for {sup 89}Zr-J591. Time-dependent surface-bound and internalized radiotracer activity were similar for both radiolabels at early times post-injection, but clearly differed beyond 24 hours. Conclusion: Binding and internalization of J591 to PSMA-expressing tumor xenografts were similar when radiolabeled with either {sup 89}Zr or {sup 124}I payload. The difference in efflux of radioactivity from tumor may be attributable to differential biological fate intracellularly of the radioisotopes. This has great significance for radioimmunotherapy and antibody-drug conjugates. Further exploration using the model will examine binding and radioisotope residence as antibody dose is increased to antigen saturation. The Center for Targeted Radioimmunotherapy and Theranostics, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center (MSK), NIH (R25-CA096945). Technical services provided by the MSK Small-Animal Imaging Core Facility were supported by the NIH (R24-CA83084, P30-CA08748, and P50-CA92629; Zanzonico). NCI, Center to Reduce Cancer Health Disparity (R21 CA153177-03; Osborne)

  1. Use of Reinforced Lightweight Clay Aggregates for Landslide Stabilisation

    SciTech Connect (OSTI)

    Herle, Vitezslav

    2008-07-08

    In spring 2006 a large landslide combined with rock fall closed a highway tunnel near Svitavy in NE part of Czech Republic and cut the main highway connecting Bohemia with Moravia regions. Stabilisation work was complicated by steep mountainous terrain and large inflow of surface and underground water. The solution was based on formation of a stabilisation fill made of reinforced free draining aggregates at the toe of the slope with overlying lightweight fill up to 10 m high reinforced with PET geogrid and steel mesh protecting soft easily degrading sandstone against weathering. Extensive monitoring made possible to compare the FEM analysis with real values. The finished work fits very well in the environment and was awarded a special prize in the 2007 transport structures contest.

  2. Neuroimaging for drug addiction and related behaviors

    SciTech Connect (OSTI)

    Parvaz M. A.; Parvaz, M.A.; Alia-Klein, N.; Woicik,P.A.; Volkow, N.D.; Goldstein, R.Z.

    2011-10-01

    In this review, we highlight the role of neuroimaging techniques in studying the emotional and cognitive-behavioral components of the addiction syndrome by focusing on the neural substrates subserving them. The phenomenology of drug addiction can be characterized by a recurrent pattern of subjective experiences that includes drug intoxication, craving, bingeing, and withdrawal with the cycle culminating in a persistent preoccupation with obtaining, consuming, and recovering from the drug. In the past two decades, imaging studies of drug addiction have demonstrated deficits in brain circuits related to reward and impulsivity. The current review focuses on studies employing positron emission tomography (PET), functional magnetic resonance imaging (fMRI), and electroencephalography (EEG) to investigate these behaviors in drug-addicted human populations. We begin with a brief account of drug addiction followed by a technical account of each of these imaging modalities. We then discuss how these techniques have uniquely contributed to a deeper understanding of addictive behaviors.

  3. Positron emitter labeled enzyme inhibitors

    DOE Patents [OSTI]

    Fowler, J.S.; MacGregor, R.R.; Wolf, A.P.

    1987-05-22

    This invention involved a new strategy for imaging and mapping enzyme activity in the living human and animal body using positron emitter-labeled suicide enzyme inactivators or inhibitors which become covalently bound to the enzyme as a result of enzymatic catalysis. Two such suicide in activators for monoamine oxidase have been labeled with carbon-11 and used to map the enzyme subtypes in the living human and animal body using PET. By using positron emission tomography to image the distribution of radioactivity produced by the body penetrating radiation emitted by carbon-11, a map of functionally active monoamine oxidase activity is obtained. Clorgyline and L-deprenyl are suicide enzyme inhibitors and irreversibly inhibit monoamine oxidase. When these inhibitors are labeled with carbon-11 they provide selective probes for monoamine oxidase localization and reactivity in vivo using positron emission tomography. 2 figs.

  4. Positron emitter labeled enzyme inhibitors

    DOE Patents [OSTI]

    Fowler, Joanna S. (Bellport, NY); MacGregor, Robert R. (Sag Harbor, NY); Wolf, Alfred P. (Setauket, NY); Langstrom, Bengt (Upsala, SE)

    1990-01-01

    This invention involves a new strategy for imaging and mapping enzyme activity in the living human and animal body using positron emitter-labeled suicide enzyme inactivators or inhibitors which become covalently bound to the enzyme as a result of enzymatic catalysis. Two such suicide inactivators for monoamine oxidase have been labeled with carbon-11 and used to map the enzyme subtypes in the living human and animal body using PET. By using positron emission tomography to image the distribution of radioactivity produced by the body penetrating radiation emitted by carbon-11, a map of functionally active monoamine oxidase activity is obtained. Clorgyline and L-deprenyl are suicide enzyme inhibitors and irreversibly inhibit monoamine oxidase. When these inhibitors are labeled with carbon-11 they provide selective probes for monoamine oxidase localization and reactivity in vivo using positron emission tomography.

  5. Multilayer moisture barrier

    DOE Patents [OSTI]

    Pankow, Joel W; Jorgensen, Gary J; Terwilliger, Kent M; Glick, Stephen H; Isomaki, Nora; Harkonen, Kari; Turkulainen, Tommy

    2015-04-21

    A moisture barrier, device or product having a moisture barrier or a method of fabricating a moisture barrier having at least a polymer layer, and interfacial layer, and a barrier layer. The polymer layer may be fabricated from any suitable polymer including, but not limited to, fluoropolymers such as polyethylene terephthalate (PET) or polyethylene naphthalate (PEN), or ethylene-tetrafluoroethylene (ETFE). The interfacial layer may be formed by atomic layer deposition (ALD). In embodiments featuring an ALD interfacial layer, the deposited interfacial substance may be, but is not limited to, Al.sub.2O.sub.3, AlSiO.sub.x, TiO.sub.2, and an Al.sub.2O.sub.3/TiO.sub.2 laminate. The barrier layer associated with the interfacial layer may be deposited by plasma enhanced chemical vapor deposition (PECVD). The barrier layer may be a SiO.sub.xN.sub.y film.

  6. Three dimensional imaging detector employing wavelength-shifting optical fibers

    DOE Patents [OSTI]

    Worstell, W.A.

    1997-02-04

    A novel detector element structure and method for its use is provided. In a preferred embodiment, one or more inorganic scintillating crystals are coupled through wavelength shifting optical fibers (WLSFs) to position sensitive photomultipliers (PS-PMTs). The superior detector configuration in accordance with this invention is designed for an array of applications in high spatial resolution gamma ray sensing with particular application to SPECT, PET and PVI imaging systems. The design provides better position resolution than prior art devices at a lower total cost. By employing wavelength shifting fibers (WLSFs), the sensor configuration of this invention can operate with a significant reduction in the number of photomultipliers and electronics channels, while potentially improving the resolution of the system by allowing three dimensional reconstruction of energy deposition positions. 11 figs.

  7. Study on a negative hydrogen ion source with hot cathode arc discharge

    SciTech Connect (OSTI)

    Lin, S. H. Fang, X.; University of Chinese Academy of Sciences, Beijing 100039 ; Zhang, H. J.; Qian, C.; Ma, B. H.; Wang, H.; Li, X. X.; Zhang, X. Z.; Sun, L. T.; Zhang, Z. M.; Yuan, P.; Zhao, H. W.

    2014-02-15

    A negative hydrogen (H{sup ?}) ion source with hot cathode arc discharge was designed and fabricated as a primary injector for a 10 MeV PET cyclotron at IMP. 1 mA dc H{sup ?} beam with ? {sub N,} {sub RMS} = 0.08 ??mm?mrad was extracted at 25 kV. Halbach hexapole was adopted to confine the plasma. The state of arc discharge, the parameters including filament current, arc current, gas pressure, plasma electrode bias, and the ratio of I{sub e{sup ?}}/I{sub H{sup ?}} were experimentally studied. The discussion on the result, and opinions to improve the source were given.

  8. Three dimensional imaging detector employing wavelength-shifting optical fibers

    DOE Patents [OSTI]

    Worstell, William A. (Framingham, MA)

    1997-01-01

    A novel detector element structure and method for its use is provided. In a preferred embodiment, one or more inorganic scintillating crystals are coupled through wavelength shifting optical fibers (WLSFs) to position sensitive photomultipliers (PS-PMTs). The superior detector configuration in accordance with this invention is designed for an array of applications in high spatial resolution gamma ray sensing with particular application to SPECT, PET and PVI imaging systems. The design provides better position resolution than prior art devices at a lower total cost. By employing wavelength shifting fibers (WLSFs), the sensor configuration of this invention can operate with a significant reduction in the number of photomultipliers and electronics channels, while potentially improving the resolution of the system by allowing three dimensional reconstruction of energy deposition positions.

  9. Tissue-like phantoms

    DOE Patents [OSTI]

    Frangioni, John V.; De Grand, Alec M.

    2007-10-30

    The invention is based, in part, on the discovery that by combining certain components one can generate a tissue-like phantom that mimics any desired tissue, is simple and inexpensive to prepare, and is stable over many weeks or months. In addition, new multi-modal imaging objects (e.g., beads) can be inserted into the phantoms to mimic tissue pathologies, such as cancer, or merely to serve as calibration standards. These objects can be imaged using one, two, or more (e.g., four) different imaging modalities (e.g., x-ray computed tomography (CT), positron emission tomography (PET), single photon emission computed tomography (SPECT), and near-infrared (NIR) fluorescence) simultaneously.

  10. Synthesis of 2'-deoxy-2'-[.sup.18F]fluoro-5-methyl-1-B-D-arabinofuranosyluracil (.sup.18F-FMAU)

    DOE Patents [OSTI]

    Li, Zibo; Cai, Hancheng; Conti, Peter S

    2014-12-16

    The present invention relates to methods of synthesizing .sup.18F-FMAU. In particular, .sup.18F-FMAU is synthesized using one-pot reaction conditions in the presence of Friedel-Crafts catalysts. The one-pot reaction conditions are incorporated into a fully automated cGMP-compliant radiosynthesis module, which results in a reduction in synthesis time and simplifies reaction conditions. The one-pot reaction conditions are also suitable for the production of 5-substituted thymidine or cytidine analogs. The products from the one-pot reaction (e.g. the labeled thymidine or cytidine analogs) can be used as probes for imaging tumor proliferative activity. More specifically, these [.sup.18F]-labeled thymidine or cytidine analogs can be used as a PET tracer for certain medical conditions, including, but not limited to, cancer disease, autoimmunity inflammation, and bone marrow transplant.

  11. Institute for Molecular Medicine Research Program

    SciTech Connect (OSTI)

    Phelps, Michael E

    2012-12-14

    The objectives of the project are the development of new Positron Emission Tomography (PET) imaging instrumentation, chemistry technology platforms and new molecular imaging probes to examine the transformations from normal cellular and biological processes to those of disease in pre-clinical animal models. These technology platforms and imaging probes provide the means to: 1. Study the biology of disease using pre-clinical mouse models and cells. 2. Develop molecular imaging probes for imaging assays of proteins in pre-clinical models. 3. Develop imaging assays in pre-clinical models to provide to other scientists the means to guide and improve the processes for discovering new drugs. 4. Develop imaging assays in pre-clinical models for others to use in judging the impact of drugs on the biology of disease.

  12. Numerical Verification of the Power Transfer and Wakefield Coupling in the Clic Two-Beam Accelerator

    SciTech Connect (OSTI)

    Candel, Arno; Li, Z.; Ng, C.; Rawat, V.; Schussman, G.; Ko, K.; Syratchev, I.; Grudiev, A.; Wuensch, W.; /CERN

    2011-08-19

    The Compact Linear Collider (CLIC) provides a path to a multi-TeV accelerator to explore the energy frontier of High Energy Physics. Its two-beam accelerator (TBA) concept envisions complex 3D structures, which must be modeled to high accuracy so that simulation results can be directly used to prepare CAD drawings for machining. The required simulations include not only the fundamental mode properties of the accelerating structures but also the Power Extraction and Transfer Structure (PETS), as well as the coupling between the two systems. Time-domain simulations will be performed to understand pulse formation, wakefield damping, fundamental power transfer and wakefield coupling in these structures. Applying SLAC's parallel finite element code suite, these large-scale problems will be solved on some of the largest supercomputers available. The results will help to identify potential issues and provide new insights on the design, leading to further improvements on the novel two-beam accelerator scheme.

  13. State of the art in electromagnetic modeling for the Compact Linear Collider

    SciTech Connect (OSTI)

    Candel, Arno; Kabel, Andreas; Lee, Lie-Quan; Li, Zenghai; Ng, Cho; Schussman, Greg; Ko, Kwok; /SLAC

    2009-07-10

    SLAC's Advanced Computations Department (ACD) has developed the parallel 3D electromagnetic time-domain code T3P for simulations of wakefields and transients in complex accelerator structures. T3P is based on state-of-the-art Finite Element methods on unstructured grids and features unconditional stability, quadratic surface approximation and up to 6th-order vector basis functions for unprecedented simulation accuracy. Optimized for large-scale parallel processing on leadership supercomputing facilities, T3P allows simulations of realistic 3D structures with fast turn-around times, aiding the design of the next generation of accelerator facilities. Applications include simulations of the proposed two-beam accelerator structures for the Compact Linear Collider (CLIC) - wakefield damping in the Power Extraction and Transfer Structure (PETS) and power transfer to the main beam accelerating structures are investigated.

  14. Carbon attrition during the circulating fluidized bed combustion of a packaging-derived fuel

    SciTech Connect (OSTI)

    Mastellone, M.L.; Arena, U.

    1999-05-01

    Cylindrical pellets of a market-available packaging-derived fuel, obtained from a mono-material collection of polyethylene terephthalate (PET) bottles, were batchwise fed to a laboratory scale circulating fluidized bed (CFB) combustor. The apparatus, whose riser was 41 mm ID and 4 m high, was operated under both inert and oxidizing conditions to establish the relative importance of purely mechanical attrition and combustion-assisted attrition in generating carbon fines. Silica sand particles of two size distributions were used as inert materials. For each run, carbon load and carbon particle size distribution in the riser and rates of attrited carbon fines escaping the combustor were determined as a function of time. A parallel investigation was carried out with a bubbling fluidized bed (BFB) combustor to point out peculiarities of attrition in CFB combustors. After devolatilization, PET pellets generated fragile aggregates of char and sand, which easily crumbled, leading to single particles, partially covered by a carbon-rich layer. The injected fixed carbon was therefore present in the bed in three phases: an A-phase, made of aggregates of sand and char, an S-phase, made of individual carbon-covered sand particles and an F-phase, made of carbon fines, abraded by the surfaces of the A- and S-phases. The effects of the size of inert material on the different forms under which fixed carbon was present in the bed and on the rate of escape of attrited carbon fines from the combustor were investigated. Features of carbon attrition in CFB and BFB combustors are discussed.

  15. Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway

    SciTech Connect (OSTI)

    Volkow, N.D.; Wang, G.; Volkow, N.D.; Wang, G.-J.; Newcorn, J.H.; Kollins, S.H.; Wigal, T.L.; Telang, F.; Folwer, J.S.; Goldstein, R.Z.; Klein, N.; Logan, J.; Wong, C.; Swanson, J.M.

    2010-08-17

    Attention-deficit hyperactivity disorder (ADHD) is typically characterized as a disorder of inattention and hyperactivity/impulsivity but there is increasing evidence of deficits in motivation. Using positron emission tomography (PET), we showed decreased function in the brain dopamine reward pathway in adults with ADHD, which, we hypothesized, could underlie the motivation deficits in this disorder. To evaluate this hypothesis, we performed secondary analyses to assess the correlation between the PET measures of dopamine D2/D3 receptor and dopamine transporter availability (obtained with [{sup 11}C]raclopride and [{sup 11}C]cocaine, respectively) in the dopamine reward pathway (midbrain and nucleus accumbens) and a surrogate measure of trait motivation (assessed using the Achievement scale on the Multidimensional Personality Questionnaire or MPQ) in 45 ADHD participants and 41 controls. The Achievement scale was lower in ADHD participants than in controls (11 {+-} 5 vs 14 {+-} 3, P < 0.001) and was significantly correlated with D2/D3 receptors (accumbens: r = 0.39, P < 0.008; midbrain: r = 0.41, P < 0.005) and transporters (accumbens: r = 0.35, P < 0.02) in ADHD participants, but not in controls. ADHD participants also had lower values in the Constraint factor and higher values in the Negative Emotionality factor of the MPQ but did not differ in the Positive Emotionality factor - and none of these were correlated with the dopamine measures. In ADHD participants, scores in the Achievement scale were also negatively correlated with symptoms of inattention (CAARS A, E and SWAN I). These findings provide evidence that disruption of the dopamine reward pathway is associated with motivation deficits in ADHD adults, which may contribute to attention deficits and supports the use of therapeutic interventions to enhance motivation in ADHD.

  16. Recent advances in the risk assessment of melamine and cyanuric acid in animal feed

    SciTech Connect (OSTI)

    Dorne, Jean Lou; Vandenbroeck, Marc; Mennes, Wim; Knutsen, Helle K.; Vernazza, Francesco; Edler, Lutz; Benford, Diane

    2013-08-01

    Melamine can be present at low levels in food and feed mostly from its legal use as a food contact material in laminates and plastics, as a trace contaminant in nitrogen supplements used in animal feeds, and as a metabolite of the pesticide cyromazine. The mechanism of toxicity of melamine involves dose-dependent formation of crystals with either endogenous uric acid or a structural analogue of melamine, cyanuric acid, in renal tubules resulting in potential acute kidney failure. Co-exposure to melamine and cyanuric acid in livestock, fish, pets and laboratory animals shows higher toxicity compared with melamine or cyanuric acid alone. Evidence for crystal formation between melamine and other structural analogs i.e. ammelide and ammeline is limited. Illegal pet food adulterations with melamine and cyanuric acid and adulteration of milk with melamine resulted in melaminecyanuric acid crystals, kidney damage and deaths of cats and dogs and melamineuric acid stones, hospitalisation and deaths of children in China respectively. Following these incidents, the tolerable daily intake for melamine was re-evaluated by the U.S. Food and Drug Administration, the World Health Organisation, and the Scientific Panel on Contaminants in the Food Chain of the European Food Safety Authority (EFSA). This review provides an overview of toxicology, the adulteration incidents and risk assessments for melamine and its structural analogues. Particular focus is given to the recent EFSA risk assessment addressing impacts on animal and human health of background levels of melamine and structural analogues in animal feed. Recent research and future directions are discussed. - Highlights: ? Melamine in food and feed. ? Forms crystals in kidney with uric acid or cyanuric acid. ? Toxicity higher with cyanuric acid. ? Recent EFSA risk assessment. ? Animal and human health.

  17. Heavy-quark production and elliptic flow in Au+Au collisions at √sNN=62.4 GeV

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Adare, A.

    2015-04-28

    In this study, we present measurements of electrons and positrons from the semileptonic decays of heavy-flavor hadrons at midrapidity (|y|< 0.35) in Au+Au collisions at √sNN = 62.4 GeV. The data were collected in 2010 by the PHENIX experiment that included the new hadron-blind detector. The invariant yield of electrons from heavy-flavor decays is measured as a function of transverse momentum in the range 1 < peT < 5 GeV/c. The invariant yield per binary collision is slightly enhanced above the p+p reference in Au+Au 0%–20%, 20%–40%, and 40%–60% centralities at a comparable level. At this low beam energy thismore » may be a result of the interplay between initial-state Cronin effects, final-state flow, and energy loss in medium. The v₂ of electrons from heavy-flavor decays is nonzero when averaged between 1.3 < peT < 2.5 GeV/c for 0%–40% centrality collisions at √sNN = 62.4 GeV. For 20%–40% centrality collisions, the v₂ at √sNN = 62.4 GeV is smaller than that for heavy-flavor decays at √sNN = 200 GeV. The v₂ of the electrons from heavy-flavor decay at the lower beam energy is also smaller than v₂ for pions. Both results indicate that the heavy-quarks interact with the medium formed in these collisions, but they may not be at the same level of thermalization with the medium as observed at √sNN = 200 GeV.« less

  18. Rapid Disease Progression With Delay in Treatment of Non-Small-Cell Lung Cancer

    SciTech Connect (OSTI)

    Mohammed, Nasiruddin [Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI (United States); Kestin, Larry Llyn, E-mail: lkestin@beaumont.ed [Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI (United States); Grills, Inga Siiner; Battu, Madhu; Fitch, Dwight Lamar [Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI (United States); Wong, Ching-yee Oliver [Department of Nuclear Medicine, William Beaumont Hospital, Royal Oak, MI (United States); Margolis, Jeffrey Harold [Department of Medical Oncology, William Beaumont Hospital, Royal Oak, MI (United States); Chmielewski, Gary William; Welsh, Robert James [Department of Thoracic Surgery, William Beaumont Hospital, Royal Oak, MI (United States)

    2011-02-01

    Purpose: To assess rate of disease progression from diagnosis to initiation of treatment for Stage I-IIIB non-small-cell lung cancer (NSCLC). Methods and Materials: Forty patients with NSCLC underwent at least two sets of computed tomography (CT) and 18-fluorodeoxyglucose positron emission tomography (PET) scans at various time intervals before treatment. Progression was defined as development of any new lymph node involvement, site of disease, or stage change. Results: Median time interval between first and second CT scans was 13.4 weeks, and between first and second PET scans was 9.0 weeks. Median initial primary maximum tumor dimension (MTD) was 3.5 cm (0.6-8.5 cm) with a median standardized uptake value (SUV) of 13.0 (1.7-38.5). The median MTD increased by a median of 1.0 cm (mean, 1.6 cm) between scans for a median relative MTD increase of 35% (mean, 59%). Nineteen patients (48%) progressed between scans. Rate of any progression was 13%, 31%, and 46% at 4, 8, and 16 weeks, respectively. Upstaging occurred in 3%, 13%, and 21% at these intervals. Distant metastasis became evident in 3%, 13%, and 13% after 4, 8, and 16 weeks, respectively. T and N stage were associated with progression, whereas histology, grade, sex, age, and maximum SUV were not. At 3 years, overall survival for Stage III patients with vs. without progression was 18% vs. 67%, p = 0.05. Conclusions: With NSCLC, treatment delay can lead to disease progression. Diagnosis, staging, and treatment initiation should be expedited. After 4-8 weeks of delay, complete restaging should be strongly considered.

  19. Noninvasive Imaging of Administered Progenitor Cells

    SciTech Connect (OSTI)

    Steven R Bergmann, M.D., Ph.D.

    2012-12-03

    The objective of this research grant was to develop an approach for labeling progenitor cells, specifically those that we had identified as being able to replace ischemic heart cells, so that the distribution could be followed non-invasively. In addition, the research was aimed at determining whether administration of progenitor cells resulted in improved myocardial perfusion and function. The efficiency and toxicity of radiolabeling of progenitor cells was to be evaluated. For the proposed clinical protocol, subjects with end-stage ischemic coronary artery disease were to undergo a screening cardiac positron emission tomography (PET) scan using N-13 ammonia to delineate myocardial perfusion and function. If they qualified based on their PET scan, they would undergo an in-hospital protocol whereby CD34+ cells were stimulated by the administration of granulocytes-colony stimulating factor (G-CSF). CD34+ cells would then be isolated by apharesis, and labeled with indium-111 oxine. Cells were to be re-infused and subjects were to undergo single photon emission computed tomography (SPECT) scanning to evaluate uptake and distribution of labeled progenitor cells. Three months after administration of progenitor cells, a cardiac PET scan was to be repeated to evaluate changes in myocardial perfusion and/or function. Indium oxine is a radiopharmaceutical for labeling of autologous lymphocytes. Indium-111 (In-111) decays by electron capture with a t{sub } of 67.2 hours (2.8 days). Indium forms a saturated complex that is neutral, lipid soluble, and permeates the cell membrane. Within the cell, the indium-oxyquinolone complex labels via indium intracellular chelation. Following leukocyte labeling, ~77% of the In-111 is incorporated in the cell pellet. The presence of red cells and /or plasma reduces the labeling efficacy. Therefore, the product needed to be washed to eliminate plasma proteins. This repeated washing can damage cells. The CD34 selected product was a 90-99% pure population of leukocytes. Viability was assessed using Trypan blue histological analysis. We successfully isolated and labeled ~25-30 x 10{sup 7} CD34+ lymphocytes in cytokine mobilized progenitor cell apharesis harvests. Cells were also subjected to a stat gram stain to look for bacterial contamination, stat endotoxin LAL to look for endotoxin contamination, flow cytometry for evaluation of the purity of the cells and 14-day sterility culture. Colony forming assays confirm the capacity of these cells to proliferate and function ex-vivo with CFU-GM values of 26 colonies/ 1 x 10{sup 4} cells plated and 97% viability in cytokine augmented methylcellulose at 10-14 days in CO{sub 2} incubation. We developed a closed-processing system for the product labeling prior to infusion to maintain autologous cell integrity and sterility. Release criteria for the labeled product were documented for viability, cell count and differential, and measured radiolabel. We were successful in labeling the cells with up to 500 uCi/10{sup 8} cells, with viability of >98%. However, due to delays in getting the protocol approved by the FDA, the cells were not infused in humans in this location (although we did successfully use CD34+ cells in humans in a study in Australia). The approach developed should permit labeling of progenitor cells that can be administered to human subjects for tracking. The labeling approach should be useful for all progenitor cell types, although this would need to be verified since different cell lines may have differential radiosensitivity.

  20. Microfluidic Technology Platforms for Synthesizing, Labeling and Measuring the Kinetics of Transport and Biochemical Reactions for Developing Molecular Imaging Probes

    SciTech Connect (OSTI)

    Phelps, Michael E.

    2009-09-01

    Radiotracer techniques are used in environmental sciences, geology, biology and medicine. Radiotracers with Positron Emission Tomography (PET) provided biological examinations of ~3 million patients 2008. Despite the success of positron labeled tracers in many sciences, there is limited access in an affordable and convenient manner to develop and use new tracers. Integrated microfluidic chips are a new technology well matched to the concentrations of tracers. Our goal is to develop microfluidic chips and new synthesis approaches to enable wide dissemination of diverse types of tracers at low cost, and to produce new generations of radiochemists for which there are many unfilled jobs. The program objectives are to: 1. Develop an integrated microfluidic platform technology for synthesizing and 18F-labeling diverse arrays of different classes of molecules. 2. Incorporate microfluidic chips into small PC controlled devices (Synthesizer) with a platform interfaced to PC for electronic and fluid input/out control. 3. Establish a de-centralized model with Synthesizers for discovering and producing molecular imaging probes, only requiring delivery of inexpensive [18F]fluoride ion from commercial PET radiopharmacies vs the centralized approach of cyclotron facilities synthesizing and shipping a few different types of 18F-probes. 4. Develop a position sensitive avalanche photo diode (PSAPD) camera for beta particles embedded in a microfluidic chip for imaging and measuring transport and biochemical reaction rates to valid new 18F-labeled probes in an array of cell cultures. These objectives are met within a research and educational program integrating radio-chemistry, synthetic chemistry, biochemistry, engineering and biology in the Crump Institute for Molecular Imaging. The Radiochemistry Training Program exposes PhD and post doctoral students to molecular imaging in vitro in cells and microorganisms in microfluidic chips and in vivo with PET, from new technologies for radiochemistry (macro to micro levels), biochemistry and biology to imaging principles, tracer kinetics, pharmacokinetics and biochemical assays. New generations of radiochemists will be immersed in the biochemistry and biology for which their labeled probes are being developed for assays of these processes. In this program engineers and radio-chemists integrate the principles of microfluidics and radiolabeling along with proper system design and chemistry rule sets to yield Synthesizers enabling biological and pharmaceutical scientists to develop diverse arrays of probes to pursue their interests. This progression would allow also radiochemists to focus on the further evolution of rapid, high yield synthetic reactions with new enabling technologies, rather than everyday production of radiotracers that should be done by technologists. The invention of integrated circuits in electronics established a platform technology that allowed an evolution of ideas and applications far beyond what could have been imagined at the beginning. Rather than provide a technology for the solution to a single problem, it is hoped that microfluidic radiochemistry will be an enabling platform technology for others to solve many problems. As part of this objective, another program goal is to commercialize the technologies that come from this work so that they can be provided to others who wish to use it.

  1. The ionic charge of Copper-64 complexes conjugated to an engineered antibody effects biodistribution

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Dearling, Jason L. J.; Smith, Suzanne V.; Paterson, Brett M.; Akurathi, Vamisidhar; Betanzos-Lara, Soledad; Treves, S. Ted; Voss, Stephan D.; White, Jonathan M.; Huston, James S.; Donnelly, Paul S.; et al

    2015-04-15

    The development of biomolecules as imaging probes requires radiolabeling methods that do not significantly influence their biodistribution. Sarcophagine (Sar) chelators form extremely stable complexes with copper, and are therefore a promising option for labeling proteins with ⁶⁴Cu. However, initial studies using the first-generation sarcophagine bifunctional chelator SarAr to label the engineered antibody fragment ch14.18-ΔCH2 (MW 120 kDa) with ⁶⁴Cu showed high tracer retention in the kidneys,(>38% injected dose per gram (ID/g) 48 h post-injection), presumably because the high local positive charge on the CuII-SarAr moiety resulted in increased binding of the labeled protein to the negatively charged basal cells ofmore » the glomerulus. To test this hypothesis, ch14.18-ΔCH2 was conjugated with a series of Sar derivatives of decreasing positive charge and three commonly used macrocyclic polyaza polycarboxylate (PAC) BFCs. The immunoconjugates were labeled with ⁶⁴Cu and injected into mice, and PET/CT images were obtained at 24 and 48 h post injection (p.i.). At 48 h p.i., ex vivo biodistribution was carried out. In addition, to demonstrate the potential of metastasis detection using ⁶⁴Cu-labeled ch14.18-ΔCH2, a preclinical imaging study of intrahepatic neuroblastoma tumors was performed carried out. Reducing the positive charge on the Sar chelators decreased kidney uptake of Cu-labeled ch14.18-ΔCH2 by more than 6-fold, from >45 ID/g to <6% ID/g, while the uptake in most other tissues, including liver, was relatively unchanged. However, despite this dramatic decrease, the renal uptake of the PAC BFCs was generally lower than that of the Sar derivatives, as was the liver uptake. Uptake of ⁶⁴Cu-labeled ch14.18-ΔCH2 in neuroblastoma hepatic metastases was detected using PET.« less

  2. The ionic charge of Copper-64 complexes conjugated to an engineered antibody effects biodistribution

    SciTech Connect (OSTI)

    Dearling, Jason L. J.; Smith, Suzanne V.; Paterson, Brett M.; Akurathi, Vamisidhar; Betanzos-Lara, Soledad; Treves, S. Ted; Voss, Stephan D.; White, Jonathan M.; Huston, James S.; Donnelly, Paul S.; Packard, Alan B.

    2015-04-15

    The development of biomolecules as imaging probes requires radiolabeling methods that do not significantly influence their biodistribution. Sarcophagine (Sar) chelators form extremely stable complexes with copper, and are therefore a promising option for labeling proteins with ⁶⁴Cu. However, initial studies using the first-generation sarcophagine bifunctional chelator SarAr to label the engineered antibody fragment ch14.18-ΔCH2 (MW 120 kDa) with ⁶⁴Cu showed high tracer retention in the kidneys,(>38% injected dose per gram (ID/g) 48 h post-injection), presumably because the high local positive charge on the CuII-SarAr moiety resulted in increased binding of the labeled protein to the negatively charged basal cells of the glomerulus. To test this hypothesis, ch14.18-ΔCH2 was conjugated with a series of Sar derivatives of decreasing positive charge and three commonly used macrocyclic polyaza polycarboxylate (PAC) BFCs. The immunoconjugates were labeled with ⁶⁴Cu and injected into mice, and PET/CT images were obtained at 24 and 48 h post injection (p.i.). At 48 h p.i., ex vivo biodistribution was carried out. In addition, to demonstrate the potential of metastasis detection using ⁶⁴Cu-labeled ch14.18-ΔCH2, a preclinical imaging study of intrahepatic neuroblastoma tumors was performed carried out. Reducing the positive charge on the Sar chelators decreased kidney uptake of Cu-labeled ch14.18-ΔCH2 by more than 6-fold, from >45 ID/g to <6% ID/g, while the uptake in most other tissues, including liver, was relatively unchanged. However, despite this dramatic decrease, the renal uptake of the PAC BFCs was generally lower than that of the Sar derivatives, as was the liver uptake. Uptake of ⁶⁴Cu-labeled ch14.18-ΔCH2 in neuroblastoma hepatic metastases was detected using PET.

  3. Enhanced striatal dopamine release during food stimulation in binge eating disorder

    SciTech Connect (OSTI)

    Wang, g.j.; Wang, G.-J.; Geliebter, A.; Volkow, N.D.; Telang, F.W.; Logan, Jaynbe, M.C.; Galanti, K.; Selig, P.A.; Han, H.; Zhu, W.; Wong, C.T.; Fowler, J.S.

    2011-01-13

    Subjects with binge eating disorder (BED) regularly consume large amounts of food in short time periods. The neurobiology of BED is poorly understood. Brain dopamine, which regulates motivation for food intake, is likely to be involved. We assessed the involvement of brain dopamine in the motivation for food consumption in binge eaters. Positron emission tomography (PET) scans with [{sup 11}C]raclopride were done in 10 obese BED and 8 obese subjects without BED. Changes in extracellular dopamine in the striatum in response to food stimulation in food-deprived subjects were evaluated after placebo and after oral methylphenidate (MPH), a drug that blocks the dopamine reuptake transporter and thus amplifies dopamine signals. Neither the neutral stimuli (with or without MPH) nor the food stimuli when given with placebo increased extracellular dopamine. The food stimuli when given with MPH significantly increased dopamine in the caudate and putamen in the binge eaters but not in the nonbinge eaters. Dopamine increases in the caudate were significantly correlated with the binge eating scores but not with BMI. These results identify dopamine neurotransmission in the caudate as being of relevance to the neurobiology of BED. The lack of correlation between BMI and dopamine changes suggests that dopamine release per se does not predict BMI within a group of obese individuals but that it predicts binge eating.

  4. Addiction: Beyond dopamine reward circuitry

    SciTech Connect (OSTI)

    Volkow, N.D.; Wang, G.; Volkow, N.D.; Wang, G.-J.; Fowler, J.S.; Tomasi, D.; Telang, F.

    2011-09-13

    Dopamine (DA) is considered crucial for the rewarding effects of drugs of abuse, but its role in addiction is much less clear. This review focuses on studies that used PET to characterize the brain DA system in addicted subjects. These studies have corroborated in humans the relevance of drug-induced fast DA increases in striatum [including nucleus accumbens (NAc)] in their rewarding effects but have unexpectedly shown that in addicted subjects, drug-induced DA increases (as well as their subjective reinforcing effects) are markedly blunted compared with controls. In contrast, addicted subjects show significant DA increases in striatum in response to drug-conditioned cues that are associated with self-reports of drug craving and appear to be of a greater magnitude than the DA responses to the drug. We postulate that the discrepancy between the expectation for the drug effects (conditioned responses) and the blunted pharmacological effects maintains drug taking in an attempt to achieve the expected reward. Also, whether tested during early or protracted withdrawal, addicted subjects show lower levels of D2 receptors in striatum (including NAc), which are associated with decreases in baseline activity in frontal brain regions implicated in salience attribution (orbitofrontal cortex) and inhibitory control (anterior cingulate gyrus), whose disruption results in compulsivity and impulsivity. These results point to an imbalance between dopaminergic circuits that underlie reward and conditioning and those that underlie executive function (emotional control and decision making), which we postulate contributes to the compulsive drug use and loss of control in addiction.

  5. Anatomic and functional imaging of tagged molecules in animals

    DOE Patents [OSTI]

    Weisenberger, Andrew G. (Yorktown, VA); Majewski, Stanislaw (Grafton, VA); Paulus, Michael J. (Knoxville, TN); Gleason, Shaun S. (Knoxville, VA)

    2007-04-24

    A novel functional imaging system for use in the imaging of unrestrained and non-anesthetized small animals or other subjects and a method for acquiring such images and further registering them with anatomical X-ray images previously or subsequently acquired. The apparatus comprises a combination of an IR laser profilometry system and gamma, PET and/or SPECT, imaging system, all mounted on a rotating gantry, that permits simultaneous acquisition of positional and orientational information and functional images of an unrestrained subject that are registered, i.e. integrated, using image processing software to produce a functional image of the subject without the use of restraints or anesthesia. The functional image thus obtained can be registered with a previously or subsequently obtained X-ray CT image of the subject. The use of the system described herein permits functional imaging of a subject in an unrestrained/non-anesthetized condition thereby reducing the stress on the subject and eliminating any potential interference with the functional testing that such stress might induce.

  6. The cyclotron laboratory and the RFQ accelerator in Bern

    SciTech Connect (OSTI)

    Braccini, S.; Ereditato, A.; Kreslo, I.; Nirkko, M.; Weber, M.; Scampoli, P.; Bremen, K. von

    2013-07-18

    Two proton accelerators have been recently put in operation in Bern: an 18 MeV cyclotron and a 2 MeV RFQ linac. The commercial IBA 18/18 cyclotron, equipped with a specifically conceived 6 m long external beam line ending in a separate bunker, will provide beams for routine 18-F and other PET radioisotope production as well as for novel detector, radiation biophysics, radioprotection, radiochemistry and radiopharmacy developments. The accelerator is embedded into a complex building hosting two physics laboratories and four Good Manufacturing Practice (GMP) laboratories. This project is the result of a successful collaboration between the Inselspital, the University of Bern and private investors, aiming at the constitution of a combined medical and research centre able to provide the most cutting-edge technologies in medical imaging and cancer radiation therapy. The cyclotron is complemented by the RFQ with the primary goals of elemental analysis via Particle Induced Gamma Emission (PIGE), and the detection of potentially dangerous materials with high nitrogen content using the Gamma-Resonant Nuclear Absorption (GRNA) technique. In this context, beam instrumentation devices have been developed, in particular an innovative beam profile monitor based on doped silica fibres and a setup for emittance measurements using the pepper-pot technique. On this basis, the establishment of a proton therapy centre on the campus of the Inselspital is in the phase of advanced study.

  7. Silicon Oxynitride Thin Film Barriers for PV Packaging (Poster)

    SciTech Connect (OSTI)

    del Cueto, J. A.; Glick, S. H.; Terwilliger, K. M.; Jorgensen, G. J.; Pankow, J. W.; Keyes, B. M.; Gedvilas, L. M.; Pern, F. J.

    2006-10-03

    Dielectric, adhesion-promoting, moisture barriers comprised of silicon oxynitride thin film materials (SiOxNy with various material stoichiometric compositions x,y) were applied to: 1) bare and pre-coated soda-lime silicate glass (coated with transparent conductive oxide SnO2:F and/or aluminum), and polymer substrates (polyethylene terephthalate, PET, or polyethylene napthalate, PEN); plus 2) pre- deposited photovoltaic (PV) cells and mini-modules consisting of amorphous silicon (a-Si) and copper indium gallium diselenide (CIGS) thin-film PV technologies. We used plasma enhanced chemical vapor deposition (PECVD) process with dilute silane, nitrogen, and nitrous oxide/oxygen gas mixtures in a low-power (< or = 10 milliW per cm2) RF discharge at ~ 0.2 Torr pressure, and low substrate temperatures < or = 100(degrees)C, over deposition areas ~ 1000 cm2. Barrier properties of the resulting PV cells and coated-glass packaging structures were studied with subsequent stressing in damp-heat exposure at 85(degrees)C/85% RH. Preliminary results on PV cells and coated glass indicate the palpable benefits of the barriers in mitigating moisture intrusion and degradation of the underlying structures using SiOxNy coatings with thicknesses in the range of 100-200 nm.

  8. Increasing the rate of hydrogen oxidation without increasing the overpotential: A bio-inspired iron molecular electrocatalyst with an outer coordination sphere proton relay

    SciTech Connect (OSTI)

    Darmon, Jonathan M.; Kumar, Neeraj; Hulley, Elliott B.; Weiss, Charles J.; Raugei, Simone; Bullock, R. Morris; Helm, Monte L.

    2015-03-05

    Oxidation of hydrogen (H?) to protons and electrons for energy production in fuel cells is catalyzed by platinum, but its low abundance and high cost present drawbacks to widespread adoption. Precisely controlled proton delivery and removal is critical in hydrogenase enzymes in nature that catalyze H? oxidation using earth-abundant metals (iron and nickel). Here we report a synthetic iron complex, (CpC5F4N)Fe(PEtN(CH2)3NMe2PEt)(Cl), that serves as a precatalyst for the oxidation of H?, with turnover frequencies of 290 s? in fluorobenzene, under 1 atm of H? using 1,4-diazabicyclo[2.2.2]octane (DABCO) as the exogenous base. The cooperative effect of the primary, secondary and outer coordination spheres for moving protons in this remarkably fast catalyst emphasizes the key role of pendant amines in mimicking the functionality of the proton pathway in the hydrogenase enzymes.

  9. Determinants of residential electricity consumption: Using smart meter data to examine the effect of climate, building characteristics, appliance stock, and occupants' behavior

    SciTech Connect (OSTI)

    Kavousian, A; Rajagopal, R; Fischer, M

    2013-06-15

    We propose a method to examine structural and behavioral determinants of residential electricity consumption, by developing separate models for daily maximum (peak) and minimum (idle) consumption. We apply our method on a data set of 1628 households' electricity consumption. The results show that weather, location and floor area are among the most important determinants of residential electricity consumption. In addition to these variables, number of refrigerators and entertainment devices (e.g., VCRs) are among the most important determinants of daily minimum consumption, while number of occupants and high-consumption appliances such as electric water heaters are the most significant determinants of daily maximum consumption. Installing double-pane windows and energy-efficient lights helped to reduce consumption, as did the energy-conscious use of electric heater. Acknowledging climate change as a motivation to save energy showed correlation with lower electricity consumption. Households with individuals over 55 or between 19 and 35 years old recorded lower electricity consumption, while pet owners showed higher consumption. Contrary to some previous studies, we observed no significant correlation between electricity consumption and income level, home ownership, or building age. Some otherwise energy-efficient features such as energy-efficient appliances, programmable thermostats, and insulation were correlated with slight increase in electricity consumption. (C) 2013 Elsevier Ltd. All rights reserved.

  10. Pyrrolo isoquinolines

    DOE Patents [OSTI]

    Goodman, Mark M.; Shi, Bing Z.

    2000-01-01

    Compounds of the formula: ##STR1## wherein X, Y, and R, independently of one another, is each a H; halogen, wherein said halogen is selected from the group consisting of .sup.123 I, .sup.124 I, .sup.125 I, .sup.131 I, .sup.75 Br, .sup.76 Br, .sup.77 Br, .sup.82 Br, .sup.18 F, or .sup.210 At; small alkyl, small alkenyl, or small alkynyl, any of which contains from one to about six carbon atoms and optionally having a carbon atom replaced by an O or S; or halogen substituted-small alkyl, halogen substituted-small alkenyl, or halogen substituted-small alkynyl wherein said compound contains at least one radioacitve halogen. The compounds bind to the serotonin transporter. Depending upon the choice of halogen substituent, the compounds are useful for PET or SPECT imaging, diagnosis and treatment of psychiatric disorders such as depression, anxiety, obsessive-compulsive disorder, and other conditions associated with defects of serotonin transporter function.

  11. Novel Fluorine-Containing NMDA Antagonists for Brain Imaging: In Vitro Evaluation

    SciTech Connect (OSTI)

    Alvarado, M.; Biegon, A.

    2001-01-01

    The NMDA receptor has been implicated in neuronal death following stroke, brain injury and neurodegenerative disorders (e.g. Alzheimer's, Parkinson's and Huntington's disease) and in physiological functions (e.g. memory and cognition). Non-competitive antagonists, such as MK- 801 and CNS-1102, that block the action of glutamate at the NMDA receptor have been shown to be neuroprotective by blocking the influx of calcium into the cells. As a result, they are being considered as therapeutic agents for the above mentioned diseases. Several Fluorine-containing novel analogs of NMDA channel blockers have been synthesized and evaluated in search of a compound suitable for 18F labeling and Positron Emission Tomography (PET). Based on in vitro binding assay studies on rat brain membranes, the novel compounds examined displayed a range of affinities. Preliminary analyses indicated that chlorine is the best halogen on the ring, and that ethyl fluoro derivatives are more potent than methyl-fluoro compounds. Further analysis based on autoradiography will be needed to examine the regional binding characteristics of the novel compounds examined in this study. Labeling with 18F will allow the use of these compounds in humans, generating new insights into mechanisms and treatment of diseases involving malfunction of the glutamatergic system in the brain.

  12. Detection of submicron scale cracks and other surface anomalies using positron emission tomography

    DOE Patents [OSTI]

    Cowan, Thomas E.; Howell, Richard H.; Colmenares, Carlos A.

    2004-02-17

    Detection of submicron scale cracks and other mechanical and chemical surface anomalies using PET. This surface technique has sufficient sensitivity to detect single voids or pits of sub-millimeter size and single cracks or fissures of millimeter size; and single cracks or fissures of millimeter-scale length, micrometer-scale depth, and nanometer-scale length, micrometer-scale depth, and nanometer-scale width. This technique can also be applied to detect surface regions of differing chemical reactivity. It may be utilized in a scanning or survey mode to simultaneously detect such mechanical or chemical features over large interior or exterior surface areas of parts as large as about 50 cm in diameter. The technique involves exposing a surface to short-lived radioactive gas for a time period, removing the excess gas to leave a partial monolayer, determining the location and shape of the cracks, voids, porous regions, etc., and calculating the width, depth, and length thereof. Detection of 0.01 mm deep cracks using a 3 mm detector resolution has been accomplished using this technique.

  13. High performance flexible top-emitting warm-white organic light-emitting devices and chromaticity shift mechanism

    SciTech Connect (OSTI)

    Shi, Hongying; Deng, Lingling; Chen, Shufen E-mail: wei-huang@njupt.edu.cn; Xu, Ying; Zhao, Xiaofei; Cheng, Fan; Huang, Wei E-mail: wei-huang@njupt.edu.cn; Jiangsu-Singapore Joint Research Center for Organic/Bio- Electronics and Information Displays and Institute of Advanced Materials, Nanjing University of Technology, Nanjing 211816

    2014-04-15

    Flexible warm-white top-emitting organic light-emitting devices (TEOLEDs) are fabricated onto PET substrates with a simple semi-transparent cathode Sm/Ag and two-color phosphors respectively doped into a single host material TCTA. By adjusting the relative position of the orange-red EML sandwiched between the blue emitting layers, the optimized device exhibits the highest power/current efficiency of 8.07 lm/W and near 13 cd/A, with a correlated color temperature (CCT) of 4105 K and a color rendering index (CRI) of 70. In addition, a moderate chromaticity variation of (-0.025, +0.008) around warm white illumination coordinates (0.45, 0.44) is obtained over a large luminance range of 1000 to 10000 cd/m{sup 2}. The emission mechanism is discussed via delta-doping method and single-carrier device, which is summarized that the carrier trapping, the exciton quenching, the mobility change and the recombination zone alteration are negative to color stability while the energy transfer process and the blue/red/blue sandwiched structure are contributed to the color stability in our flexible white TEOLEDs.

  14. Surface Treatment of Polymers by Ion Beam Irradiation to Control the Human Osteoblast Adhesion: Fluence and Current Density Study

    SciTech Connect (OSTI)

    Guibert, G.; Mikhailov, S.; Rossel, T.; Weder, G.; Betschart, B.; Meunier, C.

    2009-03-10

    In the biomaterial field, the modification of surfaces are used to create polymers with high performances, preserving their bulk properties and creating specific interactions between the designed surfaces and the cells or tissues. The polymers were irradiated with a 900 keV Helium beam to modify their surface properties. Cell cultivation on the samples was done using human osteoblasts cells (hFOB 1.19). For PTFE, PS and PEEK polymers, the cell adhesion occurs after reached some threshold values of fluences. For PET or PMMA polymers, the cells adhere on the non irradiated samples, however the fluence value modifies the cell density. For PMMA and PTFE both, the fluence and the current density influence the cell adhesion. By modifying the appropriate parameters on each material, the control of the cell adhesion is possible. Indeed the surface treatment must be selected and adapted according to the further application: for biosensors, tissue engineering, tissue regeneration, neural probes, drug delivery, bio-actuators etc.

  15. Examination of a Junction-Box Adhesion Test for Use in Photovoltaic Module Qualification (Presentation)

    SciTech Connect (OSTI)

    Miller, D. C.; Wohlgemuth, J. H.

    2012-08-01

    Engineering robust adhesion of the junction-box (j-box) is a hurdle typically encountered by photovoltaic (PV) module manufacturers during product development. There are historical incidences of adverse effects (e.g., fires) caused when the j-box/adhesive/module system has failed in the field. The addition of a weight to the j-box during the 'damp heat' IEC qualification test is proposed to verify the basic robustness of its adhesion system. The details of the proposed test will be described, in addition to the preliminary results obtained using representative materials and components. The described discovery experiments examine moisture-cured silicone, foam tape, and hot-melt adhesives used in conjunction with PET or glass module 'substrates.' To be able to interpret the results, a set of material-level characterizations was performed, including thermogravimetric analysis, differential scanning calorimetry, and dynamic mechanical analysis. PV j-boxes were adhered to a substrate, loaded with a prescribed weight, and then placed inside an environmental chamber (at 85C, 85% relative humidity). Some systems did not remain attached through the discovery experiments. Observed failure modes include delamination (at the j-box/adhesive or adhesive/substrate interface) and phase change/creep. The results are discussed in the context of the application requirements, in addition to the plan for the formal experiment supporting the proposed modification to the qualification test.

  16. Examination of a Junction-Box Adhesion Test for Use in Photovoltaic Module Qualification: Preprint

    SciTech Connect (OSTI)

    Miller, D. C.; Wohlgemuth, J. H.

    2012-08-01

    Engineering robust adhesion of the junction-box (j-box) is a hurdle typically encountered by photovoltaic (PV) module manufacturers during product development. There are historical incidences of adverse effects (e.g., fires) caused when the j-box/adhesive/module system has failed in the field. The addition of a weight to the j-box during the 'damp heat' IEC qualification test is proposed to verify the basic robustness of its adhesion system. The details of the proposed test will be described, in addition to the preliminary results obtained using representative materials and components. The described discovery experiments examine moisture-cured silicone, foam tape, and hot-melt adhesives used in conjunction with PET or glass module 'substrates.' To be able to interpret the results, a set of material-level characterizations was performed, including thermogravimetric analysis, differential scanning calorimetry, and dynamic mechanical analysis. PV j-boxes were adhered to a substrate, loaded with a prescribed weight, and then placed inside an environmental chamber (at 85C, 85% relative humidity). Some systems did not remain attached through the discovery experiments. Observed failure modes include delamination (at the j-box/adhesive or adhesive/substrate interface) and phase change/creep. The results are discussed in the context of the application requirements, in addition to the plan for the formal experiment supporting the proposed modification to the qualification test.

  17. The design and fabrication of two portal vein flow phantoms by different methods

    SciTech Connect (OSTI)

    Yunker, Bryan E. Lanning, Craig J.; Shandas, Robin; Hunter, Kendall S.; Chen, S. James

    2014-02-15

    Purpose: This study outlines the design and fabrication techniques for two portal vein flow phantoms. Methods: A materials study was performed as a precursor to this phantom fabrication effort and the desired material properties are restated for continuity. A three-dimensional portal vein pattern was created from the Visual Human database. The portal vein pattern was used to fabricate two flow phantoms by different methods with identical interior surface geometry using computer aided design software tools and rapid prototyping techniques. One portal flow phantom was fabricated within a solid block of clear silicone for use on a table with Ultrasound or within medical imaging systems such as MRI, CT, PET, or SPECT. The other portal flow phantom was fabricated as a thin walled tubular latex structure for use in water tanks with Ultrasound imaging. Both phantoms were evaluated for usability and durability. Results: Both phantoms were fabricated successfully and passed durability criteria for flow testing in the next project phase. Conclusions: The fabrication methods and materials employed for the study yielded durable portal vein phantoms.

  18. The 1986 residential occupant survey

    SciTech Connect (OSTI)

    Ivey, D.L.; Alley, P.K.

    1987-04-01

    In 1986, Pacific Northwest Laboratory developed the Residential Occupant Survey-Spring '86, which was implemented. The overall purpose of the study was to collect demographic, attitudinal, and behavioral data related to the use and conservation of electricity in dwellings participating in the Bonneville Power Administration's End-Use Load and Conservation Assessment Program (ELCAP). Information was collected on the respondents' perceptions of the energy efficiency of their dwelling, temperature the dwelling was kept when people were at home and awake during the last heating season, which rooms, if any, were not heated during the last heating season, number of times the dwelling was unoccupied for at least one week, number of times pets were let out of the dwelling per day, attitudes toward energy use and conservation and several socio-demographic variables such as age, sex, and total household income. The results of the data analyses showed age to be an important factor for reported indoor temperature and perceived energy efficiency of the dwelling. The results also showed that almost 60% of the ELCAP occupants do not heat one or more rooms during the heating season, and almost 45% of the ELCAP dwellings were unoccupied for at least one week during the reporting period. In terms of the reported allocation of household income for household energy expenses, the results showed that the reported dollar amount spent for the expenses remained relatively constant over income levels.

  19. Converting Energy to Medical Progress [Nuclear Medicine

    DOE R&D Accomplishments [OSTI]

    2001-04-01

    For over 50 years the Office of Biological and Environmental Research (BER) of the United States Department of Energy (DOE) has been investing to advance environmental and biomedical knowledge connected to energy. The BER Medical Sciences program fosters research to develop beneficial applications of nuclear technologies for medical diagnosis and treatment of many diseases. Today, nuclear medicine helps millions of patients annually in the United States. Nearly every nuclear medicine scan or test used today was made possible by past BER-funded research on radiotracers, radiation detection devices, gamma cameras, PET and SPECT scanners, and computer science. The heart of biological research within BER has always been the pursuit of improved human health. The nuclear medicine of tomorrow will depend greatly on today's BER-supported research, particularly in the discovery of radiopharmaceuticals that seek specific molecular and genetic targets, the design of advanced scanners needed to create meaningful images with these future radiotracers, and the promise of new radiopharmaceutical treatments for cancers and genetic diseases.

  20. Taiwan`s experience with municipal waste recycling

    SciTech Connect (OSTI)

    Lee, C.H.

    1998-12-31

    Currently, each person on the average produces 1.15 kg of the municipal waste per day and a total of 9 million metric tons were generated annually in Taiwan. The disposal of such a huge amount of waste presents tremendous challenge for the island due to the scarcity of landfills and incineration facilities available locally. EPA of Taiwan, R.O.C. thus takes an active role in promoting waste recycling to reduce the garbage produced in municipalities. In order to efficiently utilize the government`s human and financial resources used in recycling, started from January 31, 1989, EPA has mandated the producer responsibility recycling program for several designated post-consumer products such as PET, PVC bottles, scrap tires, scrap motor vehicles, etc. Producer responsibility recycling program specifies that the manufacturers, importers and sellers of these designated products have the responsibility to retrieve their products and recycle them properly. Several negative effects have been encountered while the implementation of this producer responsibility recycling program in Taiwan which resulted in a modification of this recycling program recently. This paper presents the encountered experiences on the implementation of municipal waste recycling program in Taiwan.

  1. Processing and properties of a solid energy fuel from municipal solid waste (MSW) and recycled plastics

    SciTech Connect (OSTI)

    Gug, JeongIn Cacciola, David Sobkowicz, Margaret J.

    2015-01-15

    Highlights: • Briquetting was used to produce solid fuels from municipal solid waste and recycled plastics. • Optimal drying, processing temperature and pressure were found to produce stable briquettes. • Addition of waste plastics yielded heating values comparable with typical coal feedstocks. • This processing method improves utilization of paper and plastic diverted from landfills. - Abstract: Diversion of waste streams such as plastics, woods, papers and other solid trash from municipal landfills and extraction of useful materials from landfills is an area of increasing interest especially in densely populated areas. One promising technology for recycling municipal solid waste (MSW) is to burn the high-energy-content components in standard coal power plant. This research aims to reform wastes into briquettes that are compatible with typical coal combustion processes. In order to comply with the standards of coal-fired power plants, the feedstock must be mechanically robust, free of hazardous contaminants, and moisture resistant, while retaining high fuel value. This study aims to investigate the effects of processing conditions and added recyclable plastics on the properties of MSW solid fuels. A well-sorted waste stream high in paper and fiber content was combined with controlled levels of recyclable plastics PE, PP, PET and PS and formed into briquettes using a compression molding technique. The effect of added plastics and moisture content on binding attraction and energy efficiency were investigated. The stability of the briquettes to moisture exposure, the fuel composition by proximate analysis, briquette mechanical strength, and burning efficiency were evaluated. It was found that high processing temperature ensures better properties of the product addition of milled mixed plastic waste leads to better encapsulation as well as to greater calorific value. Also some moisture removal (but not complete) improves the compacting process and results in higher heating value. Analysis of the post-processing water uptake and compressive strength showed a correlation between density and stability to both mechanical stress and humid environment. Proximate analysis indicated heating values comparable to coal. The results showed that mechanical and moisture uptake stability were improved when the moisture and air contents were optimized. Moreover, the briquette sample composition was similar to biomass fuels but had significant advantages due to addition of waste plastics that have high energy content compared to other waste types. Addition of PP and HDPE presented better benefits than addition of PET due to lower softening temperature and lower oxygen content. It should be noted that while harmful emissions such as dioxins, furans and mercury can result from burning plastics, WTE facilities have been able to control these emissions to meet US EPA standards. This research provides a drop-in coal replacement that reduces demand on landfill space and replaces a significant fraction of fossil-derived fuel with a renewable alternative.

  2. Measured dose rate constant from oncology patients administered 18F for positron emission tomography

    SciTech Connect (OSTI)

    Quinn, Brian; Holahan, Brian; Aime, Jean; Humm, John; St Germain, Jean; Dauer, Lawrence T.

    2012-10-15

    Purpose: Patient exposure rate measurements verify published patient dose rate data and characterize dose rates near 2-18-fluorodeoxyglucose ({sup 18}F-FDG) patients. A specific dose rate constant based on patient exposure rate measurements is a convenient quantity that can be applied to the desired distance, injection activity, and time postinjection to obtain an accurate calculation of cumulative external radiation dose. This study reports exposure rates measured at various locations near positron emission tomography (PET) {sup 18}F-FDG patients prior to PET scanning. These measurements are normalized for the amount of administered activity, measurement distance, and time postinjection and are compared with other published data. Methods: Exposure rates were measured using a calibrated ionization chamber at various body locations from 152 adult oncology patients postvoid after a mean uptake time of 76 min following injection with a mean activity of 490 MBq {sup 18}F-FDG. Data were obtained at nine measurement locations for each patient: three near the head, four near the chest, and two near the feet. Results: On contact with, 30 cm superior to and 30 cm lateral to the head, the mean (75th percentile) dose rates per unit injected activity at 60 min postinjection were 0.482 (0.511), 0.135 (0.155), and 0.193 (0.223) {mu}Sv/MBq h, respectively. On contact with, 30 cm anterior to, 30 cm lateral to and 1 m anterior to the chest, the mean (75th percentile) dose rates per unit injected activity at 60 min postinjection were 0.623 (0.709), 0.254 (0.283), 0.190 (0.218), and 0.067 (0.081) {mu}Sv/MBq h respectively. 30 cm inferior and 30 cm lateral to the feet, the mean (75th percentile) dose rates per unit injected activity at 60 min postinjection were 0.024 (0.022) and 0.039 (0.044) {mu}Sv/MBq h, respectively. Conclusions: The measurements for this study support the use of 0.092 {mu}Sv m{sup 2}/MBq h as a reasonable representation of the dose rate anterior from the chest of patients immediately following injection. This value can then be reliably scaled to the desired time and distance for planning and staff dose evaluation purposes. At distances closer than 1 m, a distance-specific dose rate constant of 0.367 {mu}Sv/MBq h at 30 cm is recommended for accurate calculations. An accurate patient-specific dose rate constant that accounts for patient-specific variables (e.g., distribution and attenuation) will allow an accurate evaluation of the dose rate from a patient injected with an isotope rather than simply utilizing a physical constant.

  3. Normal Conducting CLIC Technology

    SciTech Connect (OSTI)

    Jensen, Erk

    2006-01-03

    The CLIC (Compact Linear Collider) multi-lateral study group based at CERN is studying the technology for an electron-positron linear collider with a centre-of-mass energy up to 5 TeV. In contrast to the International Linear Collider (ILC) study which has chosen to use super-conducting cavities with accelerating gradients in the range of 30-40 MV/m to obtain centre-of-mass collision energies of 0.5-1 TeV, the CLIC study aims to use a normal-conducting system based on two-beam technology with gradients of 150 MV/m. It is generally accepted that this change in technology is not only necessary but the only viable choice for a cost-effective multi-TeV collider. The CLIC study group is studying the technology issues of such a machine, and is in particular developing state-of-the-art 30 GHz molybdenum-iris accelerating structures and power extraction and transfer structures (PETS). The accelerating structure has a new geometry which includes fully-profiled RF surfaces optimised to minimize surface fields, and hybrid damping using both iris slots and radial waveguides. A newly-developed structure-optimisation procedure has been used to simultaneously balance surface fields, power flow, short and long-range transverse wakefields, RF-to-beam efficiency and the ratio of luminosity to input power. The slotted irises allow a simple structure fabrication by high-precision high-speed 3D milling of just four pieces, and an even easier bolted assembly in a vacuum chamber.

  4. TIME-RESOLVED 1-10 keV CRYSTAL SPECTROMETER FOR THE Z MACHINE AT SANDIA NATIONAL LABORATORIES

    SciTech Connect (OSTI)

    D. V. Morgan; S. Gardner; R. Liljestrand; M. Madlener; S. Slavin; M. Wu

    2003-06-01

    We have designed, fabricated, calibrated, and fielded a fast, time-resolved 1-10 keV crystal spectrometer to observe the evolution of wire pinch spectra at the Z machine at Sandia National Laboratories. The instrument has two convex cylindrical crystals (PET and KAP). Both crystals Bragg reflect x-rays into an array of ten silicon diodes, providing continuous spectral coverage in twenty channels from 1.0 to 10 keV. The spectral response of the instrument has been calibrated from 1.0 to 6.3 keV at beamline X8A at the National Synchrotron Light Source. The time response of the 1-mm2 silicon detectors was measured with the Pulsed X-ray Source at Bechtel Nevada's Los Alamos Operations, where 2-nanosecond full-width half-maximum (FWHM) waveforms with 700-picosecond rise times typically were observed. The spectrometer has been fielded recently on several experimental runs at the Z Machine. In this paper, we present the time-resolved spectra resulting from the implosions of double-nested tungsten wire arrays onto 5-mm diameter foam cylinders. We also show the results obtained for a double-nested stainless steel wire array with no target cylinder. The spectrometer was located at the end of a 7.1-meter beamline on line-of sight (LOS)21/22, at an angle 12{sup o} above the equatorial plane, and was protected from the debris field by a customized dual-slit fast valve. The soft detector channels below 2.0 keV recorded large signals at pinch time coinciding with signals recorded on vacuum x-ray diodes (XRDs). On experiment Z993, the spectrometer channels recorded a second pulse with a hard x-ray emission spectrum several nanoseconds after pinch time.

  5. WILD PIG ATTACKS ON HUMANS

    SciTech Connect (OSTI)

    Mayer, J.

    2013-04-12

    Attacks on humans by wild pigs (Sus scrofa) have been documented since ancient times. However, studies characterizing these incidents are lacking. In an effort to better understand this phenomenon, information was collected from 412 wild pig attacks on humans. Similar to studies of large predator attacks on humans, data came from a variety of sources. The various attacks compiled occurred in seven zoogeographic realms. Most attacks occurred within the species native range, and specifically in rural areas. The occurrence was highest during the winter months and daylight hours. Most happened under non-hunting circumstances and appeared to be unprovoked. Wounded animals were the chief cause of these attacks in hunting situations. The animals involved were typically solitary, male and large in size. The fate of the wild pigs involved in these attacks varied depending upon the circumstances, however, most escaped uninjured. Most human victims were adult males traveling on foot and alone. The most frequent outcome for these victims was physical contact/mauling. The severity of resulting injuries ranged from minor to fatal. Most of the mauled victims had injuries to only one part of their bodies, with legs/feet being the most frequent body part injured. Injuries were primarily in the form of lacerations and punctures. Fatalities were typically due to blood loss. In some cases, serious infections or toxemia resulted from the injuries. Other species (i.e., pets and livestock) were also accompanying some of the humans during these attacks. The fates of these animals varied from escaping uninjured to being killed. Frequency data on both non-hunting and hunting incidents of wild pig attacks on humans at the Savannah River Site, South Carolina, showed quantitatively that such incidents are rare.

  6. Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Fowler, Joanna S.; Logan, Jean; Volkow, Nora D.; Shumay, Elena; McCall-Perez, Fred; Gilmor, Michelle; Jayne, Millard; Wang, Gene-Jack; Alexoff, David L.; Apelskog-Torres, Karen; et al

    2015-10-29

    Selegiline (L-deprenyl) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) at the conventional dose (10 mg/day oral) that is used in the treatment of Parkinson’s disease. However, controlled studies have demonstrated antidepressant activity for high doses of oral selegiline and for transdermal selegiline suggesting that when plasma levels of selegiline are elevated, brain MAO-A might also be inhibited. Zydis selegiline (Zelapar®) is an orally disintegrating formulation of selegiline, which is absorbed through the buccal mucosa producing higher plasma levels of selegiline and reduced amphetamine metabolites compared to equal doses of conventional selegiline. Although there is indirect evidence thatmore » Zydis selegiline at high doses loses its selectivity for MAO-B, there is no direct evidence that it also inhibits brain MAO-A in humans. We measured brain MAO-A in 18 healthy men after a 28-day treatment with Zydis selegiline (2.5, 5.0, or 10 mg/day) and in 3 subjects receiving the selegiline transdermal system (Emsam patch, 6 mg/day) using PET and the MAO-A radiotracer [¹¹C]clorgyline. We also measured dopamine transporter (DAT) availability in three subjects from the 10 mg group. The 10 mg Zydis selegiline dose significantly inhibited MAO-A (36.9 ± 19.7%, range 11–70%, p<0.007)) but not DAT; and while Emsam also inhibited MAO-A (33.2 ± 28.9 (range 9-68%) the difference did not reach significance (p=0.10)) presumably because of the small sample size. Our results provide the first direct evidence of brain MAO-A inhibition in humans by formulations of selegiline, which are currently postulated but not verified to target brain MAO-A in addition to MAO-B.« less

  7. CFD Modeling and Image Analysis of Exhaled Aerosols due to a Growing Bronchial Tumor: towards Non-Invasive Diagnosis and Treatment of Respiratory Obstructive Diseases

    SciTech Connect (OSTI)

    Xi, Jinxiang; Kim, JongWon; Si, Xiuhua A.; Corley, Richard A.; Kabilan, Senthil; Wang, Shengyu

    2015-02-06

    Diagnosis and prognosis of tumorigenesis are generally performed with CT, PET, or biopsy. Such methods are accurate, but have the limitations of high cost and posing additional health risks to patients. In this study, we introduce an alternative computer aided diagnostic tool that can locate malignant sites caused by tumorigenesis in a non-invasive and low-cost way. Our hypothesis is that exhaled aerosol distribution is unique to lung structure and is sensitive to airway structure vari-ations. With appropriate approaches, it is possible to locate the disease site, determine the disease severity, and subsequently formulate a targeted drug delivery plan to treat the disease. This study numerically evaluated the feasibility of the proposed breath test in an image-based lung model with varying pathological stages of a bronchial squamous tumor. Large eddy simulations and a Lagran-gian tracking approach were used to model respiratory airflows and aerosol dynamics. Respira-tions of tracer aerosols of 1 m at a flow rate of 20 L/min were simulated, with the distributions of exhaled aerosols recorded on a filter at the mouth exit. Aerosol patterns were quantified with multiple analytical techniques such as concentration disparity, spatial scanning and fractal analysis. We demonstrated that a growing bronchial tumor induced notable variations in both the airflow and exhaled aerosol distribution. These variations became more apparent with increasing tumor severity. The exhaled aerosols exhibited distinctive pattern parameters such as spatial probability, fractal dimension, and multifractal spectrum. Results of this study show that morphometric measures of the exhaled aerosol pattern can be used to detect and monitor the pathological states of respiratory diseases in the upper airway. The proposed breath test also has the potential to locate the site of the disease, which is critical in developing a personalized, site-specific drug de-livery protocol.

  8. Technical Note: Building a combined cyclotron and MRI facility: Implications for interference

    SciTech Connect (OSTI)

    Hofman, Mark B. M.; Kuijer, Joost P. A.; Ridder, Jan Willem de; Perk, Lars R.; Verdaasdonk, Rudolf M.

    2013-01-15

    Purpose: With the introduction of hybrid PET/MRI systems, it has become more likely that the cyclotron and MRI systems will be located close to each other. This study considered the interference between a cyclotron and a superconducting MRI system. Methods: Interactions between cyclotrons and MRIs are theoretically considered. The main interference is expected to be the perturbation of the magnetic field in the MRI due to switching on or off the magnetic field of the cyclotron. MR imaging is distorted by a dynamic spatial gradient of an external inplane magnetic field larger than 0.5-0.04 {mu}T/m, depending on the specific MR application. From the design of a cyclotron, it is expected that the magnetic fringe field at large distances behaves as a magnetic dipolar field. This allows estimation of the full dipolar field and its spatial gradients from a single measurement. Around an 18 MeV cyclotron (Cyclone, IBA), magnetic field measurements were performed on 5 locations and compared with calculations based upon a dipolar field model. Results: At the measurement locations the estimated and measured values of the magnetic field component and its spatial gradients of the inplane component were compared, and found to agree within a factor 1.1 for the magnetic field and within a factor of 1.5 for the spatial gradients of the field. In the specific case of the 18 MeV cyclotron with a vertical magnetic field and a 3T superconducting whole body MR system, a minimum distance of 20 m has to be considered to prevent interference. Conclusions: This study showed that a dipole model is sufficiently accurate to predict the interference of a cyclotron on a MRI scanner, for site planning purposes. The cyclotron and a whole body MRI system considered in this study need to be placed more than 20 m apart, or magnetic shielding should be utilized.

  9. Production of .sup.64 Cu and other radionuclides using a charged-particle accelerator

    DOE Patents [OSTI]

    Welch, Michael J. (Creve Couer, MO); McCarthy, Deborah W. (Maryland Heights, MO); Shefer, Ruth E. (Newton, MA); Klinkowstein, Robert E. (Winchester, MA)

    2000-01-01

    Radionuclides are produced according to the present invention at commercially significant yields and at specific activities which are suitable for use in radiodiagnostic agents such as PET imaging agents and radiotherapeutic agents and/or compositions. In the method and system of the present invention, a solid target having an isotopically enriched target layer electroplated on an inert substrate is positioned in a specially designed target holder and irradiated with a charged-particle beam. The beam is preferably generated using an accelerator such as a biomedical cyclotron at energies ranging from about 5 MeV to about 25 MeV. The target is preferably directly irradiated, without an intervening attenuating foil, and with the charged particle beam impinging an area which substantially matches the target area. The irradiated target is remotely and automatically transferred from the target holder, preferably without transferring any target holder subassemblies, to a conveyance system which is preferably a pneumatic or hydraulic conveyance system, and then further transferred to an automated separation system. The system is effective for processing a single target or a plurality of targets. After separation, the unreacted target material can be recycled for preparation of other targets. In a preferred application of the invention, a biomedical cyclotron has been used to produce over 500 mCi of .sup.64 Cu having a specific activity of over 300 mCi/.mu.g Cu according to the reaction .sup.64 Ni(p,n).sup.64 Cu. These results indicate that accelerator-produced .sup.64 Cu is suitable for radiopharmaceutical diagnostic and therapeutic applications.

  10. OZSPEC-2: An improved broadband high-resolution elliptical crystal x-ray spectrometer for high-energy density physics experiments (invited)

    SciTech Connect (OSTI)

    Heeter, R. F.; Anderson, S. G.; Booth, R.; Brown, G. V.; Emig, J.; Fulkerson, S.; McCarville, T.; Norman, D.; Schneider, M. B.; Young, B. K. F.

    2008-10-15

    A novel time, space, and energy-resolved x-ray spectrometer has been developed which produces, in a single snapshot, a broadband and relatively calibrated spectrum of the x-ray emission from a high-energy density laboratory plasma. The opacity zipper spectrometer (OZSPEC-1) records a nearly continuous spectrum for x-ray energies from 240 to 5800 eV in a single shot. The second-generation OZSPEC-2, detailed in this work, records fully continuous spectra on a single shot from any two of these three bands: 270-650, 660-1580, and 1960-4720 eV. These instruments thus record thermal and line radiation from a wide range of plasmas. These instruments' single-shot bandwidth is unmatched in a time-gated spectrometer; conversely, other broadband instruments are either time-integrated (using crystals or gratings), lack spectral resolution (diode arrays), or cover a lower energy band (gratings). The OZSPECs are based on the zipper detector, a large-format (100x35 mm) gated microchannel plate detector, with spectra dispersed along the 100 mm dimension. OZSPEC-1 and -2 both use elliptically bent crystals of OHM, RAP, and/or PET. Individual spectra are gated in 100 ps. OZSPEC-2 provides one-dimensional spatial imaging with 30-50 {mu}m resolution over a 1500 {mu}m field of view at the source. The elliptical crystal design yields broad spectral coverage with resolution E/{delta}E>500, strong rejection of hard x-ray backgrounds, and negligible source broadening for extended sources. Near-term applications include plasma opacity measurements, detailed spectra of inertial fusion Hohlraums, and laboratory astrophysics experiments.

  11. The correlation between reactivity and ash mineralogy of coke

    SciTech Connect (OSTI)

    Kerkkonen, O.; Mattila, E.; Heiniemi, R.

    1996-12-31

    Rautaruukki is a modern integrated Finnish steel works having a production of 2.4 mil. t/year of flat products. The total fuel consumption of the two blast furnaces in 1994 was 435 kg/t HM. Coke used was 345 kg/t HM and oil injection was 90 kg/t HM. The coking plant was taken in to operation in 1987 and is the only one in Finland, which means that the coking tradition is very short. Coke production is 0.9 mil. t/year. The coking blends include 70--80% medium volatile coals having a wide range of total dilatation. From time to time disturbances in the operation of the blast furnaces have occurred in spite of the fact that the reactivity of the coke used has remained constant or even decreased. It was thought necessary to investigate the factors affecting coke reactivity, in order to better understand the results of the reactivity test. This paper deals with carbonization tests done in a 7 kg test oven using nine individual coals having volatile-matter contents of 17--36% (dry) and seven blends made from these coals. Coke reactivity with CO{sub 2} at 1100 C (CRI) and coke strength after reaction (CSR) were determined using the test developed by the Nippon Steel Corporation. The influence of coke carbon form, porosity and especially ash mineralogy on the coke reactivity were examined. The effects of some additives; petroleum coke (pet coke), the spillage material from the coke ovens and oxidized coal, on coke quality were also studied. Typical inorganic minerals found in coals were added to one of the high volatile coals, which was then coked to determine the affect of the minerals on the properties of the coke produced.

  12. An Ionic Liquid Reaction and Separation Process for Production of Hydroxymethylfurfural from Sugars

    SciTech Connect (OSTI)

    Liu, Wei; Zheng, Feng; Li, Joanne; Cooper, Alan R.

    2014-01-01

    There has been world-wide interest to making plastics out of renewable biomass feedstock for recent years. Hydroxymethylfurfural (HMF) is viewed as an attractive alternate to terephthalic acid (TPA) for production of polyesters (PET) and polyamides. Conversion of sugars into HMF has been studied in numerous publications. In this work, a complete ionic liquid reaction and separation process is presented for nearly stoichiometric conversion of fructose into HMF. Different adsorbent materials are evaluated and silicalite material is demonstrated effective for isolation of 99% pure HMF from actual ionic liquid reaction mixtures and for recovery of the un-converted sugars and reaction intermediate along with the ionic liquid. Membrane-coated silicalite particles are prepared and studied for a practical adsorption process operated at low pressure drops but with separation performances comparable or better than the powder material. Complete conversion of fresh fructose feed into HMF in the recycled ionic liquid is shown under suitable reaction conditions. Stability of HMF product is characterized. A simplified process flow diagram is proposed based on these research results, and the key equipment such as reactor and adsorbent bed is sized for a plant of 200,000 ton/year of fructose processing capacity. The proposed HMF production process is much simpler than the current paraxylene (PX) manufacturing process from petroleum oil, which suggests substantial reduction to the capital cost and energy consumption be possible. At the equivalent value to PX on the molar basis, there can be a large gross margin for HMF production from fructose and/or sugars.

  13. Radiation Field Design and Patterns of Locoregional Recurrence Following Definitive Radiotherapy for Breast Cancer

    SciTech Connect (OSTI)

    Chen, Susie A.; Schuster, David M.; Mister, Donna; Liu Tian; Godette, Karen; Torres, Mylin A.

    2013-02-01

    Purpose: Locoregional control is associated with breast cancer-specific and overall survival in select women with breast cancer. Although several patient, tumor, and treatment characteristics have been shown to contribute to locoregional recurrence (LRR), studies evaluating factors related to radiotherapy (XRT) technique have been limited. We investigated the relationship between LRR location and XRT fields and dose delivered to the primary breast cancer in women experiencing subsequent locoregional relapse. Methods and Materials: We identified 21 women who were previously treated definitively with surgery and XRT for breast cancer. All patients developed biopsy-result proven LRR and presented to Emory University Hospital between 2004 and 2010 for treatment. Computed tomography (CT) simulation scans with XRT dose files for the initial breast cancer were fused with {sup 18}F-labeled fluorodeoxyglucose positron emission tomography (FDG PET)/CT images in DICOM (Digital Imaging and Communications in Medicine) format identifying the LRR. Each LRR was categorized as in-field, defined as {>=}95% of the LRR volume receiving {>=}95% of the prescribed whole-breast dose; marginal, defined as LRR at the field edge and/or not receiving {>=}95% of the prescribed dose to {>=}95% of the volume; or out-of-field, that is, LRR intentionally not treated with the original XRT plan. Results: Of the 24 identified LRRs (3 patients experienced two LRRs), 3 were in-field, 9 were marginal, and 12 were out-of-field. Two of the 3 in-field LRRs were marginal misses of the additional boost XRT dose. Out-of-field LRRs consisted of six supraclavicular and six internal mammary nodal recurrences. Conclusions: Most LRRs in our study occurred in areas not fully covered by the prescribed XRT dose or were purposely excluded from the original XRT fields. Our data suggest that XRT technique, field design, and dose play a critical role in preventing LRR in women with breast cancer.

  14. Development of radiohalogenated muscarinic ligands for the in vivo imaging of m-AChR by nuclear medicine techniques

    SciTech Connect (OSTI)

    McPherson, D.W.; Luo, H.; Knapp, F.F. Jr.

    1994-06-01

    Alterations in the density of acetylcholinergic muscarinic receptors (m-AChR) have been observed in various dementias. This has spurred interest in the development of radiohalogenated ligands which can be used for the non-invasive in vivo detection of m-AChR by nuclear medicine techniques. We have developed a new ligand 1-azabicyclo[2.2.2]oct-3-yl ({alpha}-hydroxy-{alpha}-(1-iodo-1-propen-3-yl)-{alpha}-phenylacetate (IQNP,12) which demonstrates high affinity for the muscarinic receptor. When labeled with radioiodine it has been shown to be selective and specific for m-ACHR. Initial studies on the separation and in vivo evaluation of the various isomers of IQNP have shown that the stereochemistry of the chiral centers and the configuration around the double bond play an important role in m-AChR subtype specificity. In vivo evaluation of these stereoisomers demonstrate that E-(R,R)-IQNP has a high affinity for the M{sub 1} muscarinic subtype while Z-(R,R)-IQNP demonstrate a high affinity for M{sub 1} and M{sub 2} receptor subtypes. These data demonstrate IQNP (12) has potential for use in the non-evasive in vivo detection of m-AChR by single photon emission computed tomography (SPECT). A brominated analogue, ``BrQNP,`` in which the iodine has been replaced by a bromine atom, has also been prepared and was shown to block the in vivo uptake of IQNP in the brain and heart and therefore has potential for positron emission tomographic (PET) studies of m-AChR.

  15. Development of Gamma-Emitting Receptor Binding Radiopharmace

    SciTech Connect (OSTI)

    Reba, Richard

    2003-02-20

    The long-term objective is to develop blood-brain barrier (BBB) permeable m2-selective (relative to m1, m3, and m4) receptor-binding radiotracers and utilize these radiotracers for quantifying receptor concentrations obtained from PET or SPECT images of human brain. In initial studies, we concluded that the lipophilicity and high affinity prevented (R,S)-I-QNB from reaching a flow-independent and receptor-dependent state in a reasonable time. Thus, it was clear that (R,S)-I-QNB should be modified. Therefore, during the last portion of this funded research, we proposed that more polar heterocycles should help accomplish that. Since reports of others concluded that radiobromination and radiofluorination of the unactivated phenyl ring is not feasible (Newkome et al,,1982), we, therefore, explored during this grant period a series of analogues of (R)-QNB in which one or both of the six-membered phenyl rings is replaced by a five-membered thienyl (Boulay et al., 1995), or furyl ring. The chemistry specific aims were to synthesize novel compounds designed to be m2-selective mAChR ligands capable of penetrating into the CNS, and develop methods for efficient radiolabeling of promising m2-selective muscarinic ligands. The pharmacology specific aims were to determine the affinity and subtype-selectivity of the novel compounds using competition binding studies with membranes from cells that express each of the five muscarinic receptor subtypes, to determine the ability of the promising non-radioactive compounds and radiolabeled novel compounds to cross the BBB, to determine the biodistribution, in-vivo pharmacokinetics, and in-vitm kinetics of promising m2-selective radioligands and to determine the distribution of receptors for the novel m2-selective radioligands using quantitative autoradiography of rat brain, and compare this distribution to the distribution of known m2-selective compounds.

  16. Suppressing the Skin-Core Structure of Injection-Molded Isotactic Polypropylene via Combination of an in situ Microfibrillar Network and an Interfacial Compatibilizer

    SciTech Connect (OSTI)

    X Yi; C Chen; G Zhong; L Xu; J Tang; X Ji; B Hsiao; Z Li

    2011-12-31

    Injection-molded semicrystalline polymer parts generally exhibited a so-called skin-core structure basically as a result of the large gradients of temperature, shear rate, stress, and pressure fields created by the boundary conditions of injection molding. Suppression of the skin-core structure is a long-term practical challenge. In the current work, the skin-core structure of the conventional injection-molded isotactic polypropylene (iPP) was largely relieved by the cooperative effects of an in situ microfibrillar network and interfacial compatibilizer. The in situ poly(ethylene terephthalate) microfibrils of 1-8 {micro}m in diameter and large aspect ratios of above 40 tended to entangle with each other to generate a microfibrillar network in the iPP melt. During injection molding, the iPP molecules experienced confined flow in the microchannels or pores formed by the microfibrillar network, which could redistribute and homogenize the flow field of polymer melt. Addition of the compatibilizer, glycidyl methacrylate-grafted iPP, restrained the molecular orientation but facilitated preservation of oriented molecules due to the chemical bonds at the interface between PET microfibrils and iPP. The cooperative effects of in situ microfibrillar network and interfacial compatibilizer led to almost the same molecular orientation across the whole thickness of the injection-molded parts. Additionally, the content of {beta} crystals in different layers of injection-molded iPP parts depended on the combined effects of the molecular orientation, the amount of oriented crystals, and the crystallization time between 105 and 140 C. The presence of the interfacial compatibilizer facilitated formation of the {beta} crystals because of preservation of the oriented molecules.

  17. Alcohol decreases baseline brain glucose metabolism more in heavy drinkers than controls but has no effect on stimulation-induced metabolic increases

    SciTech Connect (OSTI)

    Volkow, Nora D.; Fowler, Joanna S.; Wang, Gene-Jack; Kojori, Eshan Shokri; Benveniste, Helene; Tomasi, Dardo

    2015-02-18

    During alcohol intoxication the human brain increases metabolism of acetate and decreases metabolism of glucose as energy substrate. Here we hypothesized that chronic heavy drinking facilitates this energy substrate shift both for baseline and stimulation conditions. To test this hypothesis we compared the effects of alcohol intoxication (0.75g/kg alcohol versus placebo) on brain glucose metabolism during video-stimulation (VS) versus when given with no-stimulation (NS), in 25 heavy drinkers (HD) and 23 healthy controls each of whom underwent four PET-?FDG scans. We showed that resting whole-brain glucose metabolism (placebo-NS) was lower in HD than controls (13%, p=0.04); that alcohol (compared to placebo) decreased metabolism more in HD (2013%) than controls (911%, p=0.005) and in proportion to daily alcohol consumption (r=0.36, p=0.01) but found that alcohol did not reduce the metabolic increases in visual cortex from VS in either group. Instead, VS reduced alcohol-induced decreases in whole-brain glucose metabolism (1012%) compared to NS in both groups (1513%, p=0.04), consistent with stimulation-related glucose metabolism enhancement. These findings corroborate our hypothesis that heavy alcohol consumption facilitates use of alternative energy substrates (i.e. acetate) for resting activity during intoxication, which might persist through early sobriety, but indicate that glucose is still favored as energy substrate during brain stimulation. Our findings are consistent with reduced reliance on glucose as the main energy substrate for resting brain metabolism during intoxication (presumably shifting to acetate or other ketones) and a priming of this shift in heavy drinkers, which might make them vulnerable to energy deficits during withdrawal.

  18. CFD modeling and image analysis of exhaled aerosols due to a growing bronchial tumor: Towards non-invasive diagnosis and treatment of respiratory obstructive diseases

    SciTech Connect (OSTI)

    Xi, Jinxiang [Central Michigan Univ., Mount Pleasant, MI (United States); Kim, JongWon [Central Michigan Univ., Mount Pleasant, MI (United States); Si, Xiuhua A. [California Baptist Univ., Riverside, CA (United States); Corley, Richard A. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Kabilan, Senthil [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Wang, Shengyu [First Affiliated Hospital of Xi'an Medical Univ., Shaanxi (China); Mayo Clinic, Rochester, MN (United States)

    2015-01-01

    Diagnosis and prognosis of tumorigenesis are generally performed with CT, PET, or biopsy. Such methods are accurate, but have the limitations of high cost and posing additional health risks to patients. In this study, we introduce an alternative computer aided diagnostic tool that can locate malignant sites caused by tumorigenesis in a non-invasive and low-cost way. Our hypothesis is that exhaled aerosol distribution is unique to lung structure and is sensitive to airway structure variations. With appropriate approaches, it is possible to locate the disease site, determine the disease severity, and subsequently formulate a targeted drug delivery plan to treat the disease. This study numerically evaluated the feasibility of the proposed breath test in an image-based lung model with varying pathological stages of a bronchial squamous tumor. Large eddy simulations and a Lagrangian tracking approach were used to model respiratory airflows and aerosol dynamics. Respirations of tracer aerosols of 1 ?m at a flow rate of 20 L/min were simulated, with the distributions of exhaled aerosols recorded on a filter at the mouth exit. Aerosol patterns were quantified with multiple analytical techniques such as concentration disparity, spatial scanning and fractal analysis. We demonstrated that a growing bronchial tumor induced notable variations in both the airflow and exhaled aerosol distribution. These variations became more apparent with increasing tumor severity. The exhaled aerosols exhibited distinctive pattern parameters such as spatial probability, fractal dimension, and multifractal spectrum. Results of this study show that morphometric measures of the exhaled aerosol pattern can be used to detect and monitor the pathological states of respiratory diseases in the upper airway. The proposed breath test also has the potential to locate the site of the disease, which is critical in developing a personalized, site-specific drug delivery protocol.

  19. CFD modeling and image analysis of exhaled aerosols due to a growing bronchial tumor: Towards non-invasive diagnosis and treatment of respiratory obstructive diseases

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Xi, Jinxiang; Kim, JongWon; Si, Xiuhua A.; Corley, Richard A.; Kabilan, Senthil; Wang, Shengyu

    2015-01-01

    Diagnosis and prognosis of tumorigenesis are generally performed with CT, PET, or biopsy. Such methods are accurate, but have the limitations of high cost and posing additional health risks to patients. In this study, we introduce an alternative computer aided diagnostic tool that can locate malignant sites caused by tumorigenesis in a non-invasive and low-cost way. Our hypothesis is that exhaled aerosol distribution is unique to lung structure and is sensitive to airway structure variations. With appropriate approaches, it is possible to locate the disease site, determine the disease severity, and subsequently formulate a targeted drug delivery plan to treatmore » the disease. This study numerically evaluated the feasibility of the proposed breath test in an image-based lung model with varying pathological stages of a bronchial squamous tumor. Large eddy simulations and a Lagrangian tracking approach were used to model respiratory airflows and aerosol dynamics. Respirations of tracer aerosols of 1 μm at a flow rate of 20 L/min were simulated, with the distributions of exhaled aerosols recorded on a filter at the mouth exit. Aerosol patterns were quantified with multiple analytical techniques such as concentration disparity, spatial scanning and fractal analysis. We demonstrated that a growing bronchial tumor induced notable variations in both the airflow and exhaled aerosol distribution. These variations became more apparent with increasing tumor severity. The exhaled aerosols exhibited distinctive pattern parameters such as spatial probability, fractal dimension, and multifractal spectrum. Results of this study show that morphometric measures of the exhaled aerosol pattern can be used to detect and monitor the pathological states of respiratory diseases in the upper airway. The proposed breath test also has the potential to locate the site of the disease, which is critical in developing a personalized, site-specific drug delivery protocol.« less

  20. SU-E-I-80: Beta-Minus Emitting Radiotracers Improves Molecular Endoscopy

    SciTech Connect (OSTI)

    Carpenter, C; Ma, X; Sun, C; Pratx, G; Cheng, Z; Xing, L

    2014-06-01

    Purpose: Molecular Endoscopy using Cerenkov Luminescence can be used to monitor the distribution of many clinically-available PET and SPECT probes for endoscopic applications. A main limitation of Cerenkov is its limited sensitivity to small concentrations of radiotracer when using light guides s. Herein we demonstrate that the use of a high energy beta emitting radioisotope, exemplified here with 90Y provides superior sensitivity to 18F because of its higher light output and its lack of corresponding gamma emission. Methods: A series of phantom experiments were performed to compare the sensitivity and noise of the CLE system for imaging 90Y and 18F. Three vials of known concentrations of 90Y (0.008 ?Ci, 0.08 ?Ci, 1 ?Ci) were placed in centrifuge tubes and isolated from each other. One vial of 18F (100 ?Ci) was placed in the imaging chamber and imaged over the course of decay (19 hours, 43 minutes, or ?10 half-lives). Image time-points were formed from 5-minute integrations. Results: Using an SNR of 10 to define the noise-floor, the 90Y minimum detectable activity was 0.056 ?Ci. To the contrast, the minimum detectable activity for 18F was 11.63 ?Ci. These data demonstrate a 207-fold improvement in SNR of 90Y compared to 18F, when controlled for activity. Conclusion: This study demonstrated that a pure ?- radionuclide such as 90Y be used is superior to 18F for Cerenkov Endoscopy. Further study is needed to demonstrate its utility in preclinical studies, endoscopic applications, intraoperative, and radiotherapy applications.

  1. Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain

    SciTech Connect (OSTI)

    Fowler, Joanna S.; Logan, Jean; Volkow, Nora D.; Shumay, Elena; McCall-Perez, Fred; Gilmor, Michelle; Jayne, Millard; Wang, Gene-Jack; Alexoff, David L.; Apelskog-Torres, Karen; Hubbard, Barbara; Carter, Pauline; King, Payton; Fahn, Stanley; Telang, Frank; Shea, Colleen; Xu, Youwen; Muench, Lisa

    2015-10-29

    Selegiline (L-deprenyl) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) at the conventional dose (10 mg/day oral) that is used in the treatment of Parkinson’s disease. However, controlled studies have demonstrated antidepressant activity for high doses of oral selegiline and for transdermal selegiline suggesting that when plasma levels of selegiline are elevated, brain MAO-A might also be inhibited. Zydis selegiline (Zelapar®) is an orally disintegrating formulation of selegiline, which is absorbed through the buccal mucosa producing higher plasma levels of selegiline and reduced amphetamine metabolites compared to equal doses of conventional selegiline. Although there is indirect evidence that Zydis selegiline at high doses loses its selectivity for MAO-B, there is no direct evidence that it also inhibits brain MAO-A in humans. We measured brain MAO-A in 18 healthy men after a 28-day treatment with Zydis selegiline (2.5, 5.0, or 10 mg/day) and in 3 subjects receiving the selegiline transdermal system (Emsam patch, 6 mg/day) using PET and the MAO-A radiotracer [¹¹C]clorgyline. We also measured dopamine transporter (DAT) availability in three subjects from the 10 mg group. The 10 mg Zydis selegiline dose significantly inhibited MAO-A (36.9 ± 19.7%, range 11–70%, p<0.007)) but not DAT; and while Emsam also inhibited MAO-A (33.2 ± 28.9 (range 9-68%) the difference did not reach significance (p=0.10)) presumably because of the small sample size. Our results provide the first direct evidence of brain MAO-A inhibition in humans by formulations of selegiline, which are currently postulated but not verified to target brain MAO-A in addition to MAO-B.

  2. Alcohol decreases baseline brain glucose metabolism more in heavy drinkers than controls but has no effect on stimulation-induced metabolic increases

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Volkow, Nora D.; Fowler, Joanna S.; Wang, Gene-Jack; Kojori, Eshan Shokri; Benveniste, Helene; Tomasi, Dardo

    2015-02-18

    During alcohol intoxication the human brain increases metabolism of acetate and decreases metabolism of glucose as energy substrate. Here we hypothesized that chronic heavy drinking facilitates this energy substrate shift both for baseline and stimulation conditions. To test this hypothesis we compared the effects of alcohol intoxication (0.75g/kg alcohol versus placebo) on brain glucose metabolism during video-stimulation (VS) versus when given with no-stimulation (NS), in 25 heavy drinkers (HD) and 23 healthy controls each of whom underwent four PET-¹⁸FDG scans. We showed that resting whole-brain glucose metabolism (placebo-NS) was lower in HD than controls (13%, p=0.04); that alcohol (compared tomore » placebo) decreased metabolism more in HD (20±13%) than controls (9±11%, p=0.005) and in proportion to daily alcohol consumption (r=0.36, p=0.01) but found that alcohol did not reduce the metabolic increases in visual cortex from VS in either group. Instead, VS reduced alcohol-induced decreases in whole-brain glucose metabolism (10±12%) compared to NS in both groups (15±13%, p=0.04), consistent with stimulation-related glucose metabolism enhancement. These findings corroborate our hypothesis that heavy alcohol consumption facilitates use of alternative energy substrates (i.e. acetate) for resting activity during intoxication, which might persist through early sobriety, but indicate that glucose is still favored as energy substrate during brain stimulation. Our findings are consistent with reduced reliance on glucose as the main energy substrate for resting brain metabolism during intoxication (presumably shifting to acetate or other ketones) and a priming of this shift in heavy drinkers, which might make them vulnerable to energy deficits during withdrawal.« less

  3. Alcohol decreases baseline brain glucose metabolism more in heavy drinkers than controls but has no effect on stimulation-induced metabolic increases

    SciTech Connect (OSTI)

    Volkow, Nora D.; Fowler, Joanna S.; Wang, Gene-Jack; Kojori, Eshan Shokri; Benveniste, Helene; Tomasi, Dardo

    2015-02-18

    During alcohol intoxication the human brain increases metabolism of acetate and decreases metabolism of glucose as energy substrate. Here we hypothesized that chronic heavy drinking facilitates this energy substrate shift both for baseline and stimulation conditions. To test this hypothesis we compared the effects of alcohol intoxication (0.75g/kg alcohol versus placebo) on brain glucose metabolism during video-stimulation (VS) versus when given with no-stimulation (NS), in 25 heavy drinkers (HD) and 23 healthy controls each of whom underwent four PET-¹⁸FDG scans. We showed that resting whole-brain glucose metabolism (placebo-NS) was lower in HD than controls (13%, p=0.04); that alcohol (compared to placebo) decreased metabolism more in HD (20±13%) than controls (9±11%, p=0.005) and in proportion to daily alcohol consumption (r=0.36, p=0.01) but found that alcohol did not reduce the metabolic increases in visual cortex from VS in either group. Instead, VS reduced alcohol-induced decreases in whole-brain glucose metabolism (10±12%) compared to NS in both groups (15±13%, p=0.04), consistent with stimulation-related glucose metabolism enhancement. These findings corroborate our hypothesis that heavy alcohol consumption facilitates use of alternative energy substrates (i.e. acetate) for resting activity during intoxication, which might persist through early sobriety, but indicate that glucose is still favored as energy substrate during brain stimulation. Our findings are consistent with reduced reliance on glucose as the main energy substrate for resting brain metabolism during intoxication (presumably shifting to acetate or other ketones) and a priming of this shift in heavy drinkers, which might make them vulnerable to energy deficits during withdrawal.

  4. MO-G-BRF-05: Determining Response to Anti-Angiogenic Therapies with Monte Carlo Tumor Modeling

    SciTech Connect (OSTI)

    Valentinuzzi, D; Simoncic, U; Jeraj, R; Titz, B

    2014-06-15

    Purpose: Patient response to anti-angiogenic therapies with vascular endothelial growth factor receptor - tyrosine kinase inhibitors (VEGFR TKIs) is heterogeneous. This study investigates key biological characteristics that drive differences in patient response via Monte Carlo computational modeling capable of simulating tumor response to therapy with VEGFR TKI. Methods: VEGFR TKIs potently block receptors, responsible for promoting angiogenesis in tumors. The model incorporates drug pharmacokinetic and pharmacodynamic properties, as well as patientspecific data of cellular proliferation derived from [18F]FLT-PET data. Sensitivity of tumor response was assessed for multiple parameters, including initial partial oxygen tension (pO{sub 2}), cell cycle time, daily vascular growth fraction, and daily vascular regression fraction. Results were benchmarked to clinical data (patient 2 weeks on VEGFR TKI, followed by 1-week drug holiday). The tumor pO{sub 2} was assumed to be uniform. Results: Among the investigated parameters, the simulated proliferation was most sensitive to the initial tumor pO{sub 2}. Initial change of 5 mmHg can already Result in significantly different levels of proliferation. The model reveals that hypoxic tumors (pO{sub 2} ? 20 mmHg) show the highest decrease of proliferation, experiencing mean FLT standardized uptake value (SUVmean) decrease for at least 50% at the end of the clinical trial (day 21). Oxygenated tumors (pO{sub 2} 20 mmHg) show a transient SUV decrease (3050%) at the end of the treatment with VEGFR TKI (day 14) but experience a rapid SUV rebound close to the pre-treatment SUV levels (70110%) at the time of a drug holiday (day 1421) - the phenomenon known as a proliferative flare. Conclusion: Model's high sensitivity to initial pO{sub 2} clearly emphasizes the need for experimental assessment of the pretreatment tumor hypoxia status, as it might be predictive of response to antiangiogenic therapies and the occurrence of proliferative flare. Experimental assessment of other model parameters would further improve understanding of patient response.

  5. SU-E-T-256: Optimizing the Combination of Targeted Radionuclide Therapy Agents Using a Multi-Scale Patient-Specific Monte Carlo Dosimetry Platform

    SciTech Connect (OSTI)

    Besemer, A; Bednarz, B; Titz, B; Grudzinski, J; Weichert, J; Hall, L

    2014-06-01

    Purpose: Combination targeted radionuclide therapy (TRT) is appealing because it can potentially exploit different mechanisms of action from multiple radionuclides as well as the variable dose rates due to the different radionuclide half-lives. The work describes the development of a multiobjective optimization algorithm to calculate the optimal ratio of radionuclide injection activities for delivery of combination TRT. Methods: The diapeutic (diagnostic and therapeutic) agent, CLR1404, was used as a proof-of-principle compound in this work. Isosteric iodine substitution in CLR1404 creates a molecular imaging agent when labeled with I-124 or a targeted radiotherapeutic agent when labeled with I-125 or I-131. PET/CT images of high grade glioma patients were acquired at 4.5, 24, and 48 hours post injection of 124I-CLR1404. The therapeutic 131I-CLR1404 and 125ICLR1404 absorbed dose (AD) and biological effective dose (BED) were calculated for each patient using a patient-specific Monte Carlo dosimetry platform. The optimal ratio of injection activities for each radionuclide was calculated with a multi-objective optimization algorithm using the weighted sum method. Objective functions such as the tumor dose heterogeneity and the ratio of the normal tissue to tumor doses were minimized and the relative importance weights of each optimization function were varied. Results: For each optimization function, the program outputs a Pareto surface map representing all possible combinations of radionuclide injection activities so that values that minimize the objective function can be visualized. A Pareto surface map of the weighted sum given a set of user-specified importance weights is also displayed. Additionally, the ratio of optimal injection activities as a function of the all possible importance weights is generated so that the user can select the optimal ratio based on the desired weights. Conclusion: Multi-objective optimization of radionuclide injection activities can provide an invaluable tool for maximizing the dosimetric benefits in multi-radionuclide combination TRT. BT, JG, and JW are affiliated with Cellectar Biosciences which owns the licensing rights to CLR1404 and related compounds.

  6. Influence of polarization and a source model for dose calculation in MRT

    SciTech Connect (OSTI)

    Bartzsch, Stefan Oelfke, Uwe; Lerch, Michael; Petasecca, Marco; Bruer-Krisch, Elke

    2014-04-15

    Purpose: Microbeam Radiation Therapy (MRT), an alternative preclinical treatment strategy using spatially modulated synchrotron radiation on a micrometer scale, has the great potential to cure malignant tumors (e.g., brain tumors) while having low side effects on normal tissue. Dose measurement and calculation in MRT is challenging because of the spatial accuracy required and the arising high dose differences. Dose calculation with Monte Carlo simulations is time consuming and their accuracy is still a matter of debate. In particular, the influence of photon polarization has been discussed in the literature. Moreover, it is controversial whether a complete knowledge of phase space trajectories, i.e., the simulation of the machine from the wiggler to the collimator, is necessary in order to accurately calculate the dose. Methods: With Monte Carlo simulations in the Geant4 toolkit, the authors investigate the influence of polarization on the dose distribution and the therapeutically important peak to valley dose ratios (PVDRs). Furthermore, the authors analyze in detail phase space information provided byMartnez-Rovira et al. [Development and commissioning of a Monte Carlo photon model for the forthcoming clinical trials in microbeam radiation therapy, Med. Phys. 39(1), 119131 (2012)] and examine its influence on peak and valley doses. A simple source model is developed using parallel beams and its applicability is shown in a semiadjoint Monte Carlo simulation. Results are compared to measurements and previously published data. Results: Polarization has a significant influence on the scattered dose outside the microbeam field. In the radiation field, however, dose and PVDRs deduced from calculations without polarization and with polarization differ by less than 3%. The authors show that the key consequences from the phase space information for dose calculations are inhomogeneous primary photon flux, partial absorption due to inclined beam incidence outside the field center, increased beam width and center to center distance due to the beam propagation from the collimator to the phantom surface and imperfect absorption in the absorber material of the Multislit Collimator. These corrections have an effect of approximately 10% on the valley dose and suffice to describe doses in MRT within the measurement uncertainties of currently available dosimetry techniques. Conclusions: The source for the first clinical pet trials in MRT is characterized with respect to its phase space and the photon polarization. The results suggest the use of a presented simplified phase space model in dose calculations and hence pave the way for alternative and fast dose calculation algorithms. They also show that the polarization is of minor importance for the clinical important peak and valley doses inside the microbeam field.

  7. A method to synchronize signals from multiple patient monitoring devices through a single input channel for inclusion in list-mode acquisitions

    SciTech Connect (OSTI)

    OConnor, J. Michael; Pretorius, P. Hendrik; Johnson, Karen; King, Michael A.

    2013-12-15

    Purpose: This technical note documents a method that the authors developed for combining a signal to synchronize a patient-monitoring device with a second physiological signal for inclusion into list-mode acquisition. Our specific application requires synchronizing an external patient motion-tracking system with a medical imaging system by multiplexing the tracking input with the ECG input. The authors believe that their methodology can be adapted for use in a variety of medical imaging modalities including single photon emission computed tomography (SPECT) and positron emission tomography (PET). Methods: The authors insert a unique pulse sequence into a single physiological input channel. This sequence is then recorded in the list-mode acquisition along with the R-wave pulse used for ECG gating. The specific form of our pulse sequence allows for recognition of the time point being synchronized even when portions of the pulse sequence are lost due to collisions with R-wave pulses. This was achieved by altering our software used in binning the list-mode data to recognize even a portion of our pulse sequence. Limitations on heart rates at which our pulse sequence could be reliably detected were investigated by simulating the mixing of the two signals as a function of heart rate and time point during the cardiac cycle at which our pulse sequence is mixed with the cardiac signal. Results: The authors have successfully achieved accurate temporal synchronization of our motion-tracking system with acquisition of SPECT projections used in 17 recent clinical research cases. In our simulation analysis the authors determined that synchronization to enable compensation for body and respiratory motion could be achieved for heart rates up to 125 beats-per-minute (bpm). Conclusions: Synchronization of list-mode acquisition with external patient monitoring devices such as those employed in motion-tracking can reliably be achieved using a simple method that can be implemented using minimal external hardware and software modification through a single input channel, while still recording cardiac gating signals.

  8. Household mold and dust allergens: Exposure, sensitization and childhood asthma morbidity

    SciTech Connect (OSTI)

    Gent, Janneane F.; Kezik, Julie M.; Hill, Melissa E.; Tsai, Eling; Li, De-Wei; Leaderer, Brian P.

    2012-10-15

    Background: Few studies address concurrent exposures to common household allergens, specific allergen sensitization and childhood asthma morbidity. Objective: To identify levels of allergen exposures that trigger asthma exacerbations in sensitized individuals. Methods: We sampled homes for common indoor allergens (fungi, dust mites (Der p 1, Der f 1), cat (Fel d 1), dog (Can f 1) and cockroach (Bla g 1)) for levels associated with respiratory responses among school-aged children with asthma (N=1233) in a month-long study. Blood samples for allergy testing and samples of airborne fungi and settled dust were collected at enrollment. Symptoms and medication use were recorded on calendars. Combined effects of specific allergen sensitization and level of exposure on wheeze, persistent cough, rescue medication use and a 5-level asthma severity score were examined using ordered logistic regression. Results: Children sensitized and exposed to any Penicillium experienced increased risk of wheeze (odds ratio [OR] 2.12 95% confidence interval [CI] 1.12, 4.04), persistent cough (OR 2.01 95% CI 1.05, 3.85) and higher asthma severity score (OR 1.99 95% CI 1.06, 3.72) compared to those not sensitized or sensitized but unexposed. Children sensitized and exposed to pet allergen were at significantly increased risk of wheeze (by 39% and 53% for Fel d 1>0.12 {mu}g/g and Can f 1>1.2 {mu}g/g, respectively). Increased rescue medication use was significantly associated with sensitization and exposure to Der p 1>0.10 {mu}g/g (by 47%) and Fel d 1>0.12 {mu}g/g (by 32%). Conclusion: Asthmatic children sensitized and exposed to low levels of common household allergens Penicillium, Der p 1, Fel d 1 and Can f 1 are at significant risk for increased morbidity. - Highlights: Black-Right-Pointing-Pointer Few studies address concurrent allergen exposures, sensitization and asthma morbidity. Black-Right-Pointing-Pointer Children with asthma were tested for sensitivity to common indoor allergens. Black-Right-Pointing-Pointer Homes were sampled for these allergens and asthma morbidity monitored during the subsequent month. Black-Right-Pointing-Pointer Children exposed and sensitized to Penicillium, Der p, Fel d, Can f risk increased asthma morbidity. Black-Right-Pointing-Pointer These children might benefit from targeted intervention strategies.

  9. Discrete beta dose kernel matrices for nuclides applied in targeted radionuclide therapy (TRT) calculated with MCNP5

    SciTech Connect (OSTI)

    Reiner, Dora; Blaickner, Matthias; Rattay, Frank

    2009-11-15

    Purpose: Radiopharmaceuticals administered in targeted radionuclide therapy (TRT) rely to a great extent not only on beta-emitting nuclides but also on emitters of monoenergetic electrons. Recent advances like combined PET/CT devices, the consequential coregistration of both data, the concept of using beta couples for diagnosis and therapy, respectively, as well as the development of voxel models offer a great potential for developing TRT dose calculation systems similar to those available for external beam treatment planning. The deterministic algorithms in question for this task are based on the convolution of three-dimensional matrices, one representing the activity distribution and the other the dose point kernel. This study aims to report on three-dimensional kernel matrices for various nuclides used in TRT. Methods: The Monte Carlo code MCNP5 was used to calculate discrete dose kernels of beta particles including the contributions from their respective secondary radiation in soft tissue for the following nuclides: {sup 32}P, {sup 33}P, {sup 67}Cu, {sup 89}Sr, {sup 90}Y, {sup 103}Rh{sup m}, {sup 131}I, {sup 177}Lu, {sup 186}Re, and {sup 188}Re. For each nuclide a kernel cube of 10x10x10 mm{sup 3} was calculated, the dimensions of a voxel being 1 mm{sup 3}. Additional kernels with voxel sizes of 3x3x3 mm{sup 3} were simulated. Results: Comparison with the S-value data regarding {sup 32}P, {sup 89}Sr, {sup 90}Y, and {sup 131}I of the MIRD committee which were calculated with the EGS4 code showed a very good agreement, the secondary particle transport of {sup 90}Y being the only exception. Documented analytical kernels on the other side show deviations very close and very far to the source. Conclusions: The good accordance with the only discrete dose kernels published up to date justifies the method chosen. Together with the additional six nuclides, this report provides a considerable database for three-dimensional kernel matrices with regard to beta radionuclides applied in TRT. In contrast to analytical dose point kernels, the discrete kernels elude the problem of overestimation near the source and take energy depositions into account, which occur beyond the range of the continuous-slowing-down approximation (csda range). Recalculation of the 1x1x1 mm{sup 3} kernels to other dose kernels with varying voxel dimensions, cubic or noncubic, is shown to be easily manageable and thereby provides a resolution-independent system of dose calculation.

  10. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release

    DOE Public Access Gateway for Energy & Science Beta (PAGES Beta)

    Volkow, Nora D.; Wang, Gene-Jack; Smith, Lisa; Fowler, Joanna S.; Telang, Frank; Logan, Jean; Tomasi, Dardo

    2015-07-21

    Metamphetamine’s widepread abuse and concerns that it may increase Parkinson’s disease led us to assess if the reported loss of dopamine transporters (DAT) in methamphetamine abusers (MA) reflected damage to dopamine neurons. Using PET with [11C]cocaine to measure DAT, and with [11C]raclopride to measure dopamine release (assessed as changes in specific binding of [11C]raclopride between placebo and methylphenidate), which was used as marker of dopamine neuronal function, we show that MA (n=16), tested during early detoxification, had lower DAT (20-30%) but overall normal DA release in striatum (except for a small decrease in left putamen), when compared to controls (n=15).more » In controls, DAT were positively correlated with DA release (higher DAT associated with larger DA increases), consistent with DAT serving as markers of DA terminals. In contrast, MA showed a trend for a negative correlation (p=0.07) (higher DAT associated with lower DA increases), consistent with reduced DA re-uptake following DAT downregulation. MA who remained abstinent nine-months later (n=9) showed significant increases in DAT (20%) but methylphenidate-induced dopamine increases did not change. In contrast, in controls, DAT did not change when retested 9 months later but methylphenidate-induced dopamine increases in ventral striatum were reduced (p=0.05). Baseline D2/D3 receptors in caudate were lower in MA than in controls and did not change with detoxification, nor did they change in the controls upon retest. The loss of DAT in the MA, which was not associated with a concomitant reduction in dopamine release as would have been expected if DAT loss reflected DA terminal degneration; as well as the recovery of DAT after protracted detoxification, which was not associated with increased dopamine release as would have been expected if DAT increases reflected terminal regeneration, indicate that the loss of DAT in these MA does not reflect degeneration of dopamine terminals.« less

  11. CW/Pulsed H{sup ?} ion beam generation with PKU Cs-free 2.45 GHz microwave driven ion source

    SciTech Connect (OSTI)

    Peng, S. X. Ren, H. T.; Xu, Y.; Zhang, T.; Zhang, J. F.; Zhao, J.; Guo, Z. Y.; Zhang, A. L.; Chen, J. E.

    2015-04-08

    Circular accelerators used for positron emission tomography (PET, i.e. accelerator used for make radio isotopes) need several mA of CW H- ion beam for their routine operation. Other facilities, like Space Radio-Environment Simulate Assembly (SPRESA), require less than 10?mA pulsed mode H{sup ?} beam. Caesium free negative hydrogen ion source is a good choice for those facilities because of its compact structure, easy operation and low cost. Up to now, there is no H{sup ?} source able to produce very intense H{sup ?} beams with important variation of the duty factor{sup [1]}. Recently, a new version of 2.45?GHz microwave H{sup ?} ion source was designed at PKU, based on lessons learnt from the previous one. This non cesiated source is very compact thanks to its permanent magnet configuration. Special attention was paid on the design of the discharge chamber structure, electron dumping and extraction system. Source test to produce H{sup ?} ion beams in pulsed and CW mode was carried out on PKU ion source test bench. In CW mode, a 10.8?mA/30keV H{sup ?} beam with rms emittance about 0.16 ?mmmrad has been obtained with only 500?W rf power. The power efficiency reaches 21?mA/kW. In pulsed mode with duty factor of 10% (100Hz/1ms), this compact source can easily deliver 20?mA H{sup ?} ion beam at 35 keV with rms emittance about 0.2 ?mmmrad when RF power is set at 2.2 kW (peak power). Several hour successive running operation in both modes and totaling more than 200 hours proves its high quality. The outside dimension of this new H{sup ?} source body is ?116?mm 124?mm, and the entire H{sup ?} source infrastructure, including rf matching section, plasma chamber and extraction system, is ?310 180?mm. The high voltage region is limited with in a ?310?mm 230?mm diagram. Details are given in this paper.

  12. Radio-isotope production scale-up at the University of Wisconsin

    SciTech Connect (OSTI)

    Nickles, Robert Jerome

    2014-06-19

    Our intent has been to scale up our production capacity for a subset of the NSAC-I list of radioisotopes in jeopardy, so as to make a significant impact on the projected national needs for Cu-64, Zr-89, Y-86, Ga-66, Br-76, I-124 and other radioisotopes that offer promise as PET synthons. The work-flow and milestones in this project have been compressed into a single year (Aug 1, 2012- July 31, 2013). The grant budget was virtually dominated by the purchase of a pair of dual-mini-cells that have made the scale-up possible, now permitting the Curie-level processing of Cu-64 and Zr-89 with greatly reduced radiation exposure. Mile stones: 1. We doubled our production of Cu-64 and Zr-89 during the grant period, both for local use and out-bound distribution to ≈ 30 labs nationwide. This involved the dove-tailing of beam schedules of both our PETtrace and legacy RDS cyclotron. 2. Implemented improved chemical separation of Zr-89, Ga-66, Y-86 and Sc-44, with remote, semi-automated dissolution, trap-and-release separation under LabView control in the two dual-mini-cells provided by this DOE grant. A key advance was to fit the chemical stream with miniature radiation detectors to confirm the transfer operations. 3. Implemented improved shipping of radioisotopes (Cu-64, Zr-89, Tc-95m, and Ho-163) with approved DOT 7A boxes, with a much-improved FedEx shipping success compared to our previous steel drums. 4. Implemented broad range quantitative trace metal analysis, employing a new microwave plasma atomic emission spectrometer (Agilent 4200) capable of ppb sensitivity across the periodic table. This new instrument will prove essential in bringing our radiometals into FDA compliance needing CoA’s for translational research in clinical trials. 5. Expanded our capabilities in target fabrication, with the purchase of a programmable 1600 oC inert gas tube furnace for the smelting of binary alloy target materials. A similar effort makes use of our RF induction furnace, allowing small scale metallurgy with greater control. This alloy feedstock was then used to electroplate cyclotron targets with elevated melting temperatures capable of withstanding higher beam currents. 6. Finished the beam-line developments needed for the irradiation of low-melting target materials (Se and Ga) now being used for the production of Br-76, and radioactive germanium (68, 69, 71Ge). Our planned development of I-124 production has been deferred, given the wide access from commercial suppliers. The passing of these milestones has been the subject of the previous quarterly reports. These signature accomplishments were made possible by the DOE support, and have strengthened the infrastructure at the University of Wisconsin, provided the training ground for a very talented graduate research assistant (Mr. Valdovinos) and more than doubled our out-shipments of Cu-64 and Zr-89.